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Once thought of as unicellular organisms, it is now appreciated that bacteria 
can exist as multicellular collectives with emergent properties that distinguish 
them from their free-living planktonic forms. Biofilm formation is an example of 
such a multicellular behaviour which is widespread in the prokaryotic world. 
Biofilms can take diverse forms but this work focusses on the surface-attached 
biofilm formed by the organism Bacillus subtilis. This study explores the 
properties of the extracellular matrix which gives structure to the biofilm and 
protects the encased cells from a variety of environmental threats. 
The B. subtilis biofilm matrix is composed of exopolysaccharide (EPS) and the 
protein components BslA, TasA and TapA. TasA is a fibre forming protein which 
has been described in the literature as an amyloid-forming fibre, however, 
recent work contradicts this finding. The current work focusses on TapA (TasA 
anchoring/assembly protein; formerly YqxM) which is essential for the 
development of complex, structured biofilms. TapA has previously been 
described as a cell-wall associated protein needed for the formation of TasA 
fibres. TapA secretion has since been demonstrated to involve the action of the 
signal peptidase SipW with the tapA-sipW-tasA genes found together on the B. 
subtilis genome. 
Recent work from Erskine et al has demonstrated that TasA fibres (fTasA) form 
spontaneously in vitro (Erskine et al., 2018). The findings of this thesis 
determine that TapA is not needed for the ability of TasA fibres to restore 
structure when added ex vivo to a ΔtasA sinR mutant biofilm. Biochemical and 
genetic analysis of B. subtilis biofilms has led to the discovery that TapA is 
processed to a low molecular weight form in vivo and that this process is 
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dependent on the proteolytic activity of secreted proteases. Subsequently, it 
was found that a limited part of the N-terminus of the TapA protein is sufficient 
to restore rugosity to a ΔtapA mutant biofilm. Genetic analysis of the minimal 
functional unit identified key amino acids needed for the function of TapA, 
highlighting the importance of a potential β-strand secondary structure in the N-
terminus of TapA. Evidence is provided that SipW is not required for the ability 
of exoproteases to process TapA, suggestive that TapA secretion is not SipW-
dependent. Experimental evidence indicates that TapA could act as a 
chaperone facilitating the stability of TasA or as a peptide aiding the formation 
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1.1.  A brief history of multicellularity in prokaryotes 
In a Scientific American article of 1988 James A. Shapiro challenged the status 
quo in microbiology by suggesting that bacteria could be thought of as 
multicellular organisms (Shapiro, 1988). Until this point, bacteria had been 
described as unicellular autonomous organisms. It has been suggested that this 
paradigm was a consequence of the adoption of Koch’s postulates into medical 
microbiology more than a century before (Aguilar et al., 2007). Shapiro offered a 
new and important perspective drawing upon recent research detailing 
Chondromyces crocatus fruiting bodies, cyanobacterial filaments, the swarming 
behaviour of Proteus mirablis and the production of extracellular material by 
Pseudomonas putida. However, the appreciation that bacteria form multicellular 
structures was not in itself new. In 1877, the same year as Robert Koch 
published on Bacillus anthracis as the causative agent of anthrax, Ferdinand 
Cohn published hand drawings of multicellular aggregates of Bacillus subtilis 
(Cohn, 1877). It took a further 120 years before the study of B. subtilis 
aggregates, now known as biofilms, began to flourish. The term biofilm was not 
coined until 1978, by Bill Costerton (Chandki et al., 2011), but the first 
description of biofilms is attributed to Anton Von Leeuwenhoek in the 1600s. 
Leeuwenhoek is recognised as the first microbiologist and he used powerful 
microscopes, which he self-produced, to discover protists and bacteria which he 
called “animalcules”. In a letter in 1684, Leeuwenhoek described microscopic 
observations of “animals in the scurf of teeth” (Lane, 2015). Today dental 
plaque is one of the best studied examples of a biofilm. 
In the proceeding section I am going to summarise some of the major 
advancements in our understanding of bacterial multicellularity, including 
biofilms with a focus on B. subtilis. I will then review in detail the existing 
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understanding we have of the extracellular matrix which provides the structural 
complexity of the B. subtilis biofilm. Finally, I will outline the current model for 
how B. subtilis forms fibres in the biofilm with a focus on the role of the matrix 
protein TapA in this process. 
1.2. Multicellular behaviours exhibited by prokaryotes 
Bacteria can and do live as unicellular autonomous organisms but many 
species spend at least some time as part of complex multicellular communities 
and some have relinquished unicellular life completely. It is now appreciated 
that many of these communities contain multiple interacting microbial species 
(see section 1.3.3) (Claessen et al., 2014). Multicellularity was previously 
thought only to be the reserve of eukaryotes such as plants, metazoans, fungi 
and protists. However, a number of phenomena have been observed in 
prokaryotes which are indicative of a multicellular lifestyle. These include co-
ordinated motility behaviours, cell-cell adhesion, intercellular signalling, cell 
specialization, matrix production and the formation of complex structures such 
as biofilms and fruiting bodies. Examples of multicellularity include 
cyanobacteria such as Anabaena species which form filaments where cell-cell 
adhesion makes them look like “beads on a string” (Kumar et al., 2010) (Figure 
1A). A fascinating case are the multicellular magnetotactic prokaryotes (MMPs) 
(Figure 1B). MMPs swim as spherical aggregates of between 10 and 40 cells 
which inhabit aqueous environments. The MMPs have magnetic “organelles” 
called magnetosomes that are thought to help the MMPs to navigate through 
magnetic field lines in the water column, possibly in the search for nutrients 
(Keim et al., 2004b). Interestingly, the division of the entire structure is a 
concerted behaviour. The other manifestation of multicellular bacteria are 
aggregates and swarms. Swarms include bacteria such as Myxococcus xanthus 
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with its characteristic mode of motility and fruiting body formation (Claessen et 
al., 2014). Finally, aggregates include examples of some of the earliest forms of 
life on Earth.    
1.2.1. The origins of multicellularity 
Multicellularity has arisen independently in each kingdom of life and the earliest 
fossil evidence for life is found in the form of multicellular communities of 
prokaryotes (Grosberg and Strathmann, 2007; Kaiser, 2001). A 2016 
publication from Nutman et al provided evidence for life forms in 3.7 billion year 
old structures interpreted to be stromatolites (Nutman et al., 2016). 
Stromatolites are multi-layered sheets known as microbial mats (normally found 
in aqueous environments). These mats are thought to be made up of 
aggregates of photosynthetic organisms, as they are in contemporaneous 
formations found in Shark Bay, Australia. The concept of aggregates describes 
cells held together by cell-to-cell contacts both in surface attached communities 
known as biofilms (Figure 1C) and mobile biofilms, also known as flocs, where 
there is cell-to-cell contact but no surface attachment (Figure 1D) (Flemming et 
al., 2016). It is thought that for microbes, in a natural setting, the biofilm lifestyle 
is the rule rather than the exception (Hobley et al., 2015). Although much of the 
focus has been on bacterial biofilms both archaeal and eukaryotic biofilms have 
been observed (Aguilera et al., 2007; Fröls, 2013).  
There is often a distinction made in the literature between complex/true 
multicellular organisms such as the metazoa and plants and the type of 
multicellularity exhibited by prokaryotes. It is speculated that prokaryotic cells 
are by their nature energetically limited and would not, in their present form, 
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lead to the evolution of “complex life” such as is seen in the animal and plant 
worlds (Lane and Martin, 2010). 
 
Figure 1: General classes of multicellular bacteria. (A) Filaments formed by the vegetative 
cells of the cyanobacterial species Anabaena cylindrical contain differentiated heterocyst cells 
specialised for Nitrogen fixation. Cyanobacteria also form cells called akinetes which are thick-
walled, dormant cells. (B) Multicellular magnetotactic prokaryotes (MMPs) exist as 
conglomerates with an acellular central compartment around which the cells are arranged. 
Individual cells contain magnetic iron sulphur crystals. Subcellular structures depicted as dark 
spheres are thought to be lipid or polyhydroxyalkanoate inclusions (Keim et al., 2004a). In terms 
of bacterial aggregation, this may be in the form of (C) surface-attached communities or (D) 
floating ‘flocs’, both are examples of biofilms found in natural settings often in aqueous 
environments as depicted here.  
 
1.2.2. The benefits of multicellular lifestyles 
There are many benefits that multicellularity conveys that are not available to 
unicellular organisms. This includes increased size, which may help guard 
against grazing by predatory microorganisms. As an example, it has been 
shown using a microbial evolution experiment that the eukaryotic algae 
Chlamydomonas reinhardtii developed multicellular structures in response to 
the predatory ciliate Paramecium tetraurelia (Herron et al., 2018). Other benefits 
include the co-ordination of cell behaviour by intercellular signalling and cell 
differentiation where specialisation of cells for particular functions can result in a 
division of labour and the motility of cells en masse.  
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1.2.3. Cell-cell adhesion 
In multicellular communities, cells can be strongly adhered to each other such 
as in cyanobacterial filaments, or by fimbrae known as the “attachment pilus” 
found in Gram-negative and Gram-positive bacteria. Otherwise cells can 
interact by cell-cell interactions mediated by specific receptors and cognate 
ligands or non-specific molecular forces such as hydrogen bonding and van der 
waals forces (Dufrêne, 2015). A special example of bacterial adhesion is by the 
common association of a shared “glue” such as the case in the extracellular 
polymeric matrix produced by biofilm forming bacteria. Some bacteria such as 
Streptomyces species even resemble fungi in that they produce filamentous, 
syncytial cells where the branched mycelia contain compartments, which may 
have multiple chromosomes, divided along the filament by cross walls 
(Claessen et al., 2014). 
1.2.4. Bacterial communication systems 
Bacteria can signal between cells of the same species (intraspecies) and with 
cells of other species (interspecies) signalling. Quorum sensing systems have 
been demonstrated within and between species of bacteria. Fuqua et al coined 
the term quorum sensing in a landmark review paper of 1994 (Fuqua et al., 
1994). The name is derived due to the fact that behaviours regulated by quorum 
systems are only possible with a bacterial population of a sufficient size. Cell-
density-dependent processes are regulated by auto-inducers which in Gram-
negative bacteria tend to involve acyl homoserine lactones (AHL). Processes 
regulated by these systems include the production of light by Vibrio fischeri and 
Vibrio harveyi , where quorum sensing was first observed nearly 40 years ago 
(Nealson and Hastings, 1979) and virulence factor regulation in Pseudomonas 
aeruginosa amongst many others. Since this time many other types of quorum 
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sensing molecules have been discovered. In Gram-positive bacteria quorum 
sensing can be regulated by auto-inducing peptide (AIP) systems such as the 
regulation of genetic competence in B. subtilis and Streptococcus pneumoniae 
(possibly the earliest hint of quorum sensing on record) (Tomasz, 1965). To 
date quorum sensing systems have been implicated in the control of diverse 
processes such as antibiotic synthesis, exo-enzyme production and the 
regulation of  virulence in human and plant pathogens (Whiteley et al., 2017).  
1.2.5. Co-ordinated movement of bacteria en masse 
Bacterial motility can be thought of as conveying the ability of single cells (or 
multicellular communities) to either avoid dangers such as toxins, predation, the 
immune system or to aid in survival and/or the acquisition of nutrients. In the 
case of MMPs, each cell in the structure has its own flagellum which may be co-
ordinated to facilitate movement of the whole organism (Keim et al., 2004a). 
However, MMPs are a rather special case and bacterial motility can typically be 
thought of in terms of 5 common modes of movement: swimming, swarming, 
sliding, gliding and twitching,  defined by Jørgen Henrichsen in 1972  
(Henrichsen, 1972; Shrout, 2015). First of all, the concept of a swarm i.e. “to 
move about in great numbers” is important for understanding motility (Kearns, 
2010). The predatory multicellular bacteria Myxococcus xanthus moves as 
swarms of cells in concentric ripples towards prey bacteria and it is now thought 
that this movement is driven mainly by growth rather than chemotaxis (Kaiser 
and Warrick, 2011). We can use the general term “swarm” to describe this type 
of cell movement en masse. However, the term “swarming” motility specifically 
refers to cell movement dependent on the rotation of flagella and in this context 
M. xanthus does not display swarming motility. Flagella-dependent movement 
when occurring in liquid is called swimming motility and it is termed swarming 
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motility when it is on a surface. In the case of twitching motility this is a slow, 
jerky “twitching” movement of cells generated by type IV pili which extend and 
contract (Mattick, 2002). Twitching motility is displayed predominantly by Gram-
negative bacteria such as Pseudomonas aeruginosa and Vibrio cholera 
(Mattick, 2002). Myxococcus xanthus has type IV pili and twitching is one form 
of motility that contributes to its “swarming behaviour” with the other being 
gliding (Sliusarenko et al., 2007). In gliding motility, cells move in the direction of 
the long axis of the cell without the aid of appendages such as pili, fimbrae or 
flagellum. However, gliding may involve the action of adhesins which 
temporarily bind to the surface to propel the cells forward in conjunction with the 
action of bacterial cytoskeletal components or motors. In Myxococcus xanthus 
gliding is aided by the production of a polysaccharide “slime” that may lubricate 
the area surrounding the cell (Jarrell and McBride, 2008). Sliding, like gliding, is 
another example of appendage-independent motility. Sliding is dependent on 
the surface activity of biomolecules self-produced by bacteria allowing them to 
move passively from an initial point of inoculation (Shrout, 2015).  
1.2.6. Cell differentiation 
Cyanobacterial filaments, such as those of Anabaena cylcindrica, are made up 
of photosynthetic vegetative cells and specialised heterocysts (Figure 1A) 
(Claessen et al., 2014). The heterocysts do not carry out oxygenic 
photosynthesis, as they are differentiated to exclude oxygen by a number of 
physiological adaptations to protect the oxygen-sensitive process of nitrogen 
fixation which they carry out (Claessen et al., 2014). Additionally, cyanobacterial 
filaments are often found to contain akinetes (Claessen et al., 2014). Akinetes 
are thick-walled cells which are resistant to cold temperatures and dessication 
and develop in response to nutrient limitation. Another example of cell 
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differentiation in a prokaryote is the asymmetric cell division of Caulobacter 
crescentus (Hughes et al., 2012). This process gives rise to a non-motile 
stalked cell, which has a holdfast to adhere to a surface, and a “swarmer cell” 
with a single flagellum (Kearns, 2010; Skerker and Laub, 2004). Many bacteria,  
including Bacillus species and Clostridium species, develop endospores which 
are triggered by nutrient starvation. They are not true “spores”, as they are not 
offspring as such, but they are highly resistant to a number of stresses and 
confer survivability in difficult circumstances (McKenney et al., 2012). 
Historically, these classic examples of bacterial cell differentiation could be 
determined because of the gross morphological changes that were easily 
observed. In the last 30 years with the development of more advanced 
molecular biology techniques we can now look at more subtle changes in gene 
expression within specific populations of cells. This has shed light on the variety 
of different roles specialised cells can play. This will be expored in more detail in 
the context of B. subtilis in section 1.5.1. 
To summarise, there have been many advances in understanding the ways in 
which prokaryotic cells, specifically bacteria, can exhibit behaviours once 
thought to be the reserve of complex eukaryotes. It has now been shown that 
bacteria can exhibit specific cell developmental pathways, motility, cell-cell 
signalling and adhesion. The next section will address the bacterial biofilm as 
an example of a multicellular community. Biofilms, widespread in nature, can be 




1.3. Bacterial biofilms 
A biofilm is a complex community of cells which are held together and encased 
in a self-made extracellular polymeric matrix which can be comprised of protein, 
polysaccharide, lipids and extracellular DNA (eDNA) (Cairns et al., 2014). The 
concept of the biofilm matrix can be traced back in the literature to 1935 (Zobell 
and Allen, 1935). The authors submerged microscope slides in situ from the 
pier at the Scripps institute in California and they quickly became covered with 
marine bacteria. They speculated that the bacteria formed a “mucilaginous 
surface” which could form as an attachment point for the planktonic stage of 
biofouling eukaryotes which attach to ship hulls and submerged man-made 
structures. Since then it has been thoroughly demonstrated that cells within a 
biofilm exhibit distinct properties from planktonic forms (Hall-Stoodley et al., 
2004).  
1.3.1. The societal importance of understanding biofilms 
It has been reported by the World Economic Forum in their publication Global 
Risks that antimicrobial resistant infections are a major threat to global health 
(Blair et al., 2014). Biofilm formation contributes to the antimicrobial tolerance of 
infections (Van Acker et al., 2014). They can form on medical devices including 
prosthetic implants used in orthopaedics such as those used in hip 
replacements and intravascular/urinary catheters (Francolini and Donelli, 2010). 
Pioneering work in the 1980s looked into the role that biofilm formation played 
in the context of cystic fibrosis-associated respiratory infections caused by 
Pseudomonas aeruginosa (Lam et al., 1980). There is now great interest into 
the role that biofilm formation plays in the pathogenic lifestyle of many 
pathogens such as Listeria monocytogenes, Enterohaemorragic E. coli, 
Salmonella and many others. For these reasons, the development of specific 
11 
 
therapeutics which can disrupt or prevent biofilm formation is now an active 
area of research (Koo et al., 2017b). 
In terms of industrial applications, biofilms have long been utilized for their 
ability to help process wastewater. By attaching to nutrients and pollutants 
biofilm-associated microorganisms in wastewater settle out as sludge which can 
then be removed, a critical step in generating clean drinking water for human 
populations (Sehar and Naz, 2016). However, biofilms can also incur economic 
and health costs by attaching to the surface of pipes transporting clean drinking 
water risking contamination and damage to the pipes (LeChevallier et al., 1987). 
Biofilms can be engineered to modify their properties for use in a range of 
applications, for example, to increase their efficacy in processing wastewater, to 
build industrially valuable nanomaterials and in the production of renewable 
energy (Feng et al., 2013; Nguyen, 2017; Wang and Chen, 2009). In many 
cases, these properties of interest are conveyed by the extracellular polymeric 
matrix of the biofilm.  
1.3.2. The properties of the biofilm matrix 
The energetic costs of producing the matrix is considerable (Saville et al., 2011) 
so what are the benefits of making these often high-molecular weight products?  
The selective advantage of a biofilm lifestyle is that biofilms display a number of 
‘emergent properties’ (Flemming et al., 2016), in other words, specific properties 
emerge when bacteria exist as collectives which individual cells do not possess. 
Matrix production plays a key role in conveying some of these special features, 
providing structure and stability to the biofilm. Some of the matrix functions 
discussed in this section are summarised in Figure 2. Other emergent features 
of the biofilm lifestyle include cell specialisation, cells exisiting in distinct 
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physiological states, motility and regulated cell death. These concepts will be 
discussed in more detail in section 1.5.1 in the context of B. subtilis. 
 
Figure 2: The composition and functions of the biofilm matrix. The biofilm matrix may be 
composed of exopolysaccharides, proteins, eDNA and lipids. These biopolymers convey 
structural integrity to the biofilm but can also be important in the acquisition of nutrients and 
metal ions. Additionally, the matrix can have digestive capacity by the production and retention 
of a host of degradative enzymes. Quorum sensing molecules have been found to accumulate 
in the matrix. The matrix displays a number of concentration gradients of cell-cell signalling 
molecules, nutrients and oxygen which contribute to the heterogeneity of the biofilm 
environment. The concentration of oxygen and nutrients may become limited in deeper, 
anaerobic regions of the biofilm towards the substrate.   
 
Matrix components aid in the attachment of cells to surfaces and to each other, 
forming a 3-dimensional network of polymers that connects cells within the 
biofilm (Flemming and Wingender, 2010). In this way, the matrix can be thought 
of as glue that shields the biofilm cells. The different extracellular matrix (ECM) 
components within the biofilm interact by a number of weak interactions with 
electrostatic interactions and hydrogen bonding being thought to dominate. This 
was determined by using the exopolysaccharide of Pseudomonas aeruginosa 
as a model system (Mayer et al., 1999). The interactions between matrix 
components means that most biofilms display viscoelastic properties (Flemming 
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and Wingender, 2010). Elasticity is the capacity of a material to return to its 
original shape and size when stretched or compressed. Viscoelastic materials 
display elastic properties but also have a viscosity component which can be 
thought of as “resistance to flow” where a large resistance to flow would be a 
fluid such as honey by comparison with the low resistance to flow exhibited by 
water. Under compression P. aeruginosa biofilms displayed elastic properties 
until a break point was achieved after which the biofilm adopts the properties of 
a viscous fluid (Flemming and Wingender, 2010).  
The matrix also helps in resource acquisition by sequestering nutrients and 
storing water (as much as 97% of the matrix can be water) (Flemming et al., 
2016). By retaining water the matrix conveys tolerance to dessication. The 
physicochemical properties of the matrix also allows for the retention of 
extracellular enzymes which conveys digestive properties to the matrix 
(Flemming et al., 2016). Enzymes found in extracellular environments (isolated 
from marine, freshwater and wastewater sludge) can break down a range of 
biopolymers including proteins, polysaccharides, nucleic acids and lipids 
(Flemming and Wingender, 2010). The function of these enzymes may be to; 
release carbon and energy from larger molecules; aid in cell detachment from 
the biofilm or as virulence factors important during the infection process of 
clinically relevant pathogens (Flemming and Wingender, 2010). Interestingly, 
the biofilm matrix may even protect against the effect of freeze-thaw cycles on 
marine bacteria isolated from Antarctic environments. A Pseudoalteromonas 
strain was found to secrete a manan-exopolysaccharide which acted as a cryo- 
and haloprotective substance (Liu et al., 2013).  
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The sorptive properties of the biofilm matrix can serve to bind and concentrate 
metal ions. Exopolymeric substances, produced by cyanobacterial, found in 
stromatolites sequester Ca2+ and Mg2+ ions from the surrounding seawater 
(Decho et al., 2005). In some cases calcium has been found to bridge 
exopolymeric substances to increase biofilm stiffness (Körstgens et al., 2001). 
For example, it was found that calcium acts by crosslinking the polysaccharide 
alginate which is one of the main components of the biofilm matrix in the mucoid 
SG81 strain of Pseudomonas aeruginosa (Körstgens et al., 2001). The sorptive 
properties of biofilms extend also to toxic compounds. It was found that the 
exopolymeric substances of biofilms and aggregates used in wastewater 
treatment can bind to erythromycin and acetaminophen (Métivier et al., 2013).  
It has long been known that biofilms demonstrate an increased tolerance to 
antimicrobials by comparison with planktonic forms of bacteria (Stewart and 
William Costerton, 2001). The matrix is one of the components which is thought 
to contribute to these properties. The biofilm matrix may form a diffusion barrier 
to antibiotic penetration. This is a controversial view which continues to be 
debated (Van Acker et al., 2014). It has been demonstrated that aminoglycoside 
antibiotics bind to alginate in alginate-producing strains of P. aeruginosa and 
this impedes their penetration through the matrix (Gordon et al., 1988). In 
contrast, β-lactam antibiotics did not bind to alginate and penetrated faster 
(Gordon et al., 1988; Gordon et al., 1991; Nichols et al., 1989). Other 
polysaccharides of P. aeruginosa are thought to interact with antibiotics (Van 
Acker et al., 2014). The matrix also provides a barrier to the diffusion of 
disinfectants (Bridier et al., 2011) and to toxic metals. For example, matrix 
polyssacharides found in Erwinia amylovora biofilms complexed with copper to 
protect against copper stress (Ordax et al., 2010). Due to some of the findings 
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discussed above the targeted breakdown of the biofilm matrix is now being 
explored as an approach to aid in the treatment of biofilm based infections and 
the cleaning of surfaces in hospital environments to remove potential 
pathogens. 
Biofilms can also facilitate intraspecies and interspecies signalling between cells 
by increasing the localized concentration of chemical signals. It has been found 
that the concentration of quorum sensing molecules such as acyl homoserine 
lactones (AHL) can be up to 1,000 fold higher within biofilms by comparison 
with environments occupied by free-living cells (Charlton et al., 2000; Hense et 
al., 2007). It has been shown that the Fap fibrils of P. aeruginosa biofilms bind 
to quorum sensing molecules and this is thought to play a role in determining 
the localised concentration of signalling molecules within the matrix (Seviour et 
al., 2015). 
High cell density, the presence of extracellular DNA (eDNA), and the increased 
level of competence may all contribute to the exchange of genetic material 
within biofilms (Madsen et al., 2012). The role of eDNA has been established in 
the biofilms of a number of species. By treating biofilms at different stages with 
DNase to degrade extracellular DNA it has been shown that eDNA seems to be 
important for the structure of immature biofilms. The biofilms of S. epidermidis 
(Qin et al., 2007), V. cholerae (Seper et al., 2011)  and P. aeruginosa 
(Whitchurch et al., 2002) can be disrupted by DNase treatment but the 
effectiveness of this declines as the biofilm ages. It is thought that the structural 
role of eDNA is adopted by other matrix components later in development 
(Okshevsky et al., 2015). The function of eDNA is thought to be mainly 
structural, acting as an attachment point for cells and other matrix components, 
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additionally, there is now interest in the conductive role of eDNA in transferring 
electrons through the biofilm (Das et al., 2013). Finally, in some cases it has 
been shown that DNA can serve to prevent aggregation and attachment. In the 
case of the marine microorganism Phaeobacter inhibens it is thought that this 
process allows cells to leave a hostile habitat which is causing the lysis of 
siblings (Segev et al., 2015). 
1.3.3. Biofilms in nature exist as multispecies communities 
Much of what is known regarding the biofilm matrix is a result of studies using 
single-species model systems to study specific matrix components. Historically, 
the characterisation of microbial communities was dependent upon culture, 
microscopic and PCR based methods. However, advancements in culture-
independent approaches has led to the discovery and detection of diverse 
microbial species that previously went unnoticed. Approaches such as high-
throughput next generation sequencing platforms like Illumina allow for a more 
detailed description of microbial community composition and has led to the ever 
greater appreciation of the polymicrobial nature of biofilm communities and 
microbial communities generally (Wolcott et al., 2013). Dental plaque is a 
classical example of a multi-species biofilm consisting of hundreds of different 
species including bacteria and yeasts like the biofilm-forming Candida albicans 
(Ereshefsky and Pedroso, 2015).  
As the complexity of our understanding of natural biofilms increases much 
remains to be understood about the diverse processes at play within these 
living structures. For this purpose, monospecies biofilms produced by 
organisms such as B. subtilis are a mainstay in research. The study of B. 
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subtilis has led to a clearer understanding of the broad principles governing 
biofilm formation and informs the development of biofilm-specific therapeutics. 
1.4. General introduction to B. subtilis 
Bacillus is a genus of rod-shaped, Gram-positive bacteria found within the 
phylum Firmicutes. Bacillus species include pathogens of humans and animals 
such as Bacillus anthracis, the causative agent of anthrax (Moayeri et al., 
2015), and Bacillus cereus which causes food poisoning in humans often after 
the consumption of rice dishes (Bottone, 2010). Once cooked, rice which has 
been kept at room temperature for prolonged periods of time carries an 
increased risk of causing foodbourne illness. This is due to the formation of 
endospores by B. cereus which are resistant to killing during the boiling of rice 
and which can then germinate in prepared rice. The formation of resistant, 
dormant endospores in response to nutritional and environmental stress is a 
common feature of Bacillus species (Earl et al., 2008). B. subtilis is non-
pathogenic and for this reason has served as a model organism for studying 
Bacillus species. 
B. subtilis is a mesophilic organism (with optimal growth temperatures in the 
moderate range of 30-37oC). This likely places B. subtilis in the very top layer of 
soil, the O layer, which is the organic matter layer and the A layer, just 
underneath, known as the surface soil with the most accumulated organic 
matter (Hillel and Hatfield, 2005). B. subtilis produces a positive result in the 
catalase test indicating that it can inhabit an oxygenated environment 
(O'Donnell et al., 1980), the catalase enzyme is required to convert the toxic 
oxygen metabolite, hydrogen peroxide (H2O2), to oxygen and water. When key 
nutrients such as carbon, phosphorus or nitrogen become limited then B. 
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subtilis will produce resistant endospores (Chubukov and Sauer, 2014). B. 
subtilis has been isolated from a range of plants and is found in greater 
abundance than other spore forming bacteria in the rhizosphere of plants (Earl 
et al., 2008). The species B. subtilis is found ubiquitously in the soil environment 
across the globe from the Mojave dessert to more temperate climes (Roberts 
and Cohan, 1995). Due to its genetic tractability and ease of cultivation B. 
subtilis has become a model organism for understanding Bacillus species and 
the Firmicutes more broadly. B. subtilis has become the archetypal model 
organism to elucidate fundamental properties of Gram-positive bacteria. For this 
reason a host of genetic and computational tools (Mäder et al., 2011; Michna et 
al., 2013) have been available for a significant length of time. The B. subtilis 168 
strain was one of the earliest bacterial genomes to be sequenced (Kunst et al., 
1997).  
1.4.1. B. subtilis use in biotechnology  
B. subtilis species are known to produce a host of antifungal and antibacterial 
compounds with an estimated 4-5% of a typical B. subtilis genome being 
devoted to antibiotic production (Stein, 2005). For example, B. subtilis produces 
a surfactant known as surfactin which is a cyclic lipopeptide with antimicrobial 
properties (Schor et al., 2016). Across the many hundreds of B. subtilis isolates 
obtained, there are upwards of 24 different antibiotics discovered (Stein, 2005). 
Antibiotics produced by Bacillus species that have been utilised in medical 
treatments include gramycidin S, bacitracin, polymyxin and tyrotricidin (Yilmaz 
et al., 2006). 
B. subtilis has been shown to promote plant growth and this can be dependent 
on biofilm formation (Bais et al., 2004). There are now a number of studies 
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which have investigated B. subtilis biofilm formation in the context of plant roots 
(Beauregard et al., 2013; Chen et al., 2012; Chen et al., 2013). The growth 
promoting effects may also be due to the elicitation by the bacterium of induced 
systemic resistance in plants (Kloepper et al., 2004) and production of toxic 
compounds which may exclude pathogen growth (Nagórska et al., 2007). 
Naturally occurring Bacillus strains have been utilized for their bactericidal and 
fungicidal properties to prevent diseases of food crops such as blight and scab.  
One approach is to apply bacteria-containing formulations as seed treatments 
or sprays directly onto plants. It is thought that the biocontrol properties could 
arise from competition with pathogens for nutrients or attachment sites within 
the plant niche or by the production of antibacterial and antifungal compounds.  
As B. subtilis is naturally competent, genetically amenable and a prolific 
secretor of enzymes, its use in biotechnology applications is widespread and of 
great economic importance (van Dijl and Hecker, 2013). Bacillus species have 
great fermentation properties and can produce high yields of proteins and 
vitamins (Nicolas et al., 2012). They have the additional benefit of not producing 
significant toxic products. Applications of alkaline proteases originating from B. 
subtilis include their use as: components of detergent formulations and in the 
production of biomass from natural waste (Anwar and Saleemuddin, 1998). 
These enzymes have broad protease activity often replacing expensive and 
environmentally harmful chemicals in these processes. Subtilisin encoded by 
the gene aprE and other Bacillus proteases have been included in commercial 
laundry detergents and the industry continues to explore protein variants 
selecting for the ideal properties for specific applications (Anwar and 
Saleemuddin, 1998). B. subtilis also produces lipases and amylases which in 
addition to proteases aid in the breakdown of complex biological material in the 
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process of wastewater treatment. A number of B. subtilis products are approved 
for use as additives in food products already available. B. subtilis grown on 
cane molasses has been shown to produce polyhydroxyalkanoates (PHAs). 
The PHAs serve as a carbon/energy store for the bacteria that produce them.  
Interestingly, PHAs can be converted into bioplastics. Due to their 
biodegradability these are an exciting, renewable alternative to existing plastics 
(Lu et al., 2009). The B. subtilis var. natto is used to ferment soybeans into the 
“stringy” Japanese delicacy of natto. B. subtilis alongside other Bacillus species 
have been detected in the faeces and ileal biopsies of human volunteers 
(Fakhry et al., 2008) and B. subtilis is also approved as a dietary probiotic 
(Elshaghabee et al., 2017). It is taken in the spore form which is thought to help 
survival through the harsh environment of the gastro-intestinal tract such as in 
the highly acidic stomach environment. Due to the survivability of spores their 
utility as a vehicle for vaccine antigen presentation in the host has been 
explored (Duc et al., 2003). Like most probiotics there remains controversy as 
to the actual health benefits of consumption but a mechanism has been 
proposed where B. subtilis can antagonise the growth of pathogens through the 





1.5. Studying the B. subtilis biofilm 
B. subtilis biofilms in the laboratory are typically grown such that they are 
composed of a genetically identical (isogenic) population of bacterial cells. On 
agar, the biofilms form at the air-surface interface (Figure 3A), and in liquid, the 
bacteria form a pellicle biofilm at the liquid-air interface (Figure 3B). There are a 
number of different media which are known to promote biofilm formation such 
as E medium, 2x SGG (a rich medium) and MSgg (Minimal Salts glycerol 
glutamate), although the mechanism by which biofilm formation is achieved is 
not well understood (Shemesh and Chai, 2013). Recently, it was found that the 
presence of glycerol and manganese could facilitate the development of 
biofilms and pellicles in a modified LB (lysogeny broth) (Shemesh and Chai, 
2013). This indicates that the presence of glycerol and manganese as 
components in MSgg medium may be a key factor in the ability of this medium 
to promote biofilm formation. 
It was shown that “domesticated” laboratory strains of B. subtilis: 168, PY79 and 
JH642, do not typically form structured pellicles in MSgg media (Branda et al., 
2001). However, a more recent study compared 168 stocks originating from 
multiple laboratories and found that while some were unable to form complex 
colonies others developed robust biofilm structures (Gallegos-Monterrosa et al., 
2016). Additionally, it was found that the soil bacterium Lysinibacillus fusiformis 
M5 can induce wrinkle formation, in strain 168, via the production of a diffusible 
signalling molecule (hyopoxanthine) (Gallegos-Monterrosa et al., 2017). For the 
most part, the study of biofilm formation utilizes “undomesticated” natural 
isolates which form highly structured pellicles with a “vein-like appearance”. 
When spotted onto semi-solid MSgg agar plates, the natural isolates form 
colonies with a rugose architecture (Branda et al., 2001). This includes the B. 
22 
 
subtilis strain denoted NCIB3610 (Genome accession number: NZ_CM000488), 
previously known as “Marburg”. Details of the isolation of this strain remain 
mysterious and were first reported in 1930 (Conn, 1930). Strain 168 is a 
genetically competent derivative of parental strain NCIB3610 generated from x-
ray or ultra-violet (UV) light mutagenesis (Zeigler et al., 2008). Strain PY79 is 
related to 168 with both strains sharing a more recent common ancestor than 
the parental NCIB3610 strain. 
 
Figure 3: Biofilm formation as displayed by the wild-type undomesticated B. subtilis 
strain NCIB3610. (A) This image demonstrates the “wrinkled” morphology of colonies grown on 
MSgg agar plates, at an surface-air interface. (B) An image of a pellicle, NCIB3610 displays a 
rugose structure as it grows in MSgg broth, in this case at an air-liquid interface. Thanks to Elliot 
Erskine for kindly providing this pellicle image. Scale bar = 0.5 cm. 
1.5.1. Biofilms as complex microbial communities 
Despite the isogenic nature of B. subtilis biofilms, studied in laboratory 
conditions, there are a striking range of gene expression profiles on display 
within the structure (Lopez et al., 2009). This is testament to the behavioural 
plasticity of B. subtilis and alludes to the diversity of microenvironments that 
defined cell populations can find themselves in. This is generated by differences 
in nutrient availability, oxygen gradients, signal concentrations, proximity to the 
surface and other cells. These variables are dynamic, changing through space 
and time (spatio-temporal) with biofilm formation seemingly following a pre-
determined genetically encoded program. Although whether this qualifies as 
“microbial development” in a process analogous to development in higher 
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organisms remains contentious (Monds and O’Toole, 2009). The variety of 
behaviours exhibited within the B. subtilis biofilm are summarised in Figure 4, 
and I will discuss these in more detail in the following section. 
 
Figure 4: Bacillus subtilils biofilms display cells with multiple different gene expression 
profiles leading to specialization. Sporulating cells are localized at the top of aerial 
projections. It has been demonstrated that matrix producing cells and exoprotease producing 
cells form separate populations which are not mutually exclusive as matrix cells have the 
potential to become exoprotease producers and vice versa. Motility within the biofilm is 
dependent on motile cells which display surface flagella leading to swarming motility. 
Additionally, surfactin producing cells allow for the movement of cells by sliding motility. 
Cannibal cells produce toxins which results in the killing of siblings to release nutrients and 
delays entry into the energetically expensive process of sporulation. This figure is adapted from 
(Mielich-Süss and Lopez, 2015). 
1.5.2. Sporulating cells 
The heterogeneous organisation of cell phenotypes in the biofilm was 
demonstrated clearly when it was discovered that endospore formation was 
developmentally regulated within the B. subtilis NCIB3610 biofilm (Branda et al., 
2001). The authors generated a construct of the spore-associated gene sspE 
fused to lacZ and this was integrated into the genome. The resulting strain was 
then grown on MSgg agar containing X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside). In this way, the authors could locate cells within the biofilm 
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which were expressing sporulation genes. Sporulating cells turned blue 
because lacZ encodes a β-galactosidase that breaks down X-gal to produce a 
blue pigment. These cells were found to be localised at the top of aerial 
projections of NCIB3610 pellicles (Figure 5). In this same publication, the 
authors discovered that mutants lacking the spo0A gene, which encodes the 
key transcriptional regulator governing entry into sporulation, could no longer 
form biofilms with wild-type structural complexity (Branda et al., 2001). 
 
Figure 5: Sporulation genes are expressed in cells localized to the tips of aerial 
projections of B. subtilis NCIB3610 pellicle biofilms. The sporulation gene sspE was fused 
to the lacZ gene and this construct was integrated into the genome to create a reporter strain. 
The lacZ gene encodes a β-galactosidase which breaks down X-gal present in the medium to 
produce a blue compound. In this case, the blue compound is observed under conditions in 
which the sspE gene, and thus lacZ, is expressed. This image is reproduced from published 
work (Branda et al., 2001). Scale bar = 50 µM. 
1.5.3. A complex regulatory network controls matrix production 
Much light has now been shed on the complex regulatory pathways that control 
biofilm formation in B. subtilis. Since matrix production is an energetically 
expensive process it is controlled by a tightly regulated genetic program. 
Specifically, SinR is known as a “master” regulator of biofilm formation 
functioning as a negative transcriptional regulator of the matrix genes tapA-
sipW-tasA and the eps operon (Chu et al., 2006; Kearns et al., 2005). SinR 
function is in turn antagonised by the action of SinI (Kearns et al., 2005). In 
brief, when there is a low-level of Spo0A phosphorylation it can activate the 
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expression of sinI, the SinI protein then sequesters SinR relieving the inhibition 
of matrix gene expression (Figure 6A). Moreover, there is a double-negative 
feedback loop involving the slrR gene, and the SlrR and SinR proteins 
(Vlamakis et al., 2013). When SlrR levels are low, SinR represses both matrix 
gene and slrR expression. However, when SlrR levels are high it sequesters 
SinR in a complex which relieves the inhibition of matrix gene expression and of 
slrR expression (Chu et al., 2008) (Figure 6A). For these reasons, the low-SlrR 
and high-SlrR states are self-reinforcing. Finally, another pleiotropic regulator 
called AbrB was found to negatively regulate the tapA-sipw-tasA operon (Stöver 
and Driks, 1999a), in addition to repressing the eps operon (Chu et al., 2008) 
and bslA (Verhamme et al., 2009). An intricate signalling network is found 
upstream of these interactions adding further complexity to the regulation of 
biofilm formation. There are a number of environmental signals which can 
influence the phosphorylation status of Spo0A with 5 distinct sensor kinases 
inputting phosphate into the phosphorelay system upstream of Spo0A (Aguilar 




Figure 6: There is a complex regulatory network which controls the expression of the 
biofilm matrix genes. (A) A number of environmental signals including the presence of 
surfactin, glycerol, manganese and L-malic acid are detected by the Kin family of two-
component systems. Activation of these systems results in the phosphorylation of downstream 
targets ultimately influencing the level of Spo0A phosphorylation which is a response regulator 
controlling the expression of genes whose gene products are involved in matrix operon 
expression levels. A low-level of Spo0A phosphorylation results in matrix production whereas 
high-levels are linked to sporulation. The Rap family of protein phosphatases regulate the 
phosphorylation levels of Spo0B and Spo0F response regulators. Additionally, there are many 
other components feeding into this pathway that are not shown. This figure is adapted from 
(Mielich-Süss and Lopez, 2015). (B) The matrix operon or tapA operon is composed of the 
genes tapA-sipW-tasA with tapA promoter (arrow) driving expression and a putative promoter 
internal to the sipW gene giving additional control of tasA expression. Transcriptional 
terminators (lollipop) were predicted using the ARNold online server (see supplemental Figure 
S6). (C) The presence of an internal promoter within the sipW coding region is inferred by the 
increased level of tasA transcript levels, with respect to tapA and sipW, as shown by global 
transcriptome analysis of B. subtilis (Nicolas et al., 2012). The tapA operon is shown in black 
and the transcriptional units are shown in red, below which the transcription profile of each gene 
is shown for B. subtilis grown in a number of different conditions (represented by differentially 
coloured lines).  
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1.5.4. The expression of the tapA operon is bistable 
The tapA gene is present in the tapA-sipW-tasA operon (Figure 6B and Figure 
6C). Many studies have used transcriptional fusions utilizing the tapA promoter 
to control the expression of fluorescent proteins such as GFP (green fluorescent 
protein) as a read-out of matrix gene expression (Chai et al., 2008). Using this 
method it has been found that matrix gene expression is not found in all cells of 
the biofilm but in specialized matrix producing cells (Chai et al., 2008). This 
stable expression of genes in a sub-population of an isogenic community with 
no detectable expression of the same genes in the other cells of the biofilm is 
termed bistability (Dubnau and Losick, 2006). An important study used 
transcriptional reporters consisting of promoters known to control genes 
involved in matrix production (PtapA), motility (Phag) or sporulation (PsspB) 
fused to genes encoding the fluorescent protein YFP (yellow fluorescent 
protein) (Vlamakis et al., 2008). This allowed a visualisation of different gene 
expression profiles in samples from biofilms which were sectioned and 
observed using microscopy. It was found that there were well defined zones of 
expression for each of the promoters. At the 12 h time point most of the cells 
were motile but at later stages this signal was reduced and mostly restricted to 
the base and edge of the biofilm (Vlamakis et al., 2008). However, matrix 
producing cells were found as patches throughout the biofilm. As was shown 
previously sporulation cells were found in aerial structures and this occurred at 
a late stage (72 h) of biofilm formation. It was found that motile cells tend to 
become matrix cells over time within the biofilm and that sporulating cells tend 
to arise from non-motile community members (Vlamakis et al., 2008). The 
authors looked at the localisation of the three distinct cell types in cells which do 
not produce a normal extracellular matrix by using a tasA mutant which forms 
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flat, featureless biofilms. Using this method it was found that motile cells were 
no longer localised to the base of the biofilm, there was an increase in matrix 
operon expression and a dramatic decrease in sporulation. 
 
This work has since been expanded, with a tapA reporter used to detect the 
localisation of tapA expression in the context of whole complex colonies grown 
on MSgg agar (Srinivasan et al., 2018). During the first 24 h of biofilm 
development tapA expression is high throughout the colony. As the colony 
matures tapA expression becomes localised to the periphery. The presence of 
localised tapA expression near the leading edge is a result of reduced tapA 
expression in the biofilm interior over time. Cells transition from tapA expression 
to sporulation in the vicinity of this propagating front with increasing levels of 
sspB expression observed at later stages. In late stage biofilms, sporulating 
cells dominate the biofilm edge but the authors detect a thin layer of matrix 
producing cells below them. They state in conclusion that nutrient-availability is 
the main factor determining matrix production (Srinivasan et al., 2018). 
 
Importantly, it has now been shown that in some conditions tasA is expressed 
at a higher abundance than tapA and sipW and there is now experimental and 
bioinformatic evidence that the sipW coding region contains a promoter that 
may influence tasA expression (Nicolas et al., 2012). In support of this, a tasA 
deletion strain could only be complemented to wild-type when introducing the 
tasA gene with the upstream sipW sequence (Erskine et al., 2018). These 
recent findings should be kept in mind when discussing studies describing the 
expression of the matrix operon which utilise transcriptional fusions of the tapA 
promoter with a fluorescent read-out. 
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1.5.5. Motile cells 
B. subtilis strains can exhibit swimming, swarming and sliding motility (Hughes 
and Kearns, 2017). Swimming motility occurs in a liquid environment whereas 
swarming occurs on a surface (Henrichsen, 1972). Both forms of movement are 
dependent on flagellar activity. The ability of bacteria to swim can be assessed 
by growth on 0.4% (w/v) LB agar, for swimming, or in LB solidified with 0.8% 
(w/v) agar for swarming (Cairns et al., 2015). Swarming motility is a fast 
movement and in the case of B. subtilis NCIB3610 it requires the production of 
the biosurfactant surfactin (Arima et al., 1968; Kearns and Losick, 2003).  
 
Time-lapse microscopy has been used to understand the role of motility in 
biofilm formation. Fluorescent reporters were used to visualize matrix 
expression (using cells expressing PtapA-yfp) and flagella expression (Phag-
cfp). Consequentially, expression from one of the two promoters occurred in 
any single cell but not together, or in some cases not at all (Vlamakis et al., 
2008). The proportion of motile cells in the population decreases from 12h, at 
70%, to a level of 9% at 72h. These results demonstrated that matrix production 
and motility are spatiotemporally regulated within the B. subtilis biofilm. 
 
Sliding motility is flagella-independent and has been described as surface 
translocation generated by expansive forces in a growing colony (Fall et al., 
2006). This is thought to be achieved by the lowering of friction between the 
bacterial cells and the surface (Fall et al., 2006). B. subtilis has been shown to 
display sliding motility which was demonstrated using a flagella-less hag mutant 
(Fall et al., 2006). Sliding motility has been shown to be dependent on two 
distinct cell types: surfactin producers and matrix producers. These sub-
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populations combine to aid the formation of chains of cells which tightly align to 
form “Van Gogh” bundles (van Gestel et al., 2015). By this mechanism, these 
chains can then push away from the colony. 
To summarise, B. subtilis exhibits a range of motility behaviours including 
flagella-independent sliding and flagella-dependent swarming. Motile hag 
expressing (flagellar) cells are distinct from the population of cells expressing 
the matrix promoter. Finally, matrix producing cells and surfactin producing cells 
combine to generate sliding motility. 
1.5.6. DegU controls motility and enzyme production 
It is thought that B. subtilis has developed an arsenal of macromolecule 
degrading ezymes as a survival mechanism to release simpler molecules when 
nutrients become scarce, for example, during the stationary phase of growth in 
liquid culture (Msadek, 1999). The B. subtilis genome encodes at least 7 
secreted proteases and 2 cell wall associated proteases. The two component 
signal transduction system DegS-DegU controls expression of some of the 
exoprotease genes (Dahl et al., 1992; Ogura et al., 2001; Tanaka et al., 1991). 
High levels of DegU phosphorylation result in exoprotease production but inhibit 
motility (Amati et al., 2004). The expression of bacillopeptidase (bpr) gene was 
observed at a low level in cells in the biofilm at 17 h but was found to increase 
over time until late on in biofilm formation (72 hours for biofilms and 96 hours for 
pellicles) (Marlow et al., 2014). A population of highly fluorescent cells were 
found towards the surface of the biofilm and the exoprotease producing cell 
population overlapped with matrix producing cells. Also these were not 
terminally differentiated cell fates with exoprotease cells becoming matrix cells 
and vice versa (Marlow et al., 2014). In support of this result, the supernatant 
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collected from biofilms at later timepoints had higher exoprotease activity than 
that taken from immature biofilms (Marlow et al., 2014). 
1.5.7. Cannibalism and cell death in B. subtilis biofilms 
For B. subtilis, sporulation is a response to nutrient deprivation but the process 
is energy intensive and so not always desirable. In some cases B. subtilis can 
delay sporulation by directing the killing of other cells in the biofilm to release 
nutrients. So-called “cannibal” cells produce and secrete the two toxins Skf and 
Sdp, which are 26 amino acid and 42 amino acid peptides respectively. When 
added to planktonic cultures of B. subtilis only Sdp induced killing, although on 
spot test assays both showed killing effects, with Sdp being more potent (Liu et 
al., 2010). Additionally, cannibal cells are resistant to the effects of the toxins  
(González-Pastor, 2011; González-Pastor et al., 2003). As with matrix 
production, cannibalism is activated by low-levels of Spo0A phosphorylation 
leading to the expression of the two toxins (Fujita et al., 2005). For this reason, 
matrix and cannibalism populations overlap with many matrix cells also 
producing toxins (López et al., 2009). As a result of this matrix cells reduce the 
population of non-matrix producing cells by releasing toxins.  
 
In this section I have reviewed the heterogeneity of gene expression within the 
B. subtilis biofilm, which is indicative of a potential division of labour. This is 
exemplified by the sharing of TasA and EPS as demonstrated by the restoration 
of biofilm complexity upon mixing of eps and tasA mutant cells, which would 
otherwise display featureless biofilms (Dragoš et al., 2018). Given this 





1.6. The extrapolymeric matrix of B. subtilis biofilms 
1.6.1. Cells in the matrix are connected by a network of channels 
It was found that to transport nutrients from regions of high concentration to 
regions where nutrients are low the B. subtilis matrix contains a network of 
channels (Wilking et al., 2013). These channels have a low resistance to the 
flow of liquids and were found to form when B. subtilis is grown on agar (Wilking 
et al., 2013). The wrinkles of the B. subtilis biofilm contribute to the formation of 
these channels (Wilking et al., 2013). Another method of transport that is 
possible in B. subtilis biofilms is by the secretion of extracellular vesicles. It was 
found that B. subtilis 3610 produced vesicles when grown as pellicles on MSgg 
media although the content of vesicles and their function remains unclear 
(Brown et al., 2014). 
1.6.2. The function and composition of the matrix 
The B. subtilis matrix consists of an exopolysaccharide (EPS) (Branda et al., 
2001) and the protein components BslA, TasA and TapA (Branda et al., 2006; 
Romero et al., 2011). Deletion of the genes required for the production of the 
main biofilm matrix components epsA-O, bslA, tapA or tasA results in an 
abolishment of rugose biofilm morphology. TasA is the dominant protein in the 
B. subtilis biofilm (Branda et al., 2006) and TapA (formerly YqxM) has been 
reported to be required for the assembly of TasA fibres (fTasA) (Romero et al., 
2014). I will discuss TapA and TasA in detail in section 1.7. 
1.6.3. BslA forms the bacterial “raincoat” 
An interesting charactersitic of B. subtilis biofilms is that the surface of the 
biofilm is extremely non-wetting, limiting the penetration of water, liquid 
antimicrobials and even gases (Epstein et al., 2011). Given this finding a 
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number of studies followed into the mechanisms which convey these properties. 
It was found that BslA (Biofilm surface layer protein A, formerly YuaB) is an 
amphiphilic protein which contributes to the surface repellancy by forming a 
hydrophobic layer on the surface of the biofilm (Hobley et al., 2013; Kobayashi 
and Iwano, 2012). Also it was shown that BslA is a communal product which is 
shared within the biofilm (Ostrowski et al., 2011). The presence of a layer of 
BslA at the periphery of the biofilm also contributes to the physicomechanical 
properties of the biofilm by impacting on the roughness and surface stiffness 
(Kesel et al., 2016). This is illustrated by the flat, featureless biofilms formed by 
ΔbslA mutants (Ostrowski et al., 2011). BslA has been described as bi-
functional, where the dimer form of the protein is required to convey the 
hydrophobic properties of the biofilm and the monomeric form is needed for the 
structural integrity of biofilms (Arnaouteli et al., 2017). The BslA protein 
demonstrates an intriguing approach to remaining soluble despite its 
hydrophobic properties. In an aqueous environment the hydrophobic cap 
remains unstructured, however, when the protein is at an air-water interface the 
hydrophobic side chains re-orientate towards the air (Bromley et al., 2015). 
These unique properties of BslA has led to interest in its use a stabilizer of 
emulsions in the food and cosmetic industries (Stanley-Wall and MacPhee, 
2015). It has been hypothesised that the water repellancy of B. subtilis biofilms 
may be an important adaptation to the plant root environment it inhabits. It may 
function by protecting the bacteria from rainwater or from antimicrobials 
produced by competing bacteria in the soil (Arnaouteli et al., 2016). 
The eps operon is a 15 gene operon encoding putative biosynthesis and 
assembly enzymes for the production of exopolysaccharide. The deletion of the 
eps operon resulted in the formation of biofilms which were flat and entirely 
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wetting (Branda et al., 2001; Epstein et al., 2011; Kobayashi and Iwano, 2012). 
The loss of biofilm hydrophobicity in the eps mutant is predicted to be due to a 
loss of an important EPS to BslA interaction (Arnaouteli et al., 2016), as BslA is 
released into the culture supernatant of cells lacking exopolysaccharide 
(Kobayashi and Iwano, 2012). At this point in time, the composition of the 
exopolysaccharide remains unclear. There are contradictory findings with 
regards to what the identity of the major polysaccharide found in the EPS is 
(Jones et al., 2014; Roux et al., 2015). Interestingly, the mixing of an eps 
mutant with a tasA mutant can restore biofilm structure (Branda et al., 2006; 
Dragos et al., 2017). This indicates that EPS and TasA are communal goods 
shared within the biofilm and is consistent with a division of labour at the level of 
gene expression. This co-operative behaviour was found to be an evolutionary 
stable relationship in the laboratory environment (Dragoš et al., 2018). 
Extracellular DNA (eDNA) has been reported to be important for the biofilms of 
a number of strains. The release of eDNA by B. subtilis NCIB3610, grown as 
planktonic cultures in MSgg medium, has been reported (Zafra et al., 2012). 
Furthermore, the role of eDNA in biofilm formation has been studied to some 
extent in related Bacillus species (Randrianjatovo-Gbalou et al., 2017; Vilain et 
al., 2009), however, the role of eDNA in B. subtilis biofilm formation remains 
unknown.  
γ-(D,L)-Polyglutamic acid (PGA) is an exopolymer which may contribute to 
biofilm formation in B. subtilis (Stanley and Lazazzera, 2005). The expression of 
the biosynthetic gene cluster that results in the production of PGA in a 
domesticated JH642 strain of B. subtilis enhanced adhesion to polyvinylchloride 
in a crystal violet assay (Stanley and Lazazzera, 2005). However, adhesion did 
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not seem to be perturbed when PGA production was blocked by the deletion of 
the ywsC PGA biosynthesis gene in an undomesticated strain (Stanley and 
Lazazzera, 2005). Additionally, PGA was not found in a chemical analysis of the 
extracellular matrix of the model biofilm forming strain NCIB3610 and the 
deletion of ywsC in the wild-type B. subtilis isolate RO-FF-1 did not lead to a 
decrease in biofilm formation (Morikawa et al., 2006). Despite this, PGA was 
found to be a major component of the extracellular matrix of the environmental 
isolate B. subtilis B1 (Morikawa et al., 2006). As a side note, hyper-production 
of PGA by Bacillus subtilis var. natto is responsible for the stringy texture of the 
fermented Japanese food natto (Shih and Van, 2001). Furthermore, the PGA 
capsule of the pathogenic species B. anthracis is responsible for evasion from 
the immune system (Jang et al., 2011). 
 
Figure 7: The localisation of matrix components within the B. subtilis biofilm. BslA 
(purple) forms a hydrophobic layer localised to the surface on the periphery of the biofilm. TasA 
fibres (yellow) are thought to extend from the surface of biofilm embedded cells, it is not clear 
whether TasA fibres are found cell-free within the matrix. B. subtilis is a prolific secretor of exo-
proteases (green) and studies have shown that secreted-proteases are expressed in a spatio-
temporal manner within the biofilm. Exopolysaccharide is essential for wild-type biofilm 
formation but is not clear what the composition of EPS is and how it is localised within the 
biofilm. Finally, NCIB3610 has been reported to produce eDNA but it is not clear whether it is 
important for biofilm formation. TapA is a secreted protein and it has been reported to be 
needed for TasA fibre formation but more recent work has shown that TasA forms fibres 
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spontaneously in vitro without the need of TapA. The current model of TapA function places it in 
association with the cell wall of B. subtilis cells. This figure is adapted from Hobley et al., 2015. 
 
1.7. TasA fibres are a major component of the B. subtilis biofilm 
The products of the tapA-sipW-tasA operon interact to generate the protein fibre 
component of the B. subtilis matrix (Branda et al., 2006; Romero et al., 2010). 
The model proposed for the formation of these fibres is that TasA and TapA 
interact to form amyloid fibres which are anchored to the surface of the bacterial 
cell by TapA (Romero et al., 2014). It is for this reason that the name TapA, for 
TasA anchoring/assembly protein A, was given to the protein formerly known as 
YqxM. TasA is the major component of these fibres and the deletion of tasA 
blocks the formation of complex, rugose biofilms in vitro and on plant roots 
(Beauregard et al., 2013; Branda et al., 2006). In this section I am going to 
summarise the research that has led to the current understanding of the 
function of TasA and TapA. 
1.7.1. The secretion of TasA and TapA is dependent on SipW 
The tasA gene encodes a 263 amino acid protein with a sec-dependent signal 
peptide (Stöver and Driks, 1999c). Therefore, the mature, secreted protein is 
estimated to have a molecular weight of 25.7 kDa after cleavage of the signal 
peptide by the signal peptidase SipW (Stöver and Driks, 1999b). The tapA gene 
encodes a 253 amino acid protein predicted to have a molecular weight (MW) of 
29.08 kilo Daltons (kDa). The secreted TapA protein is predicted to be 24.18 
kDa in MW due to the removal of the signal peptide by a signal peptidase, 
which in the literature is reported to be SipW (Stöver and Driks, 1999a). SipW 
has been shown to have a bifunctional role in biofilm formation in B. subtilis 
JH642 (wild-type isolate) as disruption of the catalytic activity of SipW did not 
affect the ability of a biofilm to form on a solid surface (Terra et al., 2012). The 
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other role of SipW is thought to be in the upregulation in the expression of 
genes encoding matrix components (Terra et al., 2012). 
1.7.2. TasA as a fibrous protein 
Originally, TasA was described as a spore-associated protein with antibacterial 
activity (Stöver and Driks, 1999b). It is now known that TasA also forms long 
fibres which are essential for the integrity and structure of biofilms (Branda et 
al., 2006) and that TasA has an additional role in sliding motility (van Gestel et 
al., 2015). I am going to briefly summarise what is currently known about the 
role of TasA in biofilm formation. Using immunoblotting, TasA was detected in 
the matrix of B. subtilis NCIB3610 cells grown as pellicles (Branda et al., 2006). 
Next, by using gold labelled anti-TasA antibodies, in combination with 
transmission electron microscopy, it was found that TasA forms fibres that 
emanate from the surface of the cell (Romero et al., 2010). The authors 
observed the TasA fibres after 24 h of growth as pellicles at 30oC on MSgg 
media, the fibres were approximately 10-25 nm in width and variable in length. 
Additionally, they found that purified TasA fibres could be added exogenously to 
a ΔtasA mutant strain to restore biofilm formation in floating pellicles, but that 
the TasA fibres could not rescue a ΔtapA mutant biofilm defect (Romero et al., 
2011). It is important to note that there are many components in the B. subtilis 
biofilm and that these components in combination allow for the development of 
complex architecture. Consistent with this, when the bslA (formerly known as 
yuaB) gene was knocked out the over-expression of the tasA and eps genes 
could not rescue the biofilm phenotype (Patrick and Kearns, 2008).  
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1.7.3. A high resolution structure of TasA 
The first X-ray crystal structure of the TasA protein was published in late 2017 
(Diehl et al., 2018). TasA28-239, with selenomethionine incorporated, was 
crystallized as a monomeric protein at pH 4.6 and a high resolution structure 
was obtained (Figure 9A). The structure of the protein is described as a jellyroll 
fold with 2 antiparallel β-sheets with 6 small helices and extended loop regions. 
By analysing the rigidity of the structure it was concluded that there is a 
“dynamic section” which is proposed to convey structural flexibility that 
facilitates a conformational change suggested to occur upon fibre formation 
(Diehl et al., 2018). 
1.7.4. TapA anchors TasA fibres to the surface of the cell 
In 2004, TapA was implicated in biofilm formation for the first time (Hamon et 
al., 2004). It was found that, in the strain background of B. subtilis JH642, the 
disruption of the tapA gene led to reduced levels of biofilm formation on a 
plastic surface in a microtitre plate assay (Hamon et al., 2004). Subsequent 
work found that deletion of tapA eliminated complex, rugose colony formation in 
the strain NCIB3610 (Chu et al., 2006). This led to further investigation into the 
functional role of TapA. Using immunocytochemistry TapA localization could be 
visualized as puncta located on the surface of cells isolated from pellicles with 
the aid of fluorescein isothiocyanate conjugated (FITC)- secondary antibodies 
(Romero et al., 2011). Using immunogold electron microscopic analysis it was 
found that TapA could be detected in association with the cell wall of cells 
grown as pellicles (Romero et al., 2011). Furthermore, using the same 
technique it was found that TapA associates with peptidoglycan sacculi 
prepared from biofilm grown B. subtilis. It was further demonstrated that a 
ΔtapA mutant displays fewer and altered fibres emanating from the surfaces of 
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cells (Romero et al., 2011). TapA has been shown to be detected by α-TapA 
immunoblot in cell and matrix fractions of processed biofilms as a 28 kDa band 
and a smaller processed band of around 24 kDa at 24 hours. The larger band is 
proposed to be the result of cleavage of the signal peptide. At 48 h only the 24 
kDa band was observed and only in the matrix fraction (Romero et al., 2011). It 
is suggested that this is due to further processing to generate the smaller TapA 
form. The authors found by immuno-labelling TapA and TasA with antibodies 
attached to gold nanoparticles of distinct sizes that both proteins were found in 
the fibres extending from the surface of the biofilm cells in a ratio of TapA 1:10 
TasA. In a tapA mutant the levels of TasA protein are reduced as determined by 
immunoblot, meaning that a tapA mutant is broadly analogous to a ΔtapA ΔtasA 
double-mutant (Romero et al., 2011). Finally, it was found that ΔtapA and ΔtasA 
mutants do not generate wild-type biofilms upon mixing of the 2 strains (Romero 
et al., 2011). This indicated that TapA is not a shared resource within the biofilm 
in the way that TasA has shown to be (Dragoš et al., 2018). Given the above 




Figure 8: A model for TasA fibre formation. B. subtilis TasA fibres are reported to be cell-wall 
anchored and are essential for wild-type biofilm formation. TasA and TapA are reported to be 
transported by the Sec system with SipW as the signal peptidase that cleaves the signal peptide 
of both TasA and TapA. TapA is thought to anchor TasA to the cell wall making up a small 
proportion of the monomers composing TasA fibres. The biogenesis of TasA fibres is 
dependent on the products of the tapA-sipW-tasA operon. This figure is adaption from a 
publication (Hobley et al., 2015). 
1.7.5. In silico 3D structure analysis for TapA predicts a β-sheet based 
structure 
As things stand there is limited experimental insight into the structure of TapA 
and no x-ray crystal structure currently available. For this reason I used the 
online server RaptorX to predict the tertiary structure of TapA (Källberg et al., 
2012). The result of this was the prediction of an α-helix from amino acids 8-33 
which is indicative of a signal peptide region in the N-terminus of the protein 
(Figure 9B). The region between amino acids 72 and 191 forms a jellyroll-like 
fold which is similar to the β-sheet structure that has been reported for the 
solved TasA crystal structure (Figure 9B). Using alternative software, in the 
Phyre2 server to predict the TapA structure resulted in a somewhat similar 
prediction (not shown). In this case an α-helix was predicted for amino acids 3-
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37 with a TasA-like β-rich structure from amino acids 81-159 consisting of 6 β-
strands (Kelley et al., 2015). Additionally, there were 5 α-helices on the C-
terminal side of the β-rich region which are of variable lengths. Both Phyre2 and 
RaptorX predicted structures contained extensive disordered regions.  
 
Figure 9: X-ray crystallography was used to solve a TasA structure of high-resolution. (A) 
The solved crystal structure of a TasA28-239 monomer showing a β-strand rich structure with a 
consisting of 2 β-sheets to produce a jellyroll fold. (B) The predicted tertiary structure of full- 
length TapA as determined using the RaptorX server. The model is informed by the alignment 
of the TapA sequence with the protein sequence of the following known structures: the α-helix 
shown in blue (domain 1: amino acids 1-71) is informed by alignment with the structure 2a65:a 
(Yamashita et al., 2005) (p-value: 2.76-02, score: 26, uGDT(GDT):27(38)). The prediction of an 
α-helix is consistent with the presence of an N-terminal signal sequence. The structure, 2KL6A 
(unpublished), aligns to the β-sheet structure (domain 2: amino acids 72-191). This takes the 
form of 2, 4 strand β-sheets forming a jellyroll-like structure resembling a β-barrel (p-value: 4.48-
03, score 40, uGDT(GDT):50(42)). Note that the probability scores are low for the prediction of 
both domains. 
 
1.7.6. TapA is thought to be cell wall-associated 
It has been published that TapA is found in the cell wall fraction of cells grown 
as colonies or pellicles which may be how TapA is anchored to the cell surface 
(Romero et al., 2014). It was initially reported that the addition of the  D-amino 
acids as a mixture of D-leucine, D-methionine, D-tyrosine, and D-tryptophan 
could disrupt biofilm formation (Kolodkin-Gal et al., 2010). It was suggested that 
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this involved the incorporation of D-amino acids in the peptide side chains of the 
peptidoglycan making up the cell wall. It was further demonstrated that B. 
subtilis isolates which had developed a 3’ mutation in the tapA gene were 
resistant to the biofilm disassembly effects of D-amino acids. Importantly, 
follow-up work from the same laboratory found that there was not a biofilm 
specific effect of D-amino acids and that they were functioning to have a toxic 
effect on protein synthesis in Bacilus subtilis,  impacting on overall growth 
(Leiman et al., 2013; Leiman et al., 2015; Sarkar and Pires, 2015).  
 
1.8. Amyloid fibres  
Congo red and Thioflavin T (ThT) dyes have been used for many years to stain 
and detect amyloid proteins associated with human disease (Bennhold, 1922; 
Divry, 1927; Saeed and Fine, 1967). It has been observed that the deletion of 
tasA or tapA reduces the binding of Congo red to B. subtilis biofilms (Romero et 
al., 2010; Romero et al., 2011). TasA fibres have been reported to bind Congo 
Red and ThT, and for this reason TasA fibres purified ex vivo have been 
classified as functional amyloid fibres (Romero et al., 2010). I will first describe 
the properties associated with amyloid fibres and using this information provide 
evidence that TasA fibres do not display the characteristics of an amyloidogenic 
fibre.  
1.8.1. What are amyloid proteins? 
The aggregation of amyloid proteins in the brain is a shared hallmark of 
Alzheimer’s, Parkinson’s and Huntington’s disease (Selkoe and Hardy, 2016). 
Amyloid fibres are highly stable forming from monomers which nucleate into 
fibrillar deposits displaying a characteristic cross-β-sheet structure when 
analysed by X-ray diffraction such as for α-Synuclein (Figure 10) (Breydo et al., 
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2012). Amyloid fibres have a striking structure with β-sheets arranged 
perpendicular to the axis of the fibres.  
In recent years attention has been drawn to “functional” amyloid fibres present 
in the biofilms of bacterial species such as the Curli fibres of E. coli. There is 
debate as to whether “amyloid” is an appropriate descriptor for these proteins 
as it is thought that amyloid fibrils can be induced in most proteins given the 
right solvent and other conditions such as pH or temperature (MacPhee and 
Dobson, 2000). Therefore, it has been postulated that amyloid fibril formation is 
a ‘generic’ property of the polypeptide backbone possible given the appropriate 
solution conditions (Lamour et al., 2017).  
 
Figure 10: The structure of α-sunclein is made up of parallel, in register β-sheets. The 
solid-state NMR (nuclear magnetic resonance) of α-synuclein demonstrates this characteristic 
conformation displayed by amyloid fibrils (PDB:2N0A) (Tuttle et al., 2016). 
1.8.2. TasA does not form amyloid fibres 
It was found that the polymerisation of TasA could be measured, in a matrix 
preparation extracted from wild-type cells, by the addition of the amyloid-binding 
dye thioflavinT (ThT) (Romero et al., 2014). In this case, increased  
fluorescence over time was indicative of fibre formation from smaller oligomers 
(Romero et al., 2014). The polymerisation of the TasA fibres was increased 
when recombinant TapA protein was added to the preparation, as a control it 
was demonstrated that TapA did not bind ThT (Romero et al., 2014).  
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However, in contradiction to the work described above we have recently 
published that the Congo red and ThT binding activity displayed by ΔtasA- 
derived protein extracts and wild-type extracts was similar (Erskine et al., 2018). 
It should be noted that the specificity of Congo Red and ThT is not absolute. 
ThT has been shown to display enhanced fluorescence in the presence of 
amorphous aggregates of bovine serum albumin and lysozyme, for example, 
(Yang et al., 2015) and Congo red is also non-specific (Howie and Brewer, 
2009). In other words binding of dyes does not confirm amyloid structure but is 
merely suggestive.  
Given this word of caution, it was found upon further analysis that TasA fibres 
lacked the “cross-β“ structure displayed by amyloid-like fibrils (Erskine et al., 
2018). Furthermore, monomeric TasA was found to have the same secondary 
structure as the fibre form (Erskine et al., 2018). This indicated that TasA fibres 
are instead a linear assembly of monomers, with no profound structural 
rearrangement occurring.  This is in conflict with other reports which state that 
TasA undergoes a conformational change during the process of biofilm 
formation (Diehl et al., 2018). Another hallmark of amyloid-fibres is insolubility in 
SDS and a resistance to degradation by proteases. It was found that TasA was 
soluble in SDS, however, the fibre form was resistant to degradation by 
proteases (Diehl et al., 2018; Erskine et al., 2018).  
In conclusion, although TasA fibres display some of the characteristics of 
amyloid fibres (staining with amyloid dyes and resistance to proteolysis), the 
evidence suggests that TasA fibrils are assembled from monomers with a 




In summary, the study of B. subtilis biofilms has elucidated the incredible 
diversity in specialisation of cells within the biofilm. From matrix production, 
spore formation, motile cells, competent cells and surfactin producing cells. This 
demonstrates the complexity within the bacterial biofilm. The structure of the 
biofilm is conveyed by the embedding of cells in a self-produced extracellular 
polymeric matrix. The properties and function of the matrix have become a 
focussed area of interest in recent years with components such as BslA having 
exciting properties with potential biotechnological applications. There is now a 
field of research looking into fibrous biofilm proteins and their physical 
properties including those classified as functional amyloid fibres.   
1.9.1. Key aims and objectives 
In the current work biochemical, bioinformatic and genetic approaches are 
employed to aid in the understanding of how the biofilm matrix is assembled 
and the role of the secreted matrix protein TapA in this process. The aim of the 
first results section (3.1) is to analyse the active form of TapA within the biofilm. 
It is hypothesised that TapA functions as a secreted protein where the mature 
form of the protein consists of amino acids 44-253. Additionally, in vitro analysis 
of the purified TapA protein is undertaken in an attempt to understand the 
functional form in vivo. The second results section (3.2) documents our 
attempts to develop a model to probe TapA and TasA interaction. The aim of 
this section was to devise a system in which the molecular determinants of 
TapA/TasA interaction could be elucidated. Finally, in section 3.3 we carried out 
a genetic analysis with the aim to determine the minimal functional genetic unit 




2. Methods   
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2.1. Media and antibiotics 
2.1.1. LB and antibiotics 
Lysogeny broth (LB) was prepared using 10 g typtone, 10 g NaCl and 5 g yeast 
extract for 1 litre. LB agar was prepared by solidifying with 15 g of select agar 
(Sigma; A5054) for growth of B. subtilis and E. coli. For antibiotic selection with 
B. subtilis strains antibiotics were used at the following final concentrations: 
erythromycin (0.5 µg/mL), spectinomycin 100 µg/mL and MLS, erythromycin 
(0.5 µg/mL) together with lincomycin (12.5 µg/mL). For antibiotic selection with 
E. coli then ampicillin was used at a concentration of 100 µg/ mL. 
2.1.2. MSgg growth medium 
To make Minimal Salts glycerol glutamate (MSgg) 5 mM potassium phosphate, 
100 mM MOPS at pH 7.0 with agar to a final concentration of 1.5% was 
autoclaved and cooled to 55oC before being supplemented with 2 mM MgCl2, 
700 µM CaCl2, 50 µM FeCl3, 50 µM MnCl2, 1 µM ZnCl2, 2 µM thiamine, 0.5% 
(v/v) glycerol, 0.5% (w/v) glutamic acid. For induction of gene expression from 
the Pspank promoter Isopropyl β-D-1-thiogalactopyranoside (IPTG) was included 
at a final concentration of between 25 µM to 1 mM. For MSgg broth the same 
recipe was followed without the addition of agar. 
2.1.3. Phage media 
The growth medium used to propagate and transfer SSP1 phage was prepared 
by adding MgSO4 and MnSO4 to lysogeny broth (LB), to a concentration of 10 
mM and 1 µM respectively.  Phage agar was made by adding agar to a 
concentration of 1.5% (w/v) and to 0.7% (w/v) for phage top agar. To prevent 
cell lysis by lysogeny, the cells plus phage mixtures were plated onto phage 
agar containing sodium citrate at a concentration of 10 mM.  
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2.1.4. Modified competence (MC) media 
10x MC media was adapted from Konkol et al (Konkol et al., 2013) and 
prepared as a solution containing 10.7 g K2HPO4, 5.2 g KH2PO4, 20 g dextrose, 
0.88 g sodium citrate dehydrate, 2.2 g l-glutamic acid monopotassium salt, , 1 g 
casein enzymatic hydrolysate per 100 mL made up with milliQ-H2O. 3 µL of 1M 
MgSO4 and 1.75 µL of 500 mM FeCl3 was added fresh per 1 mL of 1x MC 
media prepared. A single colony was inoculated into 2 mL of MC broth and 
grown for 4.5h at 37oC with shaking, after which 400 µL of culture was mixed 
with 500 ng of plasmid, 1 µg of PCR product or approximately 1 µg of genomic 
DNA (gDNA) and grown for a further 1.5 h at 37oC with shaking. Finally, the 
culture was plated onto LB plates with the required antibiotic for selection.  
2.2. General overview of cloning and strain construction 
Escherichia coli strain MC1061 [F’ lacIQ lacZM15 Tn10 (tet)] was used for the 
maintenance and stocking of plasmids generated by restriction endonuclease 
cloning. Generally, this involved the cloning of genetic material, such as a 
variant of the tapA gene into the vector pDR110 which allowed for the 
integration, by homologous recombination, of the variant into the amyE locus of 
the B. subtilis genome. As NCIB3610 is not naturally competent, gene variants 
were first introduced into B. subtilis strain 168, which is naturally competent, by 
transformation. The genetic information could then be transferred to the biofilm 
forming strain NCIB3610 using SPP1 phage-mediated transduction. All 
experiments concerned with biofilm formation and TapA function were either 
carried out in this strain or in 3610 comIQ12L which is a modified, competent 
version of the parental strain NCIB 3610. For a full list of strains generated in 
this study please see strain table . 
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2.2.1. Plasmid extraction 
Plasmids were isolated from E. coli MC1061 grown as a 5 mL LB overnight 
culture with the presence of antibiotic selection. Briefly, the culture was pelleted 
by centrifugation, for 10 min at 3,800 x g, and the plasmid was extracted from 
the cells using the QIAprep® Spin Miniprep Kit from Qiagen following the 
manufacturer’s instructions. The use of the PB buffer is essential given the host 
strain genotype. 
2.2.2. Polymerase chain reaction (PCR) 
For PCR amplification (Saiki et al., 1985) of inserts to be cloned into the host 
vector pDR110 the commercially available Q5® High-Fidelity 2X Master Mix 
from New England Biolabs (NEB) was used. Reactions contained the following: 
200 µM dNTPs, 2.0 mM Mg2+, forward and reverse primers at a concentration of 
0.5 µM and genomic DNA or plasmid template at between 50-100 ng. The total 
volume of the reaction, made up to with ddH2O, was typically between 30 and 
50 µL. The reaction was carried out in a thermocycler, see Table 1 for more 
detail in regards to the cycling conditions. PCR amplification products were 
analysed by agarose gel electrophoresis before being gel extracted to remove 
enzymes using the QIAquick Gel Extraction Kit from Qiagen following the 
manufacturer’s instructions. 
Step Temperature Time 
Initial denaturation 98oC 30 sec 
Denaturation 98oC 10 sec 
Annealing 50-72oC (primer Tm-
dependent) 
30 sec 
Extension 72oC 30 sec per kb of DNA 
Final extension 72oC 2 min 
Hold 4-10oC  
Table 1: The PCR cycling conditions used in conjunction with the Q5® High-Fidelity 2X 
Master Mix from NEB. The Denaturation to Extension steps were generally repeated for a total 
of 30 cycles. 
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2.2.3. Restriction endonuclease digest, phosphatase treatment and gel 
extraction 
Restriction endonuclease digests generally involved the incubation of the full 
volume of the PCR amplification product with 5 µL of the recommended 10x 
buffer and 2 µL of each enzyme, usually SalI-HF and SphI-HF, obtained from 
NEB. The reaction was made up to a total volume of 50 µL using ddH2O and 
incubated at 37oC for 3-4 hours. To remove endonuclease enzymes the 
digestion reaction was purified using the QIAquick PCR Purification Kit from 
Qiagen following the manufacturer’s instructions. Digests of plasmid vectors, for 
the hosting of amplified inserts, were carried out as above but with 1 µg of 
plasmid digested. Additionally, digested vectors were subjected to an alkaline 
phosphatase treatment to prevent vector re-ligation and increase efficiency of 
ligation. After the restriction digest was carried out 4 µL of Antarctic 
phosphatase (NEB) was added to the reaction along with 6 µL of the 
recommended 10 x buffer and incubated at 37oC for 30 min, the enzyme was 
then heat-inactivated at 80oC for 2 min. Digested vectors were analysed by 
agarose gel electrophoresis to confirm digestion, followed by gel extraction to 
purify the vector and remove enzymes (carried out using the QIAquick Gel 
Extraction Kit from Qiagen).  
2.2.4. Agarose gel electrophoresis 
Following all enzymatic reactions (for example PCR products or restriction 
endonuclease digests), DNA products were resolved by horizontal agarose gel 
electrophoresis. For this 0.8 ‐ 2% (w/v) agarose gels with 1X GelRed nucleic 
acid stain (Biotium) were prepared in 1X Tris base, acetic acid and 
ethylenediaminetetraacetic acid (EDTA) (TAE) buffer (see Table 6: reagents). 
DNA samples were prepared with 6X gel loading dye (NEB) and 3 μl of 
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HyperLadder™ 1kb DNA ladder (from BioLine) was loaded alongside the 
samples. Electrophoresis was performed in 1X TAE buffer under constant 
voltage at 120 V for 60 minutes. Nucleic acids were imaged using the Gel Doc 
XR system (BioRad).  
2.2.5. DNA Ligation 
Purified DNA fragments were ligated into linearised plasmids using T4 DNA 
ligase (NEB). Reactions were prepared as follows: 400 U T4 DNA ligase, 1X T4 
DNA ligase buffer with varying volumes of plasmid and insert (normally the 
reaction was based on a vector to insert volume ratio of 1:3), with ddH2O added 
to give a total reaction volume of 20 μl. Reactions were incubated overnight at 
room temperature and 10 µL of the reaction was transformed into competent E. 
coli MC1061 cells. The E. coli cells were grown at 37oC, overnight, in the 
presence of antibiotic selection specific for the resistance conferred by the 
vector, typically ampicillin for the pDR110 and pMAD cloning vectors. 
2.2.6. Site-directed mutagenesis 
On occasions where a variant of the tapA gene was desired to have a change in 
the 3’-end of the tapA coding region, then this mutation, depending on the 
proximity to the end of the sequence, usually within 20 bp, could be introduced 
by varying the sequence of the reverse primer in a standard PCR reaction using 
Q5 polymerase. For all other site-directed mutations then a QuickChange 
protocol was carried out using KOD Hot Start DNA Polymerase (Novagen). 
Briefly, forward and reverse primers were designed to overlap with the DNA 
template at the same position. The primer sequence varied so that they 
contained the desired DNA sequence. For example, the primer sequence could 
be CUU (encoding Leucine) instead of GCU (Alanine) found at that position in 
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the DNA template, to create an amplicon which encoded CUU instead of GCU. 
Single reactions were prepared to contain the following components: 0.2 mM 
dNTPs, 1 mM MgSO, 0.5 μM forward primer, 0.5 μM reverse primer, 100 ng 
template, 1 U KOD Hotstart polymerase in PCR buffer diluted to 1X in a total 
volume of 50 μl. Cycling conditions are shown in Table 2. 
Step Temperature Time 
Initial denaturation 95oC 2 min 
Denaturation 95oC 20 sec 
Annealing 57oC (primer Tm-
dependent) 
10 sec 
Extension 70oC 4 min (30 sec per kb of 
DNA) 
Final extension 70oC 5 min 
Hold 4-10oC  
Table 2: The PCR cycling conditions used in conjunction with the KOD Hot Start DNA 
Polymerase. The Denaturation to Extension steps were generally repeated for a total of 20 
cycles. 
2.2.7. Colony PCR and sequencing  
Colony PCR was used to analyse transformants to determine whether the 
competent E. coli had successfully been transformed with the ligated insert-
vector construct. A single colony was suspended in 12 µL of ddH2O, 3 µL of this 
mixture was spotted onto a plate and a further 3 µL was used as the template in 
a PCR reaction. The PCR reaction was carried out using 10 µL of GoTaq®G2 
Green Master Mix 2x, 3 µL of template DNA, 0.5 µM of forward and reverse 
primers and made up to a final volume of 20 µL with ddH2O. PCR products 
were analysed by agarose gel electrophoresis. Positive PCRs resulted in the 
corresponding clone being stocked. The clone was confirmed by sequencing. 
Briefly, plasmid DNA was extracted from an overnight 5 mL culture of the clone. 
The plasmid was then sequenced with primers 39F and 39R (see primers: 
Table 9). All sequencing was performed by the DNA Sequencing and Services 
at the University of Dundee (http://www.dnaseq.co.uk). Raw nucleotide 
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sequencing data was analysed using the CLC Main Workbench version 6. 
BLAST was used to compare query nucleotide sequences by pairwise 
alignment to the expected sequence (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
2.2.8. Stocking E. coli strains 
E. coli strains containing plasmids constructed by cloning were stocked as 
follows: 5 mL LB broth with antibiotic (usually, if not exclusively, ampicillin) was 
inoculated with a single colony and grown overnight for 16 h after which 1 mL of 
the culture was mixed with 800 µL of 50% (v/v) glycerol, giving a final glycerol 
concentration of 22% (v/v), and stored in a cryovial at -80oC. 
2.2.9. B. subtilis genomic DNA extraction 
A single colony was used to inoculate 3 mL of LB broth and the culture was 
grown at 37oC with shaking for 3 h or alternatively overnight to increase yield. 
Bacterial cells were then pelleted by centrifugation and the pellet was re-
suspended in 180 µL of enzymatic lysis buffer  and incubated at 37oC for 30 
min. Genomic DNA was extracted using the Qiagen DNEasy Blood and Tissue 
kit following the manufacturer’s instructions.  
2.2.10. Generating competent B. subtilis 168 and transformation 
Typically for this project, once a plasmid was constructed in vitro and replicated 
in the E. coli host strain as described above it was then transformed into the 
genetically competent strain B. subtilis 168. Firstly, to generate competent cells, 
strain 168 was plated out from a frozen stock and grown overnight at 37oC. A 
single colony was used to inoculate 100 µL of LB broth and this was plated onto 
an LB plate which was grown at 22oC overnight. The next day the lawn was 
washed with 5 mL LB broth to re-suspend the cells and the OD600 of the 
resulting solution was measured. The solution was used to inoculate 12.5 mL of 
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SpC media in a 250 mL conical flask to a starting OD600 of 0.01. The culture 
was grown at 37oC with shaking until 2 hours past the onset of stationary 
phase. The culture was then diluted 1:10 in pre-warmed SpII  and grown for a 
further 90 minutes at 37oC with aeration. The cells were then collected by 
centrifugation and re-suspended in 1/10th the volume of supernatant. They were 
either used directly for transformation or stored at -80oC for later use with the 
addition of glycerol to the cells to give a final concentration of 10% (v/v) 
glycerol. Transformation was carried out by mixing 100 µL of cells 1:1 with 
transformation buffer with plasmid DNA, typically 500 ng, and this mixture was 
incubated at 37oC for 20 minutes before plating out on LB agar with antibiotic 
selection. Selection was usually on spectinomycin in the case of 
transformations with plasmid pDR110. Screening of colonies for successful 
integration at the amyE locus was carried out by patching the colonies onto LB 
plates supplemented with 1% (w/v) soluble starch. On addition of Lugol’s iodine 
solution (Sigma) the starch containing agar turns blue/black. B. subtilis cells 
with an intact amyE gene can break down the starch to form a halo in the 
presence of the iodine solution. Patches were selected that were negative for 
amylase and stocked.  
2.3. Integration of genes onto the B. subtilis chromosome and 
chromosomal deletions 
2.3.1. Integration of genetic variants at the amyE locus 
The donor 168 strain was grown at 37oC with shaking overnight in TY broth and 
200 µL of this culture was mixed with the same volume of phage broth and 1 µL 
of SPP1 phage and incubated at 37oC for 15 minutes. The mixture was then 
mixed with 3 mL of molten phage agar which was poured on top of a phage 
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agar plate. The plate was placed at 37oC until plaques had formed in most of 
the area of the top agar (approximately 3-5 hours). The top agar was then 
harvested using a sterile loop and re-suspended in 5 mL of phage broth and 
vortexed for 1 min to break up the agar. The phage were then eluted using a 
syringe with a 0.2 µM filter to isolate the phage from the donor strain cells. The 
recipient strain was grown in TY broth for 3-5 h before 900 µL of this culture 
was diluted with 9 mL of phage broth to which 60 µL of phage was added and 
this was incubated for 30 min at 37oC. The cells were finally plated onto phage 
agar with sodium citrate and antibiotic for selection. To increase the efficiency of 
transduction, when necessary, the volume of phage was varied. Screening on 
LB agar plates with 1% (w/v) was carried out as before to identify colonies that 
had undergone successful integration of the genetic construct at the amyE 
locus. 
2.3.2. In-frame markerless deletion strains of B. subtilis NCIB3610 
 
The ΔtapA deletion strain was generated by allelic exchange in a method 
similar to that previously published using the pMAD plasmid (Arnaud et al., 
2004). Briefly, a 395 bp upstream region was amplified by PCR with primers 
NSW1308 and NSW1332 and a 641 bp downstream region was amplified using 
primers NSW1333 and NSW1334. Both fragments were cloned into the pMAD 
(pMinimad) vector to generate plasmid pNW685 containg an in-frame deletion 
construct. As NCIB3610 is not naturally competent the plasmid was first 
transformed into B. subtilis 168. Briefly, the plasmid was incubated with 
competent 168 cells and transformation buffer at a volume ratio of 1:1, for 1 h at 
30oC, as that is the permissive temperature for replication of the plasmid which 
has a temperature sensitive origin of replication. The mixture was then plated 
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onto selective LB MLS plates. The pMAD plasmid confers resistance to 
erythromycin and lincomycin which are of the macrolide-lincosamide-
streptogramin (MLS) group. Several transformants were pulled together and 
inoculated into 5 mL TY broth with MLS. The culture was then incubated at 
30oC with aeration for 16 h. Phage carrying the constructed pMAD plasmid 
were generated from this culture as before and B. subtilis NCIB 3610 was 
transduced with this phage in an incubation step for 1 h in TY media at 30oC. 
Successfully transduced colonies were selected by growth for 48 h on TY agar 
plates supplemented with 10 mM sodium citrate and MLS. Sodium citrate was 
included to stop phage activity and MLS acted as selection for strains carrying 
the transduced plasmid. Several transduced colonies were pooled together to 
inoculate 5 mL of LB broth supplemented with MLS and grown at 37oC for 16 h 
with shaking. Growth at the non-permissive temperature and in the presence of 
MLS antibiotics selects for the integration of the plasmid including the 
resistance cassette into the genome. Cells that had undergone integration were 
selected for by plating the culture onto LB MLS agar. Several post-integration 
colonies were pooled together and inoculated into 5 mL of LB medium. The 
culture was grown under static conditions for 16 h at 30oC at which point the 
culture was incubated with aeration for a further 4 h at 30oC. Growth at the 
lower temperature allows for the loss of the plasmid from the chromosome. 
Colonies were plated onto LB and once grown replica patched onto LB and LB 
MLS. MLS-sensitive colonies were then screened by colony PCR and those 
which gave a positive signal were then sequenced to confirm the scar left after 
deletion of the native gene and the integrity of the regions upstream and 
downstream of the gene. The ΔtapA mutant was generated using the above 
method by Laura Hobley. The strain ΔtapA ΔtasA sinR (NRS5749) was 
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generated as part of the current work, using the same method as above by 
deletion of the tapA gene but in the strain background of ΔtasA sinR 
(NRS5248).  
2.3.3. Making exoprotease-free B. subtilis 3610 
To make markerless deletions in all 7 secreted proteases from B. subtilis 3610 
the BKE collection was utilised alongside a competent strain of B. subtilis 3610. 
The BKE collection is a knockout library of B. subtilis 168 containing over 4000 
strains, with each strain containing a single gene deletion which has been 
replaced with an Erm casette (Genomic DNA was extracted from strains 
containing an Erm resistance cassette in place of the gene of interest and used 
to transform competent B. subtilis 3610 comI (Konkol et al., 2013) before 
selection on LB erythromycin plates. The erythromycin cassette contains lox 
sites and was subsequently removed leaving a 150 bp scar by the action of a 
Cre recombinase and this gene was expressed from plasmid pDR244. The 
plasmid is heat-sensitive and was then cured by growing at 42oC. In cases in 
which transformation with genomic DNA proved unsuccessful then the mutation 
was introduced by phage transduction with SPP1 phage. Thanks to Tetyana 
Sukhodub for assistance in generating exoprotease-free 3610 comI. 
2.3.4. Stocking of Bacillus strains 
All Bacillus strains whether received from the Bacillus genetic stock centre 
(BGSC) or generated by phage transduction or transformation were twice 
passaged to generate single colonies by streaking onto LB agar plates 
(containing antibiotic where required) before a lawn plate was set up for 
stocking. To make a lawn plate a single colony was suspended in 100 µL of LB 
broth which was then plated onto LB agar and grown for 16 h at 22oC. When 
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adequate growth was attained the lawn was washed with 3 mL of LB broth and 
1 mL of the broth-cell mixture was mixed with 800 µL of 50% (v/v) glycerol, 
giving a final glycerol concentration of 22% (v/v), and stored in a cryovial at -
80oC. 
2.4. Biofilm phenotype analysis  
2.4.1. Biofilm formation assay 
Biofilms were prepared by growing B. subtilis (and strains detailed in Table 7) in 
3 mL of LB broth at 37oC with aeration for 3-4 hours before 5-10 µL of culture 
was spotted onto an MSgg agar plate. The plate was then incubated at 30oC for 
48 hours. Biofilms were imaged using the a Leica MZ16 stereoscope (Leica 
Microsystems). For strains which had been generated to harbour gene variants 
integrated into the amyE locus of the genome under the expression of the Pspank 
promoter then IPTG was included in the MSgg agar to induce expression of the 
gene. Typically, a concentration of 25 µM IPTG was used to induce expression 
of tapA gene variants. 
2.4.2. Exogenous assays using fTasA and TapA peptide (TapA44-57) 
A 3 mL LB broth culture was inoculated with a single colony and grown for 3-4 
hours at 37oC with shaking at 200 rpm. The culture was then centrifuged at 
3220 x g for 10 minutes. Half of the supernatant volume (1.5 mL) was removed 
and the pellet re-suspended in the remainder of the supernatant, to provide a 2x 
concentrated culture solution. Then 10 µL of the culture solution was mixed 1:1 
with 10 µL of fTasA protein or 10 µL of purification buffer (see Table 6) as a 
control. 10 uL of the cell/protein mixture, containing 20 µg of TasA, was then 
spotted onto MSgg plates. Biofilms were grown at 30oC for 48 h. fTasA was 
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kindly supplied by Elliot Erskine and was purified under the conditions outlined 
in (Erskine et al., 2018). 
The peptide TapA44-57 was synthesised by CS Bio Co., California, USA and re-
suspended at a concentration of ~10 µg/µL in 25 mM phosphate buffer (pH 7.0). 
This concentration is approximate as the scales were not sensitive to the 
amount of peptide being weighed. The exogeneous addition of TapA44-57 was 
carried out as above, for fTasA, with the following modifications. The cell culture 
was concentrated 4x by re-suspending in 750 µL of culture supernatant to allow 
an increased amount of peptide to be added. 2 µL of the culture solution was 
mixed with 8 µL of peptide (80 µg total) before spotting the full 10 µL onto MSgg 
agar.  
2.4.3. Protein purification 
B. subtilis TapA44-253aa was separated from a Glutathione S-transferase-tag with 
a tobacco etch virus (TEV) protease-cleavage site using the pGEX-6P-1 
system. The pGEX-6P-1 plasmid carrying the gene encoding the TapA variant 
was transformed into E. coli BL21 (DE3) pLysS. Once transformed the cells 
were grown overnight in 5 mL LB broth, the culture was then inoculated into 
auto-induction media (Studier, 2005) supplemented with ampicillin (100 µg/mL) 
at a ratio of 1:1000 (vol:vol) in a total volume of 1 litre. The cultures were 
incubated at 30oC with shaking for approximately 6-7 h at which point the 
temperature was reduced to 18oC for overnight incubation. The cell culture was 
pelleted by centrifugation for 45 min at 5020 g and re-suspended in 25 mL 
purification buffer (Tris 25 mM and NaCl 250 mM (pH 7.6) supplemented with 
Complete EDTA-free proteinase inhibitors mixture (Roche). Cell lysis was 
carried out by sonication at an amplitude of 20% for a total of 6 minutes. 
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Unlysed cells and cell debris were removed by centrifugation at 27,000 x g for 
20 min. The cleared lysate was mixed with 750 µL (per litre of culture) 
Glutathione Sepharose 4B (GE Healthcare) and gently agitated at 4oC for at 
least 3 h to allow binding of GST to the beads. The lysate/bead mixture was 
loaded onto a single-use, 25 mL gravity flow column (Bio-Rad). The beads were 
washed using 50 mL purification buffer, collected and incubated overnight at 
4oC with agitation in 25 mL of purification buffer supplemented with 1 mM DTT 
and 0.5 mg of TEV protease to release the protein from the GST-tag. The 
solution containing TapA, TEV protease, free-GST and the beads was loaded 
onto the gravity flow column. This removed the used beads which stay on the 
column. The flow-through was added to 250 µL Ni-nitrilotriacetic acid agarose 
(Qiagen) slurry to remove the TEV protease and 750 µL glutathione sepharose 
4B to remove the free GST-tag. The mixture was incubated at 4oC with agitation 
overnight, and then passed through a gravity flow column. The purified protein 
was concentrated using a Vivaspin 20 concentrator (with a MW cut-off of 5,000 
or 10,000 Sartorius). The protein was then analysed by running 28-30 µg on 
SDS-PAGE.  
2.4.4. Time course of TapA44-253 stability 
Purified TapA proteins (both TapA44-253 and TapA34-253) were stored at 4
oC in 
purification buffer. 28 µg of protein was sampled at intervals of 7 days, mixed 
with 4 x sample loading buffer (see Table 6), β-Me reducing agent and boiled at 
100oC for 10 min and then stored at -20oC. After a number of samples were 
obtained then they were run on 14% SDS-PAGE and the gel was stained with 




2.4.5. Protein extraction from biofilm prior to immunoblot analysis 
Biofilms were isolated from MSgg plates with a sterile loop and re-suspended in 
250 µL of BugBuster solution (Millipore; 71456) using a syringe with a 23 x 1 
gauge needle until solubilized. The samples were then sonicated at an 
amplitude of 25% power for 5 seconds. Sonicated biofilms were next incubated 
at 26oC for 20 min at 1,400 rpm before centrifugation at full speed for 10 min in 
a benchtop centrifuge. The liquid phase was taken and used for SDS-PAGE or 
stored at -20oC for future use. 
2.4.6. Quantification of protein concentration 
The protein concentrations of purified protein, whole cell lysates and biofilm 
lysates were determined using the Nanodrop spectrophotometer ND-1000 at an 
absorbance of 280 nm. 
2.4.7. Sodium Dodecyl Sulphate ‐ Polyacrylamide Gel Electrophoresis 
(SDS ‐ PAGE)  
Proteins were separated by SDS-polyacrylamide gel electrophoresis based on 
the method previously published (Laemmli, 1970) using the Mini-protean 
system (BioRad). The stacking gel contained: 125 mM Tris-HCl (pH 6.8), 0.1% 
(w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED and 6% (v/v) polyacrylamide. 
The resolving gel contained 375 mM Tris-HCl (pH 8.8), 0.1% (w/v) SDS, 0.1% 
(w/v) APS, 0.1% (v/v) TEMED. Polyacrylamide was added to reach a final 
concentration of either 12 or 14% (v/v). The components of the SDS running 
buffer used are found in Table 6. For analysis of purified proteins approximately 
30 µg of protein was mixed with 4x NuPAGE LDS sample buffer and 10x 
NuPAGE sample reducing agent, alternatively, samples were mixed with SDS-
PAGE loading dye and β-mercaptoethanol was used as the reducing agent. 
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Samples were boiled at 100oC for 10 min. Samples were run alongside the 
Precision plus protein dual color standard (Biorad) which was used as the 
molecular weight protein marker. The electrophoresis was carried out in SDS 
running buffer at 120 V while the samples migrated through the stacking gel and 
220 V thereafter. To visualise proteins, gels were stained using InstantBlue 
(Expedeon) and visualised using the Gel Doc XR system (BioRad). 
2.4.8. Immunoblotting 
Samples to be analysed by immunoblotting were first separated by SDS-PAGE. 
The proteins were then transferred to hydrophobic polyvinylidene difluoride 
(PVDF; Immobilon-P from Millipore) membranes with a 0.45 µM pore size by 
electroblotting using the Mini Protean system (BioRad) in Tris glycine transfer 
buffer (see Table 6) at a constant current of 100 mA for 90 min. Membranes 
were blocked with a 5% (w/v) semi-skimmed dry milk solution in TBS-tween 
0.2% (v/v) for at least 1 hour at room temperature or overnight at 4oC. The 
membrane was then incubated with the primary antibody for 45 minutes if 
αTasA was used or incubated overnight at 4oC where αTapA or αTapA serum 
were used (see Table 3). The membrane was then washed 3 times with TBS-
tween 0.2% (v/v) to remove unbound primary antibody before incubation with 
the species-specific secondary HRP-conjugated antibody (Pierce) for 1 hour at 
room temperature in TBS-tween 0.2% (v/v). 3 times washes with TBS-tween 
0.2% (v/v) were carried out as before and development was induced with 
Enhanced Chemi-Luminescence reagents (ECL; BioRad Clarity). Imaging was 












TapA (B. subtilis) Rabbit 1:2,500 (incubated 
overnight) 
This work 
TapA serum (B. subtilis) Rabbit 1:2,500 (incubated 
overnight) 
A. Driks (Loyola 
University) 
TasA (B. subtilis) Rabbit 1:25,000 for 45 min (Ostrowski et al., 
2011) 
Secondary antibody 
αRabbit Goat 1:5,000 incubated 
for 1 hour 
(commercial: 
Pierce) 
Table 3: Antibodies used in this study.  
2.4.9. Supernatant protease activity assay 
Lawn plates were set up by re-suspending a single colony in 100 µL of LB 
medium and plating the re-suspension onto LB agar. Lawn plates were 
incubated overnight at room temperature. After approximately 24 h lawns were 
re-suspended in 5 mL of MSgg broth using a sterile inoculation loop. 
Absorbance at 600 nm was measured in a spectrophotometer in order to 
determine bacterial optical density (OD600). The volume of re-suspended cells to 
inoculate was calculated based on a starting OD600 of between 0.001 and 0.01. 
Cultures were grown overnight in 25 mL MSgg broth in a 250 mL conical flask in 
a water bath set to 37oC with shaking at 130 rpm. Cultures at an OD600 ≥2 were 
harvested and normalized to 5 mL of the culture with the lowest OD600 (or 
alternatively normalization was carried out to the equivalent of 5 mL of culture at 
an OD600 of 2). The harvested culture was then pelleted by centrifugation at 
3220 x g for 10 min and the full volume of supernatant was filter-sterilized to 
remove bacterial cells. The supernatant protease activity assay was set up by 
mixing supernatant 1:1 (vol:vol) with purified TapA protein and incubating the 
mixture at 37oC for 24 h. This gave a final TapA protein concentration in the 
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assay of 5 µg/µL, and a total amount of 150 µg. Heat-inactivation of the 
supernatant was carried out by incubating the supernatant samples at 100oC for 
10 min prior to use. 
2.4.10. Protease plate assays 
Protease plate assays were carried as previously published (Verhamme et al., 
2007). The production of exoproteases was assayed by the use of LB agar 
plates supplemented with 1.5% (w/v) dried milk powder. Strains of interest were 
each grown in 3 mL of LB broth at 37oC to an OD600nm of at least 1. The strains 
were then normalized to an OD600nm of 0.01 by dilution in LB broth. 10 µL of the 
prepared cell culture was spotted onto the LB milk agar plate and grown for 18 
h at 37oC prior to being photographed.  
2.4.11. Protein identification 
Identification of proteins from biofilm lysates was carried out by first running 
samples by SDS-PAGE and then visualising protein by staining the gel with 
InstantBlue and then cutting out the band of interest with a sterile scalpel before 
sending for analysis. Proteins were identified by LC-MS-MS following tryptic 
digest and peptides were identified using the Mascot database. Mass 
spectrometry analysis was carried out by the FingerPrints Proteomics and Mass 
Spectrometry Facility at the University of Dundee. 
2.4.12. Edman sequencing 
Briefly, the sample was prepared for analysis by separating 30 µg of TapA44-253 
protein (after 84 days of storage at 4oC) by SDS-PAGE on a 14% gel. The 
protein was then transferred to an immobilon-P PVDF membrane. The 
membrane was stained with InstantBlue to allow for the detection of a strongly 
staining band, corresponding to the stable TapA degradation product, which 
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was then cut out using a sterile scalpel and provided for analysis. Thanks to 
Dave Campbell and Bob Gourlay of the MRC protein Phosphorylation Unit in 
Dundee for Edman analysis carried out on a Shimadzu PPSQ-30 protein 
sequencer. 
2.5. RNA methodology 
 
The following procedure was carried out to confirm the expression of the tapA 
gene in strain NRS5787 (PY79 protease-free KO7) received from the Bacillus 
genetic stock centre (BGSC).  
 
2.5.1. RNA extraction 
Cultures were grown overnight in 25 mL MSgg broth in a 250 mL conical flask 
at 37oC at 130 rpm from a starting OD600 of 0.01. Cells were harvested by 
centrifugation at an OD600 of between 1.71 and 1.9 and the amount of cells 
used for downstream RNA extraction normalized to the equivalent of 3 mL of 
cells at an OD600 equal to1. RNA extraction was carried out using the 
RiboPure™ RNA Purification Kit (Ambion) and the manufacturer’s instructions 
were followed. Briefly, this method involves the use of beads to lyse the cells 
and a phenol-chloroform precipitation method to isolate RNA from other cellular 
material. To remove potential DNA carryover from the purification process 
DNase I treatment was employed using Ribopure DNaseI (Ambion). 4 U of 
DNaseI were incubated with 100 µL of RNA, from the previous step, alongside 
the corresponding DNase buffer and incubated at 37oC for 30 min. DNase 
inactivation reagent was then used to stop the activity of DNaseI. The RNA 
quality was then assessed by measuring RNA concentration using the 
Nanodrop ND-1000 then approximately 150 ng of RNA was resolved on a 2% 
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(w/v) agarose gel by electrophoresis. High quality RNA was confirmed by the 
presence of 2 distinct bands corresponding to ribosomal RNA and by the lack of 
smearing indicative of a sample that has not significantly degraded.  
2.5.2. Synthesis of complementary DNA (cDNA) 
cDNA synthesis was carried out using the SuperScript™ III First-Strand 
Synthesis System (Invitrogen). Briefly, a mixture of 300 ng of RNA, 50 ng of 
hexamer primers and 1 mM mixed dNTPs were incubated at 65oC for 5 min and 
then held on ice for at least 1 min. The cDNA synthesis mastermix was then 
added to each reaction to make a solution containing 5 mM MgCl2, 10 uM DTT, 
200 U Supercript III, 1 x RT buffer and 40 U of RNase out and made up to 20 µL 
with nuclease-free water. The reactions were then placed in a thermocycler on 
the following program: 10 min at 25oC, 50 min at 50oC and 5 min at 85oC. 
Thereafter cDNA was stored at -20oC.  
2.5.3. Semi-quantitative reverse transcription (RT) PCR 
To confirm successful removal of DNA from the purified RNA and the synthesis 
of cDNA from an RNA template a PCR was carried out using primers which 
anneal to the 16S rRNA gene (Primers DEN5 and DEN7 see Table 9) using g2 
green mastermix PCR in a 20 µL PCR reaction, for the programme outlined in 
Table 4. On confirmation of cDNA synthesis semi-quantitative RT-PCR of the 
tapA gene was carried out using primers NSW 528 and NSW 529, using 100 ng 
of template cDNA. Then 8 µL or 12 µL, for the 16S and the tapA PCR 
amplification products were run on 1% (w/v) agarose gel electrophoresis and 




Step Temperature Time 
Initial denaturation 95oC 2 min 
Denaturation 95oC 15 sec 
Annealing 56oC for 16S and 50oC 
for tapA 
30 sec 
Extension 72oC 1 min (30 sec per kb of 
DNA) 
Final extension 72oC 5 min 
Hold 4-10oC  
Table 4: The PCR conditions used in the thermocycler for semi-quantitative reverse 
transcription (RT) PCR. The Denaturation to Extension steps were cycled 35 times for 16S 
gene amplification and 35 times for tapA gene amplification. 
 
2.6. Bioinformatics 
Analysis of the tapA operon was carried out by using the online server ARNold 
to predict the presence of transcriptional terminators (Gautheret and Lambert, 
2001; Hofacker et al., 1994; Lesnik et al., 2001; Macke et al., 2001). 
Comparative analysis of tapA operons was carried out using the Jalview 2 
workbench (Waterhouse et al., 2009). Briefly, tapA, sipW and tasA ORFs 
(Table 5), originating from related Bacillus species, were analysed by pairwise 
sequence alignment with reference to the B. subtilis sequences to determine 
percentage sequence identity. 
 
TapA protein homologs were identified using BlastP (Altschul et al., 1990; 
Altschul et al., 1997). Searching was carried out within the non-redundant 
protein sequence database for each of the organisms of interest using the 
amino acid sequence of the TapA protein originating from B. subtilis as the 
query. Protein sequences of TapA homologues were aligned using Clustal 
Omega using default settings (Sievers et al., 2011). Percentage identity 
between TapA orthologues was calculated with reference to B. subtilis TapA 
using the pairwise alignment function on the Jalview 2 workbench. For the 
prediction of signal peptides for all TapA variants then the SignalP 4.1 server 
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was used and set to the organism group: Gram-positive (Petersen et al., 2011). 
Secondary structure prediction was carried out using the JPred 4 server 
(Drozdetskiy et al., 2015). The prediction of TapA tertiary structure was carried 
out using the Phyre2 (Kelley et al., 2015) and RaptorX (Källberg et al., 2012; Ma 
et al., 2012; Ma et al., 2013; Peng and Xu, 2010, 2011a, b) servers. The 
visualisation of the experimentally determined crystal structures of TasA and α-
synuclein were carried out by loading the corresponding data file from the 
protein databank into the PyMol programme, as was the visualisation of the 
predicted tertiary structures of TapA (DeLano, 2016).  
 
Genome description  GenBank Genome 
accession number 
B. subtilis NCIB3610 CP020102.1 
B. amyloliquefaciens FZB42 CP000560.1 
B. paralicheniformis* MIZE01000002.1 
B. pumilis SAFR-032 CP000813.4 
B. cereus NC7401  AP007209 
 
Table 5: GenBank accession numbers for the genomes in which the tapA homologs used 
in this study originate from. (*) The genetic material used to amplify the B. paralicheniformis 
tapA homolog was originally annotated as originating from B. licheniformis, however, on 
searching on the Blastn database with the sequence result of this amplicon it aligned more 
closely with the B. paralicheniformis sequences. The sequence was very similar to the B. 
licheniformis sequence expected but with some minor differences, note that this sequence may 
vary from the actual tapA sequence for this B. paralicheniformis strain as the primers were 
designed for B. licheniformis and likely introduced B. licheniformis specific tapA sequence 





2.7. Buffers, solutions and reagents 
Buffer/solution Components 
Generating competent 168 B. subtilis and transformation 
SpC 1 X T-Base  
1 mM MgSO4  
0.5% (w/v) Glucose 
SpII 1 X T-Base  
35 mM MgSO4  
0.5% (w/v) Glucose    
0.1% (w/v) Yeast extract    
0.01% (w/v) Casamino Acids 
40 μg/ml Tryptophan 
Wash buffer 1X T-Base  
1 mM Mg2SO4 
Transformation buffer 1 X T-Base  
2 mM EDTA 
General solutions 
TAE Buffer 40 mM Tris  
1.142% (w/v) Acetate  
1 mM EDTA 
DNA Loading Buffer (NEB) 2.5%(w/v) Ficoll®-400  
11mM EDTA  
3.3 mM Tris-HCl  
0.017% (w/v) SDS  
0.015% (w/v) bromophenol blue  
pH 8 
B. subtilis biofilm lysis buffer: 
BugBuster protein extraction reagent 
(Novagen) 
Contains detergent rLysozyme solution and 
Bezonase (nuclease) 
Buffers for protein work 
Sample loading buffer for SDS-PAGE 60 mM Tris-HCl (pH 8.8)  
4% (v/v) β-Mercaptoethanol  
2% (w/v) SDS  
10% (v/v) Glycerol  
0.04% (w/v) Bromophenol Blue 
NuPage Loading dye and reducing agent Contains: glycerine 
lithium dodecyl sulphate 
coomassie G250 
phenol red 
50 mM dithiothreitol (DTT)  
SDS Running Buffer 25 mM Tris  
192 mM Glycine  
0.1% (v/v) SDS 
InstantBlue protein stain Coomassie dye 
Phosphoric acid 
Solubilizing agents 
Purification buffer Tris 25 mM  
NaCl 250 mM (pH 7.6 with concentrated HCl) 
Immunoblot (Western blot) 
Western transfer buffer 25 mM Tris  
192 mM Glycine  
0.2% (v/v) Tween-20  
20% (v/v) Methanol 
Tris Buffered Saline Tween (TBST) 20 mM Tris-HCl 
pH 8.0  
150 mM NaCl  
0.2% (v/v) Tween 
ECL Biorad Clarity 
Contains: Peroxide and Luminol enhancer 
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reagents to be mixed 1:1 
Miscellaneous 
Enzymatic lysis buffer (lysis of B. subtilis 
cells) 
20 mM Tris-HCl at pH 8.0 
2 mM sodium EDTA 
1.2% (v/v) Triton X-100 
20 mg/mL lysozyme 







2.8. Strains, plasmids and primers used in this study 
2.8.1. Strain table  
Strain Relevant genotype/description a Source/construction b 
168 trpC2 BGSC 
NCIB3610 prototroph BGSC 
NRS3789 168 pMiniMAD ΔtapA pNW685→168 
NRS5048 168 pMiniMAD ΔtasA pNW1448→168 
NRS2012 NCIB3610 sinIR::spec (Kearns et al., 2005) 
NRS3936 NCIB3610 ΔtapA Laura Hobley (This work) 
NRS5267 NCIB3610 ΔtasA (Erskine et al., 2018) 
NRS5248 NCIB3610 ΔtasA sinR SPP1 NRS5048→NCIB3610 
NRS5487 168 pMiniMAD ΔsipW pNW2021→168 
NRS5488 NCIB3610 ΔsipW SPP1 NRS5487→NCIB3610 
NRS1144 B. subtilis RO-FF-1 (Roberts and Cohan, 1995) 
NRS5142 B. subtilis ATCC 9799  (Duthie, 1944) BGSC:3A14 
NRS5145 B. subtilis B-14393T (Priest et al., 1988) BGSC:10A5 
NRS1314 NCIB3610 degU::pBL201 (cml) (Verhamme et al., 2007) 
NRS5041 168 amyE::P-spank-tapAB_sub*-lacI (spc) pNW1438→168 
NRS5042 168 amyE::P-spank-tapAB_pum**-lacI (spc) pNW1439→168 
NRS5043 168 amyE::P-spank-tapAB_amy***-lacI (spc) pNW1440→168 
NRS5741 168 amyE::P-spank-tapAB_para****-lacI (spc) pNW1800→168 
NRS5742 168 amyE::P-spank-tapAB_sub_1-193-lacI (spc) pNW1801→168 
NRS5045 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub-lacI 
(spc) 
SPP1 NRS5041→NRS3936 
Generated by Rachel Gillespie 
NRS5046 NCIB3610 ΔtapA + amyE::P-spank-tapAB_pum-lacI 
(spc) 
SPP1 NRS5042→NRS3936 
Generated by Rachel Gillespie 
NRS5047 NCIB3610 ΔtapA + amyE::P-spank-tapAB_amy-lacI 
(spc) 
SPP1 NRS5043→NRS3936 
Generated by Rachel Gillespie 




NRS5744 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-193-
lacI (spc) 
SPP1 NRS5742→NRS3936 
NRS5749 NCIB3610 ΔtapA ΔtasA sinR SPP1 NRS3789→NRS5248 
NRS5760 168  amyE::P-spank-tapA-sipW-tasA-lacI (spc) pNW1840→168 
NRS5763 NCIB3610 ΔtapA ΔtasA sinR + amyE::P-spank-
tapA-sipW-tasA-lacI (spc) 
SPP1 NRS5760→NRS5749 
NRS5770 168 amyE::P-spank-tapABs_1-188aa-lacI (spc) pNW1806→168 
NRS5789 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
188aa-lacI (spc) 
SPP1 NRS5770→NRS3936 
NRS5771 168 amyE::P-spank-tapABs_1-183aa-lacI (spc) pNW1807→168 
NRS5790 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
183aa-lacI (spc) 
SPP NRS15771→NRS3936 
NRS5772 168 amyE::P-spank-tapABs_1-178aa-lacI (spc) pNW1808→168 
NRS5791 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-178aa-
lacI (spc) 
SPP1 NRS5772→NRS3936 
NRS5785 168 amyE::P-spank-tapABs_1-173aa-lacI (spc) pNW1810→168 
NRS5793 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-173aa-
lacI (spc) 
SPP1 NRS5785→NRS3936 
NRS5799 168 amyE::P-spank-tapABs_1-133aa-lacI (spc) pNW1815→168 
NRS5805 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-133aa-
lacI (spc) 
SPP1 NRS5799→NRS3936 
NRS5800 168 amyE::P-spank-tapABs_1-143aa-lacI (spc) pNW1816→168 
NRS5806 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-143aa-
lacI (spc) 
SPP1 NRS5800→NRS3936 
NRS5801 168 amyE::P-spank-tapABs_1-153aa-lacI (spc) pNW1817→168 





Strain Relevant genotype/description a Source/construction b 
NRS5802 168 amyE::P-spank-tapABs_1-163aa-lacI (spc) pNW1818→168 
NRS5814 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-163aa-
lacI (spc) 
SPP1 NRS5802→NRS3936 
NRS5819 168 amyE::P-spank-tapABs_1-123aa-lacI (spc) pNW1819→168 
NRS5987 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-123aa-
lacI (spc) 
SPP1 NRS5819→NRS3936 
NRS5985 168 amyE::P-spank-tapABs_1-113aa-lacI (spc) pNW1820→168 
NRS5988 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-113aa-
lacI (spc) 
SPP1 NRS5985→NRS3936 
NRS5986 168 amyE::P-spank-tapABs_1-103aa-lacI (spc) pNW1821→168 
NRS5989 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-103aa-
lacI (spc) 
SPP1 NRS5986→NRS3936 
NRS5996 168 amyE::P-spank-tapABs_1-50aa-lacI (spc) pNW1822→168 
NRS6002 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-50aa-
lacI (spc) 
SPP1 NRS5996→NRS3936 
NRS5997 168 amyE::P-spank-tapABs_1-71aa-lacI (spc) pNW1823→168 
NRS6003 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-71aa-
lacI (spc) 
SPP1 NRS5997→NRS3936 
NRS5998 168 amyE::P-spank-tapABs_1-88aa-lacI (spc) pNW1824→168 
NRS6004 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-88aa-
lacI (spc) 
SPP1 NRS5998→NRS3936 
NRS5999 168 amyE::P-spank-tapABs_1-95aa-lacI (spc) pNW1825→168 
NRS6005 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-95aa-
lacI (spc) 
SPP1 NRS5999→NRS3936 
NRS6024 168 amyE::P-spank-tapABs_1-56aa-lacI (spc) pNW1829→168 
NRS6025 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-56aa-
lacI (spc) 
SPP1 NRS6024→NRS3936 
NRS6036 168 amyE::P-spank-tapABs_1-57aa-lacI (spc) pNW1830→168 
NRS6041 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-57aa-
lacI (spc) 
SPP1 NRS6036→NRS3936 
NRS6037 168 amyE::P-spank-tapABs_1-58aa-lacI (spc) pNW1831→168 
NRS6042 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-58aa-
lacI (spc) 
SPP1 NRS6037→NRS3936 
NRS6038 168 amyE::P-spank-tapABs_1-59aa-lacI (spc) pNW1832→168 
NRS6043 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-59aa-
lacI (spc) 
SPP1 NRS6038→NRS3936 
NRS6039 168 amyE::P-spank-tapABs_1-60aa-lacI (spc) pNW1833→168 
NRS 6044 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-60aa-
lacI (spc) 
SPP1 NRS6039→NRS3936 
NRS6040 168 amyE::P-spank-tapABs_1-65aa-lacI (spc) pNW1834→168 
NRS6045 NCIB3610 ΔtapA + amyE::P-spank-tapABs_1-65aa-
lacI (spc) 
SPP1 NRS6040→NRS3936 
NRS5995 168 amyE::P-spank-lacI (spc) pDR110→168 
BGSC1A747 B. subtilis strain PY79 BGSC stocked as NRS5786 
PY79-KO1 PY79 ∆nprE (KO1) BGSC stocked as NRS5807 
PY79-KO2 PY79 ∆nprE ∆aprE (KO2) BGSC stocked as NRS5808 
PY79-KO3 PY79 ∆nprE ∆aprE∆ epr (KO3) BGSC stocked as NRS5809 
PY79-KO4 PY79 ∆nprE ∆aprE ∆epr ∆mpr (KO4) BGSC stocked as NRS5810 
PY79-KO5 PY79 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB (KO5) BGSC stocked as NRS5811 
PY79-KO6 PY79 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB ∆vpr (KO6) BGSC stocked as NRS5812 
PY79-KO7 PY79 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB ∆vpr ∆bpr 
(KO7) 
BGSC stocked as NRS5787 
NRS5788 168 amyE::P-spank-tapAΔcons-lacI (spc) pNW1814→168 
NRS5794 NCIB3610 ΔtapA + amyE::P-spank-tapAΔcons-lacI 
(spc) 
SPP1 NRS5788→NRS3936 
NRS6058 168 amyE::P-spank-tapAB_sub_A44P-lacI (spc) pNW1838→168 
NRS6059 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_A44P -
lacI (spc) 
SPP1 NRS6058→NRS3936 
NRS6379 168 amyE::P-spank-tapA(rbs)-tasA(ss)1-27aa- pNW1828→168 
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Strain Relevant genotype/description a Source/construction b 
tapA44-57 
NRS6478 NCIB3610 ΔtapA + amyE::P-spank-tapA(rbs)-
tasA(ss)1-27aa-tapA44-57aa 
NRS6020→NRS3936 
NRS6489 168 amyE::P-spank-tapAB_pum1-40aa pNW1875→168 
NRS6508 NCIB3610 ΔtapA + amyE::P-spank-tapAB_pum1-40aa SPP1 NRS6489→NRS3936 
NRS6490 168 amyE::P-spank-tapAB_pum1-41aa pNW1876→168 
NRS6509 NCIB3610 ΔtapA + amyE::P-spank-tapAB_pum1-41aa SPP1 NRS6490→NRS3936 
NRS6491 168 amyE::P-spank-tapAB_pum1-42aa pNW1877→168 
NRS6510 NCIB3610 ΔtapA + amyE::P-spank-tapAB_pum1-42aa SPP1 NRS6491→NRS3936 
NRS6492 168 amyE::P-spank-tapAB_pum1-43aa pNW1878→168 
NRS6511 NCIB3610 ΔtapA + amyE::P-spank-tapAB_pum1-43aa SPP1 NRS6492→NRS3936 
NRS6481 168 amyE::P-spank-tapAB_amy1-57aa pNW1871→168 
NRS6504 NCIB3610 ΔtapA + amyE::P-spank-tapAB_amy1-57aa SPP1 NRS6481→NRS3936 
NRS6482 168 amyE::P-spank-tapAB_amy1-58aa pNW1872→168 
NRS6505 NCIB3610 ΔtapA + amyE::P-spank-tapAB_amy1-58aa SPP1 NRS6482→NRS3936 
NRS6483 168 amyE::P-spank-tapAB_amy1-59aa pNW1873→168 
NRS6506 NCIB3610 ΔtapA + amyE::P-spank-tapAB_amy1-59aa SPP1 NRS6483→NRS3936 
NRS6484 168 amyE::P-spank-tapAB_amy1-60aa pNW1874→168 
NRS6507 NCIB3610 ΔtapA + amyE::P-spank-tapAB_amy1-60aa SPP1 NRS6484→NRS3936 
NRS6497 168 amyE::P-spank-tapAB_para1-57aa pNW1879→168 
NRS6512 NCIB3610 ΔtapA + amyE::P-spank-tapAB_para1-57aa SPP1 NRS6497→NRS3936 
NRS6498 168 amyE::P-spank-tapAB_para1-58aa pNW1880→168 
NRS6513 NCIB3610 ΔtapA + amyE::P-spank-tapAB_para1-58aa SPP1 NRS6498→NRS3936 
NRS6499 168 amyE::P-spank-tapAB_para1-59aa pNW1881→168 
NRS6514 NCIB3610 ΔtapA + amyE::P-spank-tapAB_para1-59aa SPP1 NRS6499→NRS3936 
NRS6500 168 amyE::P-spank-tapAB_para1-60aa pNW1882→168 
NRS6515 NCIB3610 ΔtapA + amyE::P-spank-tapAB_para1-60aa SPP1 NRS6500→NRS3936 
NRS5990 168 bpr::erm trpC2 BKE15300 (Koo et al., 2017a) 
NRS6010 168 vpr::erm trpC2 BKE38090 (Koo et al., 2017a) 
NRS6011 168 nprB::erm trpC2 BKE11100 (Koo et al., 2017a) 
NRS6012 168 mpr::erm trpC2 BKE02240 (Koo et al., 2017a) 
NRS6013 168 epr::erm trpC2 BKE38400 (Koo et al., 2017a) 
NRS6014 168 aprE::erm trpC2 BKE10300 (Koo et al., 2017a) 
NRS6015 168 nprE::erm trpC2 BKE14700 (Koo et al., 2017a) 
NRS6017 NCIB3610 comIQ12L BGSC 3A38 
NRS6046 NCIB3610 comI bpr::erm  SPP1 NRS6046→NRS6017 
NRS6047 NCIB3610 comI Δbpr (KO1) pDR244→NRS6046 
NRS6048 NICB3610 comI Δbpr vpr::erm gDNA 6010→NRS6047 
NRS6049 NCIB3610 comI Δbpr Δvpr (KO2) pDR244→NRS6048 
NRS6060 NCIB3610 comI Δbpr Δvpr nprB::erm gDNA 6011→NRS6049 
NRS6061 NCIB3610 comI Δbpr Δvpr ΔnprB (KO3) pDR244→NRS6060 
NRS6062 NCIB3610 comI Δbpr Δvpr ΔnprB mpr::erm SPP1 NRS6012→NRS6061 
NRS6063 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr (KO4) pDR244→NRS6062 
NRS6064 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr epr::erm gDNA 6013→NRS6063 
NRS6065 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr Δepr 
(KO5) 
pDR244→NRS6065 
NRS6340 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr Δepr 
aprE::erm 
gDNA 6014→NRS6063 
NRS6341 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr Δepr 
ΔaprE (KO6) 
pDR244→NRS6340 
NRS6361 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr Δepr 
ΔaprE nprE::erm 
gDNA 6015→NRS6063 
NRS6362 NCIB3610 comI Δbpr Δvpr ΔnprB Δmpr Δepr 
ΔaprE ΔnprE (KO7) 
pDR244→NRS6361 
NRS6366 168 amyE::P-spank-tapAB_sub_1-57aa(T57A)-lacI (spc) pNW1849→168 
NRS6384 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(T57A)-lacI (spc) 
SPP1 NRS6366→NRS3936 
NRS6367 168 amyE::P-spank-tapAB_sub_1-57aa(Q56A)-lacI (spc) pNW1850→168 
NRS6385 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1- SPP1 NRS6367→NRS3936 
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Strain Relevant genotype/description a Source/construction b 
57aa(Q56A)-lacI (spc) 
NRS6368 168 amyE::P-spank-tapAB_sub_1-57aa(L55I)-lacI (spc) pNW1851→168 
NRS6386 NCIB 3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(L55I)-lacI (spc) 
SPP1 NRS6368→NRS3936 
NRS6369 168 amyE::P-spank-tapAB_sub_1-57aa(L55K)-lacI (spc) pNW1852→168 
NRS6387 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(L55K)-lacI (spc) 
SPP1 NRS6369→NRS3936 
NRS6373 168 amyE::P-spank-tapAB_sub_1-57aa(L55A)-lacI (spc) pNW1858→168 
NRS6472 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(L55A)-lacI (spc) 
SPP1 NRS6373→NRS3936 
NRS6370 168 amyE::P-spank-tapAB_sub_1-57aa(S54A)-lacI (spc) pNW1853→168 
NRS6388 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(S54A)-lacI (spc) 
SPP1 NRS6370→NRS3936 
NRS6371 168 amyE::P-spank-tapAB_sub_1-57aa(V53I)-lacI (spc) pNW1854→168 
NRS6389 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(V53I)-lacI (spc) 
SPP1 NRS6371→NRS3936 
NRS6479 168 amyE::P-spank-tapAB_sub_1-57aa(V53K)-lacI (spc) pNW1865→168 
NRS6502 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(V53K)-lacI (spc) 
SPP1 NRS6479→NRS3936 
NRS6374 168 amyE::P-spank-tapAB_sub_1-57aa(V53A)-lacI (spc) pNW1859→168 
NRS6473 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(V53A)-lacI (spc) 
SPP1 NRS6374→NRS3936 
NRS6377 168 amyE::P-spank-tapAB_sub_1-57aa(D52A)-lacI (spc) pNW1866→168 
NRS6476 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(D52A)-lacI (spc) 
SPP1 NRS6377→NRS3936 
NRS6378 168 amyE::P-spank-tapAB_sub_1-57aa(D52L)-lacI (spc) pNW1867→168 
NRS6477 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(D52L)-lacI (spc) 
SPP1 NRS6378→NRS3936 
NRS6501 168 amyE::P-spank-tapAB_sub_1-57aa(D52N)-lacI (spc) pNW1869→168 
NRS6516 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(D52N)-lacI (spc) 
SPP1 NRS6501→NRS3936 
NRS6372 168 amyE::P-spank-tapAB_sub_1-57aa(F51A)-lacI (spc) pNW1857→168 
NRS6390 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(F51A)-lacI (spc) 
SPP1 NRS6372→NRS3936 
NRS6376 168 amyE::P-spank-tapAB_sub_1-57aa(D47A)-lacI (spc) pNW1863→168 
NRS6475 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(D47A)-lacI (spc) 
SPP1 NRS6376→NRS3936 
NRS6375 168 amyE::P-spank-tapAB_sub_1-57aa(F45A)-lacI (spc) pNW1862→168 
NRS6474 NCIB3610 ΔtapA + amyE::P-spank-tapAB_sub_1-
57aa(F45A)-lacI (spc) 
SPP1 NRS6375→NRS3936 
NRS2705 168 amyE::P-spank- sipW-tasA-lacI (spc) pNW1619→168 
NRS6519 NCIB3610 ΔtapA + amyE::P-spank- sipW- tasA-
lacI (spc) 
SPP1 NRS6519→NRS3936 
NRS6520 NCIB3610 amyE::P-spank- tapAB_sub_1-57aa(L55K)-lacI 
(spc) 
SPP1 NRS6369→NCIB3610 
NRS6521 NCIB3610 amyE::P-spank- tapAB_sub_1-57aa(L55A)-lacI 
(spc) 
SPP1 NRS6373→NCIB3610 
NRS6522 NCIB3610 amyE::P-spank- tapAB_sub_1-57aa(F45A)-lacI 
(spc) 
SPP1 NRS6375→NCIB3610 
MC1061 F’ lacIQ lacZM15 Tn10 (tet) E. coli Genetic Stock Centre 
BL21 F–ompT hsdSB (rB–), (mB–)gal dcm (DE3) (Studier and Moffatt, 1986) 
NRS2661 E. coli BL21 pGEX-6P-1+TEV-site+tapAB_sub44-253aa pNW1600→E.coli BL21 
NRS5034 E. coli BL21 pGEX-6P-1+TEV-site+tapAB_sub34-253aa pNW1441→E.coli BL21 
NRS5028 E. coli BL21 pGEX-6P-1+TEV site+tasAB sub28-261aa (Erskine et al., 2018) 
NRS6016 E. coli CDR 1055 pDR244 BGSC ECE274 
 
Table 7: Strain Table. a) Drug resistance cassettes are indicated as the following: (spc) 
spectinomycin resistance, (erm) erythromycin resistance and (cml) chloramphenicol resistance. 
b) BGSC is the Bacillus genetic stock centre. c) The direction of strain construction is indicated 
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with an arrow (→) from the genetic source either phage (SPP1), plasmid (pNW) or genomic 
DNA (gDNA) to the recipient strain. *Allele of tapA amplified from NCIB3610 (B_sub or Bs), 
**Allele of tapA amplified from Bacillus pumilis strain SAFR-032 (B_pum), ***Allele of tapA 
amplified from Bacillus amyloliquefaciens strain FZB42 (B_amy) and ****Allele of tapA amplified 
from Bacillus paralicheniformis (B_para). Note that the B. paralicheniformis isolate was originally 
annotated as B. licheniformis but re-assigned based on the similarity of the tapA gene sequence 




2.8.2. Plasmid table 
Plasmid Description  Source 
pDR110 B. subtilis integration vector for IPTG-induced expression (Britton et al., 2002) 
pGEX-6P-1 Vector for overexpression of GST-fused proteins GE Healthcare 
pMiniMAD Temp sensitive allelic replacement vector (Patrick and Kearns, 
2008) 
pNW685 pMinimad ΔtapA This work (Laura 
Hobley) 
pNW1448 pMinimad ΔtasA (Erskine et al., 2018) 
pNW2021 pMinimad ΔsipW This work (Elliot 
Erskine) 
pNW1804 pDR110- tapA-sipW-tasA This work (Elliot 
Erskine) 
pNW1438 pDR110-tapA B sub* Rachel Gillespie 
pNW1439 pDR110-tapA B pum** Rachel Gillespie 
pNW1440 pDR110-tapA B amy*** Rachel Gillespie 
pNW1800 pDR110-tapA B para**** This work 
pNW1801 pDR110-tapA B sub 1-193aa This work 
pNW1806 pDR110-tapA B sub 1-188aa This work 
pNW1807 pDR110-tapA B sub 1-183aa This work 
pNW1808 pDR110-tapA B sub 1-178aa This work 
pNW1810 pDR110-tapA B sub 1-173aa This work 
pNW1818 pDR110-tapA B sub 1-163aa This work 
pNW1817 pDR110-tapA B sub 1-153aa This work 
pNW1816 pDR110-tapA B sub 1-143aa This work 
pNW1815 pDR110-tapA B sub 1-133aa This work 
pNW1819 pDR110-tapA B sub 1-123aa This work 
pNW1820 pDR110-tapA B sub 1-113aa This work 
pNW1821 pDR110-tapA B sub 1-103aa This work 
pNW1825 pDR110-tapA B sub 1-95aa This work 
pNW1824 pDR110-tapA B sub 1-88aa This work 
pNW1823 pDR110-tapA B sub 1-71aa This work 
pNW1834 pDR110-tapA B sub 1-65aa This work 
pNW1833 pDR110-tapA B sub 1-60aa This work 
pNW1832 pDR110-tapA B sub 1-59aa This work 
pNW1831 pDR110-tapA B sub 1-58aa This work 
pNW1830 pDR110-tapA B sub 1-57aa This work 
pNW1829 pDR110-tapA B sub 1-56aa This work 
pNW1822 pDR110-tapA B sub 1-50aa This work 
pNW1814 pDR110- tapAB sub 111-SKAAAAAAKL-120 This work 
pNW1864 pDR110-tapAB sub RBS -tasAB sub 1-27aa-tapAB sub 44-57aa GenScript  
pNW1838 pDR110-tapA B sub  A44P This work 
pNW1871 pDR110-tapAB amy 1-57aa This work 
pNW1872 pDR110-tapAB amy 1-58aa This work 
pNW1873 pDR110-tapAB amy 1-59aa This work 
pNW1874 pDR110-tapAB amy 1-60aa This work 
pNW1875 pDR110-tapAB pum 1-40aa This work 
pNW1876 pDR110-tapAB pum 1-41aa This work 
pNW1877 pDR110-tapAB pum 1-42aa This work 
pNW1878 pDR110-tapAB pum 1-43aa This work 
pNW1879 pDR110-tapAB para 1-57aa This work 
pNW1880 pDR110-tapAB para 1-58aa This work 
pNW1881 pDR110-tapAB para 1-59aa This work 
pNW1882 pDR110-tapAB para 1-60aa This work 
pNW1849 pDR110-tapAB sub 1-57(T57A) This work 
pNW1850 pDR110-tapAB sub 1-57(Q56A) This work 
pNW1851 pDR110-tapAB sub 1-57(L55I) This work 
pNW1852 pDR110-tapAB sub 1-57(L55K) This work 
pNW1858 pDR110-tapAB sub 1-57(L55A) This work 
pNW1853 pDR110-tapAB sub 1-57(S54A) This work 
pNW1854 pDR110-tapAB sub 1-57(V53I) This work 
77 
 
Plasmid Description  Source 
pNW1865 pDR110-tapAB sub 1-57(V53K) This work 
pNW1859 pDR110-tapAB sub 1-57(V53A) This work 
pNW1866 pDR110-tapAB sub 1-57(D52A) This work 
pNW1867 pDR110-tapAB sub 1-57(D52L) This work 
pNW1869 pDR110-tapAB sub 1-57(D52N) This work 
pNW1857 pDR110-tapAB sub 1-57(F51A) This work 
pNW1863 pDR110-tapAB sub 1-57(D47A) This work 
pNW1862 pDR110-tapAB sub 1-57(F45A) This work 
pNW1600 pGEX-6P-1-tapAB sub44-253 This work 
pNW1804 pDR110-tapA-sipW-tasA This work 
pNW1619 pDR110-sipW-tasA-lacI (spc) (Erskine et al., 2018) 
pNW1600 pGEX-6P-1+TEV-site+tapAB_sub44-253aa This work (Laura 
D'Ignazio) 
pNW1441 pGEX-6P-1+TEV-site+tapAB_sub34-253aa This work Rachel 
Gillespie 
pNW1437 pGEX-6P-1+TEV-site+tasAB sub28-261aa (Erskine et al., 2018) 
Table 8: The plasmids used in this work. *Allele of tapA amplified from NCIB 3610 (B_sub), 
**Allele of tapA amplified from Bacillus pumilis strain SAFR-032 (B_pum), ***Allele of tapA 
amplified from Bacillus amyloliquefaciens strain FZB42 (B_amy) and ****Allele of tapA amplified 
from Bacillus paralicheniformis (B_para). Note that the B. paralicheniformis isolate was originally 
annotated as B. licheniformis but re-assigned based on the similarity of the tapA gene sequence 




2.8.3. Primer table 
































































































































































































































































































































































































































































































































































































NSW528 CGATTGTTTCACAATCAG tapA qPCR for Primers for 
qRT-PCR of 
tapA 
NSW529 CCACTTCCACTTTGATTT tapA qPCR rev 



































Table 9: Primer table. a) Restriction sites are underlined, stop codons are in bold. b) QC = 
QuickChange (using KOD polymerase) and SDM = Site-Directed Mutagenesis. *Allele of tapA 
amplified from NCIB 3610 (B_sub), **Allele of tapA amplified from Bacillus pumilis strain SAFR-
032 (B_pum), ***Allele of tapA amplified from Bacillus amyloliquefaciens strain FZB42 (B_amy) 









3.1. A biochemical approach to understand TapA function 
3.1.1. Background 
In a 1999 study (Stöver and Driks, 1999a), research was carried out 
investigating the Bacillus subtilis gene yqxM, which would later be renamed 
tapA (for TasA assembly/anchoring protein A) (Romero et al., 2011). The 
designation TapA will be used hereafter. At that time, the function of the tapA 
gene was unknown. TapA was not detected in cells grown in rich media or in a 
number of other conditions which were tested. It was reported that TapA could 
be detected in the supernatant, but not the cell extracts, of B. subtilis PY79 cells 
grown in LB supplemented with NaCl (sodium chloride) (Stöver and Driks, 
1999a). In this case TapA was found to migrate as a protein of approximately 
38 kDa. Next, by using PY79 cells where the sipW gene was deleted, it was 
shown that the secretion of TapA was dependent on the SipW signal peptidase. 
It was also found that when tapA expression was controlled by an IPTG-
inducible Pspac promoter then the protein was secreted and found at a size of 30 
kDa. It was noted that full-length TapA produced recombinantly in E. coli was 
found at a molecular weight of 38 kDa. Finally, when both SipW and TapA were 
produced together in the same E. coli cells there was evidence that SipW 
processes TapA, in the form of a shift to a lower molecular weight of TapA, as 
detected by immunoblot. 
Investigating TapA in the conext of biofilm formation it was discovered that 
TapA localizes to both the cell and matrix fractions of pellicle biofilms grown in 
MSgg medium at the 24 h time point (Romero et al., 2011). In this case TapA 
was detected by immunoblot as 2 bands with a larger band of 28 kDa and a 
smaller band of 24 kDa. After 48 hs, only the smaller band remained detectable 
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in the matrix fraction only. The authors concluded that the 28 kDa band was 
equivalent to TapA without a signal sequence (which they predict as being from 
amino acids 1-33) and that the band of 24 kDa was indicative of further 
processing (Romero et al., 2011). Next a number of immuno-histochemical 
techniques, in combination with microscopy led to the conclusion that TapA is 
found as localised puncta associated with the cell surface and is found in TasA 
fibres anchored to the cell envelope.  Additionally, it was found by immunoblot 
that TasA levels are low in biofilms formed by the ∆tapA mutant (Romero et al., 
2011). 
The aim of this section of work was to first confirm some of the findings in 
relation to research into TapA function. We then took a fresh look starting with 
the generation of an αTapA antibody to allow for the detection of TapA in vivo. 
With the aid of an αTapA antibody, it was found that TapA is processed to a low 
molecular weight form in vivo and that this is a conserved feature of several B. 
subtilis isolates. Finally, it was demonstrated that processing of TapA is 





3.1.2. The tapA gene is essential for biofilm formation 
It has been reported that biofilm formation by B. subtilis is dependent on both 
tapA and tasA (Branda et al., 2006; Hamon et al., 2004). Here first, it was 
determined whether deletion of the ΔtapA (NRS3936) and ΔtasA (NRS5267) 
genes, separately, impacted biofilm formation as reported. Wild-type 3610, 
ΔtapA (NRS3936), ΔtasA (NRS5267) and ∆tapA + pIPTG-tapA (NRS5045) 
strains were grown on MSgg media for 48 h before image capture. Our results 
were in agreement with previous findings as deletion of either gene resulted in 
flat, featureless biofilms in contrast to the rugose, complex morphology of wild-
type 3610 (Figure 11A). To determine if the phenotype of the ΔtapA mutant 
was due to the deletion of tapA and not due to off-target mutations, we 
examined the ability of ectopically expressed tapA to complement this biofilm 
defect. To test this, the expression of tapA was induced at the amyE locus, 
under the control of the IPTG-inducible Pspank promoter, using the strain ΔtapA + 
pIPTG-tapA (NRS5045) (Figure 11A). The induction of tapA gene expression 
was shown to restore wild-type biofilm architecture (Figure 11A). These results 
demonstrated that both tasA and tapA encode products which are essential for 
the ability of B. subtilis to form biofilms as previously reported. We also noted 
that the morphology of the tapA and tasA deletion strains were reproducibly 
different. 
3.1.3. TapA is needed for the stability of TasA levels in the biofilm 
As shown above both ΔtapA and ΔtasA mutants have biofilm defects, 
additionally, published work has shown that TasA levels are found to be 
reduced in a ∆tapA mutant (Romero et al., 2011). For this reason we wanted to 
examine TasA levels in the ∆tapA mutant generated in our laboratory. 
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The aim in the following experiment was to determine whether tapA deletion 
impacts the broad protein profile in the biofilm, therefore, strains 3610 and 
ΔtapA (NRS3936) were grown as biofilms on MSgg agar for 48 h. Protein was 
extracted from the biofilms and the biofilm lysates were analysed by SDS-
PAGE. A strongly staining band of approximately 30 kDa was present in wild-
type biofilms but was absent in the ΔtapA sample (Figure 11B, Arrow denoted 
*). It was predicted that this band could either be TasA or TapA as both proteins 
are predicted to have similar molecular weights of 28.31 kDa and 29.08 kDa 
respectively. To identify the protein, this band was isolated and confirmed to 
contain TasA by mass spectrometric analysis (Figure 11C). This result 
indicated that the loss of this band in the tapA mutant is due to reduced levels of 
TasA. For further validation, the biofilm lysates from a selection of mutants were 
analysed by αTasA immunoblot. The stained SDS-PAGE gel shown in Figure 
11D serves as a loading control for this experiment. The result of the αTasA 
immunoblot demonstrates that in 3610 biofilms, TasA is found as a band of >25 
kDa with a laddering of smaller forms found at a lower molecular weight below, 
which may be degraded forms of TasA. There was no band detected in the 
ΔtasA biofilm as expected (Figure 11E). SinR is known to repress tasA 
transcription and when the sinR gene is disrupted this increases tasA 
transcription (Chu et al., 2006). Correspondingly, there are increased levels of 
TasA in the sinIR::spec (NRS2012) mutant and TasA is not detected in the 
ΔtasA sinR lysates. Importantly, there are reduced levels of TasA observed in 
ΔtapA biofilms. Furthermore, TasA levels were shown to be recovered on 
induction of tapA expression when the strain ∆tapA + pIPTG-tapA was grown in 
the presence of IPTG (Figure 11E). The presence of degraded forms of TasA is 
also shown to be dependent on the level of tapA induction. The result of these 
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experiments are in agreement with previously published work that tapA is 
needed for the stability or production of TasA levels in the biofilm. As a result of  
 
Figure 11: TapA is needed for TasA stability or production in vivo. (A) Biofilm phenotypes 
of: 3610, ΔtapA (NRS3936), ΔtasA (NRS5267) and ΔtapA + pIPTG-tapA (NRS5045) strains. 
ΔtapA + pIPTG-tapA (NRS5045) was grown in the presence and absence of IPTG. Biofilms 
were grown at 30oC for 48 h. n= 3+. (B) Biofilm lysates of 3610 and ΔtapA were analysed by 
12% SDS-PAGE, the gel is stained with InstantBlue, the maximal amount of protein was loaded 
into the well for each sample to increase the amount of material submitted for mass 
spectrometry analysis. The arrow denoted * indicates a 30 kDa band identified by mass 
spectrometry as TasA (C). (C) The results of mass spectrometry based protein identification. 
The protein sequence of TasA is shown and peptides detected which match the sequences are 
highlighted in red and bold text. n=1. (D) Biofilm lysates of 3610, ΔtapA (NRS3936), ΔtapA + 
pIPTG-tapA (NRS5045), ΔtasA (NRS5267), ΔtasA sinR (NRS5248) and sinIR::spec (NRS2012) 
were analysed by SDS-PAGE. An image of the 12% gel stained with InstantBlue serves as a 
loading control for the αTasA immunoblot shown in E. (E) αTasA immunoblot of selected biofilm 




these findings, the ΔtapA mutant may be thought of as somewhat akin to a 
ΔtapA ΔtasA double mutant, in that it lacks the tapA gene and has reduced 
TasA levels. 
3.1.4. Increased induction of tasA in a ΔtapA mutant does not restore 
biofilm formation 
It was next tested if increasing TasA levels in a ΔtapA mutant could re-instate 
biofilm formation. To test this, a second copy of tasA was introduced into the 
amyE locus of the ΔtapA mutant to generate the strain ΔtapA + pIPTG-sipW-
tasA (NRS6519). In an attempt to boost tasA levels, increasing concentrations 
of IPTG (25 µM to 1 mM) were used to induce tasA expression from the IPTG 
inducible promoter. The resulting biofilms did not display wild-type morphology 
but were distinguishable from both the ΔtapA and ΔtasA mutants (Figure 12A). 
To determine whether increased induction of tasA expression manifested as 
higher levels of TasA protein the biofilm lysates were analysed by αTasA 
immunoblot. The stained SDS-PAGE gel shown in Figure 12B serves as a 
loading control for this experiment. In the 3610 sample, TasA was found with an 
apparent molecular weight of ~30 kDa and there were degraded forms of the 
protein found at a lower molecular weight below (Figure 12C). By comparison, 
there was a reduced level of TasA in the ΔtapA mutant as was shown 
previously (Figure 12C). The lysates of the ΔtapA + pIPTG-sipW-tasA 
(NRS6519) strain either grown in the absence or presence of 25 µM of IPTG 
had comparable levels of TasA to the ΔtapA mutant (Figure 12C). Increasing 
the levels of IPTG to 50 µM, 100 µM and 1 mM did not recover the levels of 
TasA to that observed in wild-type biofilms (Figure 12C). Additionally, the 
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presence of only one lower molecular weight form of TasA was observed below 
the 30 kDa TasA band, in the ΔtapA and ΔtapA + pIPTG-sipW-tasA samples 
(Figure 12C). This lower band appeared to be found at a higher intensity as 
IPTG increased. However, this result confirmed that TasA levels could not be 
re-instated to wild-type levels by increased induction of tasA expression in a 
ΔtapA mutant.  
 
 
Figure 12: The impact of increased tasA induction, in the absence of tapA, on biofilm 
formation. (A) Biofilm phenotypes of 3610, ∆tapA and ∆tapA + pIPTG-sipW-tasA (NRS6519) 
grown at 30oC for 48 h. ∆tapA + pIPTG-sipW-tasA (NRS6519) was grown in the presence and 
absence of IPTG for induction of tasA. Biofilms were grown in the presence of varying IPTG 
concentrations. n=2. (B) Biofilms from the experiment shown in (A) were lysed and run on 14% 
SDS-PAGE which served as a loading control for the αTasA immunoblot shown in (C). For (C) 
n=1. + = 25 µM IPTG, ++ = 50 µM IPTG, +++ = 100 µM IPTG and ++++ = 1 mM IPTG. Scale 




To summarise, we have reproduced published findings that a ΔtapA mutant 
displays a biofilm defect and that TasA levels are reduced in a ΔtapA mutant. 
Attempts to re-instate TasA levels by increased induction of tasA were 
unsuccessful.  
3.1.5. TapA is found as a low molecular weight form in the biofilm 
We have gained some insight to the function of tapA by deleting the gene and 
working with the ΔtapA mutant. However, to observe TapA in vivo it was 
determined that the generation of an αTapA antibody was required. The full-
length TapA protein is calculated to have a molecular weight (MW) of 29.08 
kDa. However, TapA is thought to be a secreted protein and consistent with this 
the SignalP server predicts a signal peptide of 43 amino acids (Petersen et al., 
2011). Cleavage with a signal peptidase would yield a mature protein consisting 
of amino acids 44-253 giving a molecular weight of 24.18 kDa. For generation 
of an αTapA antibody against the mature secreted protein, the recombinant 
protein TapA34-253 was produced in E. coli BL21 (DE3) (NRS5034) cells. Note 
that TapA34-253 is the predicted mature form of the protein as previously 
published (Romero et al., 2014). Strain NRS5034 harbours the plasmid pGEX-
6P-1-tapAB_sub34-253 (pNW1441) which encodes a GST (glutathione S-
transferase) tag separated by a TEV (Tobacco Etch Virus) protease cleavage 
site from TapA34-253. The GST-tag was used for the purification of TapA34-253 
before being removed by cleavage with TEV-protease to make tag-less TapA34-
253. The protein was then used to elicit antibody production in a rabbit host. The 
antibody was initially validated by immunoblot with biofilm lysates and was then 
subsequently affinity purified using the antigen TapA44-253 as bait.  
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To test the specificity of the resulting antibody the following strains were used: 
3610, ΔtapA (NRS3936), ΔtapA + pIPTG-tapA (NRS5045), ΔtasA (NRS5267), 
ΔtasA sinR (NRS5248) and sinIR::spec (NRS2012). The strains were grown 
under biofilm conditions for 48 h and whole biofilm protein extracts isolated. The 
stained SDS-PAGE which served as a loading control for this experiment is 
shown in Figure 13A. Three bands of interest were detected in 3610 lysates 
with the αTapA antibody. These were estimated to have an apparent molecular 
weight of 30 kDa (Arrow 1), 18 kDa (Arrow 2) and 16 kDa (Arrow 3) (Figure 
13B). All 3 bands were absent in ΔtapA biofilm lysates. The detection of all 3 
bands was shown to be IPTG-dependent in ΔtapA + pIPTG-tapA biofilm lysates 
(Figure 13B).  Only the 16 kDa band was present in the ∆tasA and ∆tasA sinR 
biofilms. Therefore, it was concluded that the 16 kDa band is the only one that 
can be confidently assigned as TapA. All 3 bands were present in the 
sinIR::spec mutant with the 18 kDa band detected at a stronger intensity with 
comparison to wild-type (Figure 13B). In sinIR::spec cells, repression of the 
tapA operon is expected to be perturbed resulting in higher expression. Taken 
together, it can be concluded that the presence of the 18 kDa band is shown to 
be dependent on the presence of both the tasA and tapA genes and could 
possibly be TasA due to its absence in ∆tasA biofilm lysates (Figure 13B). The 
30 kDa band detected by the αTapA antibody is anticipated to be a non-specific 
band corresponding to TasA as it is absent in the ΔtasA mutant. It is thought to 
be equivalent to the band, identified previously as TasA, which stains strongly 
with InstantBlue when looking at 3610 biofilm lysates by SDS-PAGE (Figure 
11B). Given the unexpected nature of the findings, this result was then validated 




Comparable observations were made when αTapA serum was used (kindly 
provided by Adam Driks) (Stöver and Driks, 1999a). The same set of samples 
as shown in Figure 13B were analysed using this αTapA serum. 3 bands 
(Arrows 1, 2 and 3) were observed arranged in a similar banding pattern as 
detected with our own αTapA antibody (Figure 13C), thus validating the αTapA 
antibody we generated as part of this work. Additionally, there were a number of 
non-specific bands detected when the αTapA serum was used (Figure 13C). 
For example, an additional band of 15 kDa could be observed in 3610 biofilm 
lysates but this was found to be absent in a ΔtasA mutant and may represent 
TasA or a TasA-dependent form of TapA. 
Following on from this, mass spectrometry was used in an attempt to identify 
the composition of the 16 kDa TapA form. To obtain high levels of 16 kDa TapA, 
tapA expression was induced with 100 µM IPTG in the strain ΔtapA + pIPTG-
tapA (Figure 13D). The region of the SDS-PAGE gel, corresponding to the 16 
kDa region where TapA is detected by immunoblot, was submitted for analysis 
(denoted arrow *). The quality of this result was low, likely due to the presence 
of other proteins in the sample but 3 peptides did match to the core of the TapA 
sequence (Figure 13E).   
To conclude, an αTapA antibody was generated and shown to react non-
specifically with TasA. However, a low molecular weight 16 kDa band is 
detected when TasA is absent from the sample and can, therefore, be assigned 
as TapA. This result indicated that TapA is processed to a low molecular weight 





Figure 13: TapA is found as a low molecular weight form in biofilm lysates. (A) Biofilm 
lysates (~46 µg) were analysed on a 12% SDS-PAGE gel and stained with InstantBlue. Strains: 
3610, ΔtapA (NRS3936), ∆tapA + pIPTG-tapA (NRS5045), ΔtasA (NRS5267), ΔtasA sinR 
(NRS5248) and sinIR::spec (NRS2012) are shown. The ∆tapA + pIPTG-tapA (NRS5045) strain 
was grown in the presence and absence of IPTG as indicated. The stained gel serves as the 
loading control for the immunoblots shown in (B) and (C). (B) αTapA immunoblot using the 
TapA antibody generated as part of the current study. n=2. (C) αTapA immunoblot using serum 
kindly gifted by Adam Driks. n=1. For the immunoblots shown in (B) and (C): arrow 1 
corresponds to TasA (30 kDa band), arrow 2 indicates a TasA/TapA-dependent band (~18 kDa) 
and arrow 3 is TapA (16 kDa). (D) Biofilm lysates of 3610, ΔtapA and ΔtapA + pIPTG-tapA 
analysed by 12% SDS-PAGE, the gel is stained with InstantBlue, the maximal amount of protein 
was loaded into the well for each sample to increase the amount of material submitted for 
downstream analysis, Arrow denoted * indicates a 16 kDa band submitted for protein 
identification by mass spectrometry. Note that this is an extended version of the figure shown in 
Figure 12B. (E) Mass spectrometry result for the 16 kDa band shown in (D). n=1. The protein 
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sequence of TapA is shown and peptides detected which match the sequences are highlighted 
in red and bold text. There was a limited number of peptides detected and TapA was not a 
leading hit for this band in the mass spectrometry results. - = 0 µM IPTG, ++ = 50 µM IPTG and 
+++ = 100 µM IPTG. 
 
3.1.6. TapA processing is a conserved feature of B. subtilis isolates 
TapA was found to be processed to a low molecular weight in B. subtilis 3610, 
however, it was not known whether this trait is specific to the 3610 strain. To 
test this, it was investigated whether TapA processing is a conserved feature 
across B. subtilis isolates. Three isolates were obtained from the Bacillus 
Genetic Stock Centre (BGSC). Strain RO-FF-1 was isolated from the Mojave 
Dessert (Roberts and Cohan, 1995), strain ATCC 9799 was first reported in 
1944 as being obtained from a National Repository of Cultures (Duthie, 1944), 
and B-14393T has been published as an B. amyloliquefaciens strain (Priest et 
al., 1988). As a first step, these strains were identified phylogenetically using 
16S rRNA sequencing and confirmed to be B. subtilis species (data not shown). 
This included the strain B-14393T which was previously assigned as B. 
amyloliquefaciens. To determine whether these B. subtilis isolates formed 
biofilms the strains were grown on MSgg media for 48 h before biofilm images 
were captured. Each of the isolates developed mature biofilms with complex 
architecture (Figure 14A). The biofilms exhibited by ATCC 9799 resembled the 
appearance of those formed by 3610, however, RO-FF-1 and B-14393T 
biofilms adopted different morphologes. Following on from this it was 
investigated whether TapA undergoes processing in these isolates. To do this 
biofilms were lysed and protein extracted for analysis by αTapA immunoblot. 
TapA processing was confirmed by the observation of a similar banding pattern 
in the 3 isolates when compared to the 3610 strain. This included the presence 
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of the low molecular weight TapA band (Arrow deonoted *) which is found in the 
ΔtasA strain and absent in ΔtapA (Figure 14B). These results demonstrated 
that TapA processing in the biofilm is a feature shared across the several 
isolates of B. subtilis. 
 
Figure 14: TapA processing is conserved in Bacillus subtilis species. (A) Biofilm images of 
Bacillus subtilis isolates 3610, RO-FF-1 (NRS1144), ATCC 9799 (NRS5142) and B-14393T 
(NRS5145) showing complex colony morphology at 48 h. images representative of at least 3 
independent replicates. (B) αTapA immunoblot of biofilm lysates of the biofilms shown in (A). 
n=3. Biofilm lysate samples (~48 µg) were separated on 12% SDS-PAGE. The samples of 
3610, ΔtapA (NRS3936) and ΔtasA (NRS5267) on the left hand-side of the blot originate from a 
separate experiment and are included for comparison. Arrow 1 corresponds to TasA (30 kDa 
band), arrow 2 indicates a TasA/TapA-dependent band (~18 kDa) and arrow 3 is TapA (16 
kDa). Scale bar = 0.5 cm. 
3.1.7. Extracellular proteases display proteolytic activity against TapA in 
vitro 
As TapA is predicted to be a secreted protein, it was hypothesised that TapA 
processing in the biofilm would require the action of secreted extracellular 
proteases (referred to as exoproteases hereafter). As a starting point, it was 
tested whether exoproteases produced by B. subtilis and secreted into the 
external environment could cleave recombinant TapA in vitro. First, recombinant 
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TapA44-253 was purified from E. coli BL21 (DE3) (NRS2661) cells and the protein 
sample was prepared under reducing and denaturing conditions. The TapA44-253 
protein was found to exhibit an apparent molecular weight of 25 kDa (Figure 
15A). Higher molecular weight bands were observed and these may be 
oligomeric forms of TapA (Figure 15A). Next, to determine if recombinant TapA 
protein can be processed by exoproteases the following experiment was carried 
out. Briefly, wild-type 3610 cells were grown in MSgg broth to stationary phase. 
Cell-free supernatant was obtained by centrifugation of the culture and filtering 
of the supernatant. The supernatant was then incubated with 150 µg of the 
protein for 24 h at 37oC. The TapA44-253 protein, which served as the input for 
this assay, was found at an apparent molecular weight of ~25 kDa, as expected 
(Figure 15B). However, TapA44-253 which had been incubated with 3610 
supernatant was found as a degradation product of between 15 and 20 kDa 
(Figure 15B). Heat-inactivation of the supernatant at 100oC for 10 min 
abolished proteolytic activity (3610 +H) (Figure 15B). It was noted that higher 
molecular weight forms of TapA were observed in the input sample and in the 
protein incubated with heat-treated supernatant (3610 +H). These results 
indicated that the degradation process observed is enzymatic in nature. The 
band corresponding to the protein core of approximately 17.5 kDa, left by 
proteolysis with cell-free supernatant, was isolated and analysed by mass 
spectrometry (Figure 15C). It was found that this corresponded to the core of 
the protein from amino acids 72-184. The resulting protein based on this mass 
spectrometry analysis has a molecular weight of only 12.98 kDa but it may be 
that there are smaller peptides not detected by the mass spectrometry analysis. 
This could explain the discrepancy in size between the mass spectrometry 
result and that which was observed by SDS-PAGE analyses. The result of this 
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experiment confirmed that 3610 supernatant had proteolytic activity against 
recombinant TapA protein.  
3.1.8. TapA44-253 is unstable in vitro 
Consistent with TapA being subjected to proteolysis to a stable core, it was 
observed on multiple occasions that TapA44-253 was found to be unstable when 
stored in purification buffer (pH 7.6), at 4oC. To test this systematically, a 
controlled experiment was set up to observe the degradation process over time. 
It was found that the degradation of TapA44-253 progressed until a stable core 
was left. The stable core had an apparent molecular weight of ~17.5 kDa as 
judged by migration on SDS-PAGE (Figure 15D). As before the band was 
submitted for mass spectrometry analysis and found to comprise amino acids 
72-230, which is calculated to correspond to a protein of 18.22 kDa (Figure 
15E). Further analysis of the stable core by N-terminal sequencing, preliminarily 
indicated that the N-terminus of this protein started at amino acid 57 to give a 
protein of amino acids 57-230 which is predicted to be 20.05 kDa (Figure 15F). 
However, it should be noted that attempts to reproduce the result given by N-
terminal sequencing have not yet been successful, this is likely because the 
sample submitted is a product of a degradation process, therefore, it might not 
be of the purity required to obtain reliable results. Interestingly, the stable core 
detected here is similar to that obtained from degradation of recombinant TapA 





Figure 15: TapA is sensitive to degradation by extracellular enzymes. (A) TapA44-253 was 
purified and eluted in purification buffer, lyophilized and stored at 4oC and then re-suspended in 
water. 30 µg of protein was prepared in reducing conditions and run on 14% SDS-PAGE. (B) 
TapA44-253 protein (150 µg) was mixed 1:1 (vol:vol) with cell-free supernatant and incubated for 
24 h at 37oC. Arrow 1 indicates the degraded protein submitted for analysis shown in (C). (C) 
Protein identification result for TapA subjected to proteolysis with cell-free supernatants as 
shown in B. n=1. (D) TapA protein stored at 4oC in purification buffer was sampled at intervals 
of 7 days. The protein was boiled and subject to reducing conditions by incubation with β-Me 
and prepared samples were then stored at -20oC. 28 µg of TapA protein was run on 14% SDS-
PAGE. Arrow denoted 2 indicates the TapA stable core from week 12 which was submitted for 
protein identification. (E) Protein identification result for the TapA degradation product observed 
at week 12 shown in (C). n=1. (F) The result of Edman sequencing after 12 week old protein, 
the same sample analysed in (C), underwent N-terminal sequence analysis. n=1. Amino acids 
highlighted in green were consistent between the N-terminal sequencing result and the TapA 
sequence, amino acids in purple did not match.  The sequence of TapA is shown with matching 
peptides identified by mass spectrometry highlighted in red and bold text.  
 
3.1.9. The supernatant of PY79 has proteolytic activity against 
recombinant TapA 
Having shown that recombinant TapA is subject to degradation by the 
proteolytic activity of 3610 supernatant in vitro, it was predicted that 
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exoproteases are responsible for TapA processing in biofilms. The aim of the 
following experiment was to determine whether extracellular proteases are 
responsible for the processing of TapA to a low molecular weight in vivo. 
Testing this in B. subtilis 3610 biofilms would involve extensive mutagenesis to 
delete all of the genes encoding exoproteases. For this reason we first utilized 
available tools in the form of a Δ7 exoprotease-free B. subtilis PY79 strain, 
which is freely available to the community via the BGSC. The PY79 
exoprotease-free strain is denoted PY79-KO7 (Table 10) (Pohl et al., 2013). 
First, it was determined whether PY79 would serve as a viable model in place of 
3610 by testing the proteolytic activity of PY79 supernatant against recombinant 
TapA. Briefly, cell-free culture supernatants were obtained from PY79 
(NRS5786) and PY70-KO7 (NRS5787), which had been grown in MSgg media 
to stationary phase, and aliquots then incubated with 150 µg of TapA44-253 at 
37oC for 24 h. When TapA was co-incubated with PY79 supernatant the protein 
was found to migrate on SDS-PAGE with a lower apparent molecular weight 
when compared with the TapA44-253 that was used as the input in the assay 
(Figure 16A). To test whether this activity was exoprotease-dependent, TapA 
was co-incubated with PY79-KO7 supernatant. The product of this incubation 
was run on SDS-PAGE. In this case, TapA migrated to a similar extent as the 
input but migrated slightly further (Figure 16A). This indicated that TapA was 
subjected to a reduced level of proteolysis in the presence of PY79-KO7 
supernatant. The proteolytic activity of both PY79 and PY79-KO7 supernatants 
was abolished with heat treatment at 100oC for 10 min (PY79 +H and PY79-
KO7 +H) (Figure 16A). To summarise, PY79 supernatant displayed proteolytic 
activity against recombinant TapA protein as has been shown above for the 
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supernatant of 3610. This proteolytic activity was perturbed in a PY79-KO7 
mutant lacking genes encoding exoproteases. 
3.1.10. The general exoprotease activity of PY79 is abolished in the 
strains PY79-KO2 to PY79-KO7 
To determine which of the 7 exoproteases were important for TapA proteolytic 
activity the intermediate strains made as part of the project which generated 
PY79-KO7 were obtained from BGSC (Table 10). First, the exoprotease activity 
of PY79-KO7 and all of the intermediates strains PY79-KO1 to PY79-KO6 was 
tested. This was done by growth of the strains on LB agar, supplemented with 
1.5% (w/v) milk for 18 h at 37oC. Exoprotease activity can be observed in this 
assay by the presence of a “halo” around the growing colony which results from 
degradation of milk proteins present in the media. The strain 3610 degU was 
included as a negative control, this strain carries a disruption in the degU gene 
which regulates the expression of degradative enzymes (Cairns et al., 2015). 
3610 degU did not display proteolytic activity in this assay. It was found that 
wild-type PY79 and PY79-KO1 displayed protease activity, as judged by the 
presence of a halo around the colony (Figure 16B). However, strains PY79-
KO2 to PY79-KO7 did not display any observable proteolysis of milk proteins 
indicating reduced exoprotease activity (Figure 16B). This result demonstrated 
that the non-specific proteolytic activity, apparent by this assay, of PY79 can be 
perturbed in the absence of just two of the exoproteases, encoded by the nprE 
and aprE genes, which are deleted in the strain PY79-KO2. However, as 
multiple mutagenesis steps were carried out in order to generate strain PY79-




Strain Genotype strain number 
PY79 Parental strain NRS5786 
PY79-KO1 ∆nprE  NRS5807 
PY79-KO2 ∆nprE ∆aprE  NRS5808 
PY79-KO3 ∆nprE ∆aprE ∆epr  NRS5809 
PY79-KO4 ∆nprE ∆aprE ∆epr ∆mpr  NRS5810 
PY79-KO5 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB  NRS5811 
PY79-KO6 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB ∆vpr  NRS5812 
PY79-KO7 ∆nprE ∆aprE ∆epr ∆mpr ∆nprB ∆vpr ∆bpr  NRS5787 
Table 10: A list of the PY79 exoprotease mutant strains used in this study. 
 
Figure 16: TapA processing by PY79 supernatant is exoprotease-dependent. (A) TapA44-
253 protein (150 µg) was mixed 1:1 (vol:vol) with cell-free supernatant and incubated for 24 h at 
37oC. 30 µg of protein was run on 14% SDS-PAGE and stained with InstantBlue. The 
supernatant was incubated at 100oC for 10 min for heat-inactivation (+H). n=1. (B) PY79 
(NRS5786) and intermediate protease mutants (Table 10) were grown on LB agar containing 
1.5% milk. 3610 degU is included as an exoprotease-negative control. n=3. 
3.1.11. The tapA gene is expressed in PY79-KO7  
The PY79-derived strains used in this study have undergone multiple 
mutagenesis steps and PY79 does not form complex colony biofilms. Therefore, 
it was investigated as to whether tapA was transcribed in both the parental 
strain PY79 (NRS5786) and in the mutant strain PY79-KO7 (NRS5787). To test 
this, the strains 3610, 3610 ΔtapA (NRS3936), PY79 (NRS5786) and PY79-
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KO7 (NRS5787) were grown in MSgg broth to stationary phase (Figure 17A). 
Total RNA was extracted from cell lysates and RNA quality was assesed by 
agarose gel electrophoresis (Figure 17B). The isolation of high quality RNA 
was confirmed by the observation of distinct bands corresponding to rRNA and 
by the absence of smearing which when present is indicative of degradation in 
each of the samples. Isolated RNA was then used as the template in the 
synthesis of cDNA with a reverse transcriptase enzyme. Genomic DNA isolated 
from PY79-KO7 (PY79-KO7 gDNA) served as the positive control in the 
subsequent PCR of 16S rRNA and tapA (Figure 17C). The no template control 
was included to ensure the result of the PCR was not impacted by 
contaminating DNA sequences. It was confirmed by reverse-transcription PCR 
(RT-PCR) of the 16S rRNA gene that cDNA was successfully generated in each 
of the samples (Figure 17C). The 16S amplification was only observed in the 
samples which had been processed in the presence of the reverse transcriptase 
(RT) enzyme indicating that the RNA isolated was free of DNA contamination. 
To determine if the tapA transcript was present in the samples PCR 
amplification was carried out with tapA specific primers (Figure 17C). It was 
found that the 3610 sample contained tapA transcript which was absent in the 
ΔtapA sample, as expected. Both PY79 and PY79-KO7 were positive for the 
tapA transcript (Figure 17C). This confirms that the tapA gene is expressed in 
PY79 and PY79-KO7 grown under conditions known to induce tapA expression 
in 3610. This confirms the validity of using the PY79 and exoprotease mutants, 
which are derived from this strain, as an initial model for the investigation of 




Figure 17: The tapA transcript is present in PY79 and PY79-KO7 cells grown to stationary 
phase. (A) Growth curve of 3610, ΔtapA (NRS3936), PY79 (NRS5786) and PY79-KO7 
(NRS5787) strains grown in MSgg broth to stationary phase, as judged when growth levelled off 
at an OD600nm measurement of approximately 2.5. The x-axis measure of OD600nm is shown as a 
logarithmic scale, the y-axis shows time in hours (h). (B) RNA isolated from stationary phase 
cultures. >100 ng of purified RNA from each sample was run on a 2% agarose gel to assess 
RNA quality. (C) RT-PCR of (Top) 16S rRNA to confirm the presence of cDNA in RNA samples 
treated with reverse transcriptase (RT) and (Bottom) RT-PCR of tapA demonstrating the 
presence of tapA transcript in PY79-KO7 cells. n=1.  
3.1.12. TapA processing is perturbed in exoprotease mutants 
derived from PY79 
As demonstrated above, the tapA gene is expressed in the PY79 strain 
background, it was next investigated if the TapA protein could be detected in 
vivo and whether it undergoes processing in the absence of the exoprotease 
encoding genes. To test this, protein was extracted from cells grown under the 
same conditions as before and cell lysates were analysed by αTapA 
immunoblot. As was shown previously, 3 bands were detected by the αTapA 
antibody in the 3610 lysate and the same characteristic banding pattern was 
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observed in the PY79 lysate (Figure 18A). As expected these bands were 
absent in the ΔtapA lysate (Figure 18A). This result confirmed that PY79 cells 
produces TapA under the conditions tested. In PY79-KO7, the highest 
molecular weight TasA band of ~30 kDa was present but the other 2 bands 
were absent. Interestingly, an additional band, found below the TasA band, with 
an apparent molecular weight of ~28 kDa (Arrow *) was detected in the 
protease-free cells (Figure 18A). This band is similar in size to the calculated 
full-length TapA MW of 29.08 kDa (Figure 18A). This may represent an 
unprocessed form of TapA. These findings, in conjunction with the absence of 
the low molecular weight form of TapA and the TasA/TapA-dependent band, 
indicated that TapA processing is perturbed in PY79-KO7. 
In order to determine whether cleavage of TapA was dependent on the action of 
any specific protease the intermediate exoprotease-mutant PY79 strains (Table 
10), the TapA banding pattern was analysed by αTapA immunoblot. Strains 
were grown as before in MSgg media to stationary phase before cell lysates 
were separated by SDS-PAGE. It was found that TapA processing occurred 
similar to wild-type, with the detection of the low molecular weight 16 kDa form 
of TapA, in strains PY79-KO1 to PY79-KO5 (Figure 18B, arrow 3). The 16 kDa 
band was, however, absent in PY79-KO6 and the protease-free strain PY79-
KO7 (Figure 18B). Therefore, the loss of the low molecular weight form of TapA 
coincided with the deletion of vpr. In contrast, the TasA/TapA-dependent band 
found at an apparent molecular weight of 18 kDa was present in all strains, with 
the exception of PY79-KO7 (Figure 18B, arrow 2). In PY79-KO7 the 28 kDa 
band, which is thought to be unprocessed TapA, was observed as before 
(Figure 18B, arrow 1). To summarise, PY79-KO6 and PY79-KO7 strains 
displayed the most noticeable differences in TapA processing. This indicated 
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that either there is redundancy in exoprotease activity against TapA or that the 
final 2 exoprotease genes deleted have a specific role in processing TapA. 
 
Figure 18: TapA processing in PY79 exoprotease mutants as analysed by αTapA 
immunoblot. (A) αTapA immunoblot of 3610, ΔtapA (NRS5045), PY79 (NRS5786) and PY79-
KO7 (NRS5787) grown in MSgg broth. Arrow * = unprocessed TapA. n=1. (B) αTapA 
immunoblot of PY79 (NRS5786) and PY79 exoprotease mutant cell lysates: PY79-KO1 
(NRS5807), PY79-KO2 (NRS5808), PY79-KO3 (NRS5809), PY79-KO4 (NRS5810), PY79-KO5 
(NRS5811), PY79-KO6 (NRS5812) and PY79-KO7 (NRS5787). n=1. Arrow 1 = unprocessed 
TapA, Arrow 2 = TasA/TapA-dependent band and Arrow 3 = low molecular weight TapA. 
 
3.1.13. 3610 comI is a suitable system for studying the role of TapA 
processing in biofilm development 
As shown above, TapA processing is dependent on secreted proteases in strain 
PY79, and TapA processing is conserved in several B. subtilis species. 
Therefore, we wanted to test the role of TapA processing on biofilm formation. 
To investigate this, a protease-free version of 3610 was required. However, the 
3610 strain used in this study is not genetically competent (Nijland et al., 2010). 
To facilitate the mutagenesis process a competent derivative of 3610, named 
3610 comI was obtained (Konkol et al., 2013). First it was confirmed if strain 
3610 comI developed mature biofilms on MSgg media for 48 h. The 3610 comI 
strain formed biofilms which were indistinguishable from those formed by the 
3610 strain used throughout this work (Figure 19) and it was judged to be an 
107 
 
appropriate system for understanding the role of TapA processing in biofilm 
formation.  
 
Figure 19: The biofilm morphology of 3610 and 3610 comI. The biofilm morphology of 3610 
and 3610 comI (NRS6017) grown on MSgg agar for 48 h before image capture. Scale bar = 0.5 
cm. Images are representative of at least 3 independent replicates. 
 
3.1.14. An exoprotease-free version of 3610 comI (NRS6362) was 
generated 
To allow for the investigation of the role exoproteases play in TapA processing 
and biofilm formation, an exoprotease-free 3610 comI strain was generated. To 
make this strain, 3610 comI was transformed using B. subtilis genomic DNA 
containing a resistance cassette in place of the gene of interest. This was 
possible thanks to the use of a genome-wide deletion library which is available 
for B. subtilis (Koo et al., 2017a). Through this method, an antibiotic resistance 
cassette was incorporated in place of the wild-type gene by homologous 
recombination. On confirmation of successful disruption the cassette was then 
excised to allow the next gene to be deleted. Gene deletions that were proving 
problematic to construct by this method were successfully obtained by using 
phage transduction. The strains generated by this method are shown in Table 
11. Importantly, the exoprotease genes were deleted in the opposite order from 
which they were deleted in generating the PY79-KO7. In other words, in 
generating PY79-KO7, the nprE gene was disrupted first and the bpr was 
disrupted last (Table 10). In contrast, the bpr gene was disrupted first and the 
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nprE was disrupted last in generating 3610-KO7 (Table 11).  This decision was 
based on the above observation that PY79-KO6 and PY79-KO7 cell lysates 
displayed the most noticeable differences in TapA processing indicating that the 
genes bpr and vpr may have a specific role in processing TapA. Alternatively, it 
was suggested that the ability to cleave TapA is a redundant property shared by 
multiple or all of the exoproteases. 
Strain Genotype strain number 
3610 comI Parental strain NRS6017 
3610-KO1 Δbpr NRS6047 
3610-KO2 Δbpr Δvpr  NRS6049 
3610-KO3 Δbpr Δvpr ΔnprB  NRS6061 
3610-KO4 Δbpr Δvpr ΔnprB Δmpr  NRS6063 
3610-KO5 Δbpr Δvpr ΔnprB Δmpr Δepr  NRS6065 
3610-KO6 Δbpr Δvpr ΔnprB Δmpr Δepr ΔaprE  NRS6341 
3610-KO7 Δbpr Δvpr ΔnprB Δmpr Δepr ΔaprE ΔnprE NRS6362 
Table 11: A list of the 3610 comI exoprotease mutant strains generated in this study and 
used to aid the understanding of TapA processing in the biofilm. 
3.1.15. The general exoprotease activity of 3610-KO7 is abolished  
As was shown above the general exoprotease activity of PY79 was abolished 
on disruption of just 2 of the exoprotease genes, nprE and aprE. To allow a 
comparison, the impact on general exoprotease activity upon deletion of 
exoprotease genes in 3610 was tested. The exoprotease genes were deleted in 
reverse order from that in the PY79 mutants. The exoprotease activity of the 
exoprotease-free 3610 strain (3610-KO7), and all of the intermediate strains, 
were tested by growth on LB agar, that was supplemented with 1.5% (w/v) milk, 
for 18 h at 37oC. It was found that the wild-type 3610 strain displayed protease 
activity, as determined by the presence of a halo around the colony (Figure 
20A). The strain 3610 degU, was defective in the production of degradative 
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enzymes, and serves as a negative control in this assay and did not display 
detectable exoprotease activity (Verhamme et al., 2007). Interestingly, the halo 
around 3610 was larger than that observed around the PY79 colony grown 
under the same conditions, compare with Figure 16B. All of the intermediate 
strains from 3610-KO1 to 3610-KO6 showed a comparable halo to the 3610 
(Figure 20A). This is consistent with the idea that 3610 has more general 
exoprotease activity than PY79. This is because it was shown previously that 
most of the intermediate strains of PY79, PY79-KO3 to PY79-KO7, did not 
display any detectable exoprotease activity (Figure 16B). Importantly, the 3610-
KO7 exoprotease-free strain did not have observable proteolytic activity against 
milk proteins as judged by the absence of a halo around the colony (Figure 
20A). Therefore, the generalised exoprotease activity of strain 3610-KO7 is 
abolished as determined by an ability to degrade milk proteins. In contrast, the 
exoprotease activity of PY79 is abolished on deletion of just 2 exoprotease 
genes. 
3.1.16. The processing of TapA in the biofilm is dependent on the 
action of extracellular proteases 
To assess the impact of deleting the exoprotease genes on TapA processing, 
an αTapA immunoblot was carried out using protein extracted from 3610 comI 
and 3610 exprotease mutant biofilms. Processing in the 3610-KO1 (bpr) strain 
was similar to that observed in the wild-type biofilm, with the observation of the 
characteristic 3 bands which included the presence of the low molecular weight 
TapA band of 16 kDa (Figure 20B, Arrow 1). The low molecular weight TapA 
band was no longer observed in the 3610-KO2 to 3610-KO6 intermediate 
strains or the exoprotease-free strain 3610-KO7 (Figure 20B). The loss of this 
16 kDa band therefore coincided with the deletion of the vpr gene (the genotype 
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of 3610-KO2 is Δbpr Δvpr). This is in agreement with the result shown in Figure 
18B in which the presence of this band was shown to be dependent on the 
presence of the vpr gene in the PY79 strain background. All strains exhibited a 
band resembling the TasA/TapA dependent band present in wild-type 3610 
comI biofilms of approximately 18 kDa (Figure 20B, Arrow 2). Interestingly, a 
band of >25 kDa was visible in the 3610-KO6 and 3610-KO7 strains (Figure 
20B, Arrow 3). This band is found below the non-specific TasA band, which was 
found in all of the strains (Figure 20B, Arrow denoted TasA). It is predicted that 
this band contains unprocessed TapA.  
3.1.17. Exoproteases are not needed for complex colony 
development in 3610 biofilms 
It was shown that TapA processing in 3610 biofilms is impacted by the absence 
of exoproteases. To determine if aberrant processing of TapA had an impact on 
biofilm formation the architecture was examined. Interestingly, all of the biofilms 
formed by these strains displayed wild-type colony complexity (Figure 20C). 
This result demonstrated that gross biofilm morphology is not impacted by the 
loss of the 7 exoprotease encoding genes. 
 
3.1.18. Cell-free 3610-KO7 supernatant retains residual activity 
against TapA in vitro 
It was shown earlier that in vitro TapA cleavage by PY79 supernatant was due 
to the action of exoproteases. On construction of the 3610 exoprotease mutants 
(Table 11), it was tested whether the ability of 3610 supernatant to cleave TapA 
in vitro was impacted. To test this, purified TapA44-253 protein was incubated with 
spent culture supernatant from 3610-KO7 (NRS6362) and the integrity of the 
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protein was analysed by SDS-PAGE (Figure 20D). The 3610-KO7 culture 
supernatant retained residual proteolytic activity against TapA when compared 
to wild-type 3610 supernatant or the TapA44-253 input used in the assay (Figure 
20D). The proteolytic activity of the supernatant was abolished upon heat-
treatment as before (3610 +H and 3610-KO7 +H). It was interesting to note that 
higher molecular weight forms of TapA were observed in the input sample and 
the TapA which was incubated with heat-inactivated supernatants, however, 
these were absent in the samples in which TapA degradation could be 
observed. 
 
Figure 20: Biofilm formation in 3610 is independent of exoprotease activity. (A) 3610 comI 
strains were examined for protease activity by growth on LB 1.5% milk agar plates: 3610 comI 
(NRS6017), 3610-KO1 (NRS6047), 3610-KO2 (NRS6049), 3610-KO3 (NRS6061), 3610-KO4 
(NRS6063), 3610-KO5 (NRS6065), 3610-KO6 (NRS6341), 3610-KO7 (NRS6362). n=3. (B) 
Protein was extracted from 3610 exoprotease mutant biofilms and analysed by αTapA 
immunoblot. n=2. Arrow 1 = low molecular weight TapA, Arrow 2 = TasA/TapA-dependent band 
and Arrow 3 = unprocessed TapA. Arrow TasA denotes the non-specific TasA band detected 
using the αTapA antibody. (C) The biofilm morphology of 3610 comI and exoprotease mutants 
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derived from this parental strain. Strains were grown on MSgg for 48 h before imaging. n=5. (D) 
TapA44-253 protein was mixed 1:1 (vol:vol) with cell-free supernatant obtained from 3610-KO7, 
and incubated for 24 h at 37oC, the amount of TapA protein in the assay was 150 µg. 30 µg pf 
protein was run on 14% SDS-PAGE and stained with InstantBlue. To heat-inactivate (+H), 
supernatant was incubated at 100oC for 10 min. n=1. Note that this figure is an extended 
version of that shown in Figure 15B. Scale bar = 0.5 cm. 
 
In combination, these results demonstrate that the exoproteases of strain 3610 
are responsible for most of the proteolysis of TapA observed in the supernatant 
assay carried out. However, it may be that sufficient TapA processing occurs in 
3610-KO7, based on the residual proteolytic activity displayed by 3610-KO7 
supernatant, to produce a functional form of TapA needed for biofilm formation. 
3.1.19. Summary 
The work carried out here investigated the function of TapA in the formation of 
B. subtilis biofilms. As previously published, when either the tapA or tasA gene 
is deleted then biofilm complexity is lost. In agreement with published findings, 
reduced levels of TasA are observed in biofilms formed by the ΔtapA mutant. 
For this reason a ΔtapA mutant can be thought of as somewhat akin to a ΔtapA 
ΔtasA double mutant.  
With the aid of an αTapA antibody it was found that TapA undergoes processing 
to a low molecular weight form in vivo. PY79 was used as a model system for 
studying the role of exoproteases in this phenomenon. It was found that TapA 
processing in vivo is dependent, at least in part, on exoprotease genes. The 
generation of low molecular weight TapA (16kDa) was shown to be dependent 
on the presence of the vpr gene. However, as PY79 does not form complex 
biofilms this work was recapitulated in 3610.  
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An exoprotease-free 3610 (3610-KO7) strain was developed using a competent 
variant of 3610 called 3610 comI. The generalised exoprotease activity of 3610-
KO7 was abolished as judged by the ability to degrade milk proteins present in 
the growth substrate. Finally, it was found that TapA processing was aberrant in 
the 3610-KO7 mutant but that this strain still formed mature biofilms resembling 
wild-type in appearance. This result may be explained by the subsequent 
finding that 3610-KO7 supernatant has residual proteolytic activity against 
recombinant TapA in vitro. Additionally, it was shown that the low molecular 
weight form of TapA was dependent on the presence of the vpr gene, 




3.2. Development of a model to probe the interaction between TapA and 
TasA 
3.2.1. Background 
We have shown, in section 3.1, that TapA is a critical component in B. subtilis 
biofilms. In agreement with published findings, it was also shown that TapA is 
needed to maintain wild-type levels of TasA in the biofilm. The current model for 
TapA function is that it is a component of TasA fibres which extend from the cell 
surface, anchoring them to the cell envelope. However, there is limited 
knowledge as to which components of the TapA protein are needed for its 
function in aiding biofilm development. 
To examine, in more detail, the molecular mechanisms of the interaction 
between TapA and TasA an assay was designed. This was based on the 
finding that recombinant TasA fibres are functional in vivo. TasA produced 
heterologously in E. coli, produces fibres in vitro (hereafter referred to as fTasA 
for fibrous TasA) (Erskine et al., 2018). This ability of fibrous TasA to form in the 
absence of TapA was an interesting observation. Furthermore, contrary to 
published work when these fibres were added exogeneously, wild-type 
morphology could not be restored to ΔtasA biofilms (Erskine et al., 2018). 
Additionally, when native fibres (ntTasA), extracted from 3610, were added 
exogeneously to ΔtasA biofilms there was also no noticeable increase in 
rugosity (Erskine et al., 2018).  
 
Serendipitously, an additional loss of function mutation in the gene encoding 
sinR was detected in a separate ΔtasA isolate. The inclusion of a small region 
of duplication in the sinR coding region, essentially disrupting the coding region, 
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was confirmed by whole genome sequencing. The sinR gene is proximal to the 
tapA operon on the chromosome and so may have been disrupted during the 
homologous recombination event in which tasA was deleted. The architecture of 
this region of the genome is shown in Figure 21A. By comparison with 3610 
biofilms, a sinIR::spec (NRS2012) mutant forms biofilms with a densely wrinkled 
appearance (Figure 21B) as first observed by (Kearns et al., 2005). In contrast, 
the biofilms formed by ΔtasA sinR (NRS5248) are flat and featureless (Figure 
21B). Interestingly, it was found that the exogeneous provision of 20 µg of 
fTasA to the double mutant ΔtasA sinR (NRS5248) resulted in a densely 
wrinkled morphology, resembling that of a sinIR::spec mutant (Figure 21B). 
These results demonstrated the biological activity of recombinant fTasA in vivo. 
This finding is attributed to Elliot Erskine and has been published (Erskine et al., 
2018). 
 
It is not clear why an additional mutation was required to acheive exogeneous 
complementation of ∆tasA biofilms with fTasA. It is known that SinR functions 
as a repressor of biofilm formation inhibiting transcripton of the tapA and eps 
operons (Chu et al., 2006; Kearns et al., 2005), so it may be that increased 




Figure 21: The exogeneous provison of fTasA restores structure to a ΔtasA sinR mutant. 
(A) The architecture of the tapA operon and the location of genes sinR and sinI. Open reading 
frames (ORF) are shown as coloured, elongated arrows.  The bents arrows indicate the 
promoter which drives expression of the operon as well as the internal promoter which is found 
within the region of the sipW ORF which serves as an additional control of tasA gene 
expression. The transcriptional terminator for the tapA operon is shown as a stick and circle. 
The sinR and sinI ORFs are orientated in the opposite direction to the tapA operon and 
encoded on the opposite strand of DNA. (B) Biofilm images of 3610, sinIR::spec (NRS2012) 
and ∆tasA sinR (NRS5248). Biofilms were either spotted onto MSgg plates with buffer (+buffer) 
or fTasA (+fTasA). Images are representative of more than 3 independent replicates. Scale bars 
= 0.5 cm. 
 
Given the result presented above, it was hypothesised that by deleting tapA in 
the strain ΔtasA sinR, to generate ΔtapA ΔtasA sinR, that this may provide an 
opportunity to study the molecular basis of the relationship between TasA and 
TapA. Based on published research (Romero et al., 2011, 2014), it was 
anticipated that without the presence of TapA then exogeneous TasA fibres 
would not be able to rescue biofilm formation. TapA is reported to be a 
component of TasA fibres which anchors them to the cell. In this way, tapA 
variants could be introduced into these strains and assessed for the ability to 
restore wild-type biofilm morphology when fTasA is added exogeneously. It was 
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hoped that this might lead to the identification of protein-protein interaction sites 
between TasA and TapA. However, the tapA gene first had to be deleted in the 
ΔtasA sinR strain background to generate the strain ΔtapA ΔtasA sinR 
(NRS5749). 
3.2.2. TapA is not needed for the exogeneous complementation of ΔtasA 
sinR biofilms 
Strain ΔtapA ΔtasA sinR (NRS5749) was generated from the parental strain 
∆tasA sinR (NRS5248) by the deletion of the tapA gene using the pMAD 
plasmid (pNW685). After construction, since ΔtapA ΔtasA sinR had undergone 
multiple rounds of mutagenesis the intergrity of the strain was tested. To 
determine if the biofilm phenotype of the strain could be genetically 
complemented, the tapA operon was introduced to the amyE locus under the 
control of the IPTG inducible Pspank promoter. This generated the strain ΔtapA 
ΔtasA sinR + pIPTG-tapA-sipW-tasA (NRS5763). 3610 biofilms display 
characteristic corrugations, in contrast, the biofilms formed by the ΔtasA sinR 
double mutant and the triple mutant ΔtapA ΔtasA sinR displayed flat, 
featureless phenotypes (Figure 22A). It was shown that inducing expression of 
the tapA operon in the strain ∆tapA ∆tasA sinR + pIPTG-tapA-sipW-tasA 
(NRS5762) restored the biofilm to the densley wrinkled appearance which is 
displayed by the sinIR::spec biofilm (Figure 22A). Note that in our experience 
there is basal levels of expression from the Pspank promoter in the absence of 
IPTG. This explains the rugose morphology of ∆tapA ∆tasA sinR + pIPTG-tapA-
sipW-tasA grown without IPTG (Figure 22A). Together these results 
demonstrate that the strain could be genetically complemented with respect to 
biofilm formation and is therefore suitable for use in the development of the 
assay described above. 
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It was predicted that addition of fTasA to ΔtapA ΔtasA sinR cells would not 
restore biofilm formation due to the absence of tapA. This would then allow for 
tapA variants to be introduced and the formation of wrinkles observed.  
To test this, either 20 µg of fTasA (+fTasA) or buffer (+buffer) was added to 
cells before spotting onto biofilm forming media. 3610 and sinIR::spec  
(NRS2012) biofilms are shown for comparison and demonstrate that the 
addition of buffer or fTasA does not disrupt biofilm formation. The exogeneous 
provision of 20 µg of recombinant fTasA to ΔtasA sinR (NRS5248) cells re-
instated rugosity as shown previously (Figure 22B). Interestingly, it was found 
that rugosity could be restored to the ΔtapA ΔtasA sinR (NRS5749) mutant with 
the addition of fTasA (Figure 22B). In both cases this is shown by comparison 
with buffer only controls where purification buffer is added to cells before 
spotting (Figure 22B). The result that fTasA was shown to be functional within 
the ΔtapA ΔtasA sinR biofilm was unexpected, given that TapA is thought to be 
needed for the anchoring of TasA fibres to the cell wall of matrix embedded 
3610 cells (Romero et al., 2011). However, it may be that fTasA can still attach 
to the cell surface by some other means in the system tested here. Given the 
result that TapA was not required for fTasA activity in vivo, the model proposed 
was no longer pursued as a viable method to study TasA/TapA interaction. 






Figure 22: TapA is not needed for the function of exogeneously added fTasA in the 
biofilm. (A) Genetic complementation of ΔtapA ΔtasA sinR biofilms with the tapA operon 
expressed from an ectopic locus under the control of an IPTG inducible Pspank promoter in the 
presence of 25 µM IPTG (+IPTG). 3610, ΔtasA sinR (NRS5248), ∆tapA ΔtasA sinR (NRS5749), 
sinIR::spec (NRS2012) and ΔtapA ΔtasA sinR + pIPTG-tapA-sipW-tasA (NRS5763) biofilms are 
shown. The image of NRS5248 originates from a separate biological replicate. (B) Ex vivo 
addition of purification buffer (+buffer) as a control or 20 µg of fibrous TasA (+fTasA) to 3610, 
sinIR::spec (NRS2012), ΔtasA sinR (NRS5248) and ΔtapA ΔtasA sinR (NRS5749) biofilms. 





3.3. A genetic approach to understand TapA function 
 
Background 
In the previous section it was shown that attempts to develop a model system 
for the study of TapA and TasA interaction were unsuccessful. The finding that 
TapA is not required for the bioactivity of TasA fibres when supplied ex vivo, 
suggested that a re-evaluation of TapA function and activity was warranted. 
Here a genetic approach is taken in an effort to understand the function of 
TapA. 
 
Previously, the TRUST algorithm has been used to search for imperfect repeats 
within the TapA protein sequence as a way to identify functionally important 
sequence regions (Romero et al., 2014). The presence of internal repeats within 
coding sequences can be indicative of duplication events which can be 
important for the evolution of new or modified protein function (Szklarczyk and 
Heringa, 2004). This analysis resulted in the detection of an internal repeat 
sequence: i) from amino acids 50 to 68 and ii) from 194 to 237. It was found that 
deletion of the region from 194 to 237 had no impact on TapA function, within 
the context of biofilm formation. However, removing amino acids 50-57 resulted 
in a TapA protein (TapAΔ50-57) that could no longer restore wild-type biofilm 
formation when produced in a ΔtapA mutant background. It was found that this 
protein acted in a dominant negative manner when it was produced in wild-type 
3610 cells that had the wild-type TapA protein (Romero et al., 2014). This 
resulted in defective biofilm structure at early stages of formation, from 12-18 h, 
and at 24 h. Replacement of residues 50-57 with the amino acid sequence 
LGPGIGNG also resulted in functionless TapA. It was found that cells 
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harbouring only the TapAΔ50-57 form of the protein had a defect in TasA 
localisation which was now only found in the cell portion of fractionated biofilms 
instead of both the cell and matrix fractions. Immunocytochemistry with αTapA 
antibodies, in combination with microscopy was used to detect the localization 
of TapA on B. subtilis cells. By this method TapA was found to organize in 
discrete foci on the cell surface. It was also found that purified TapA protein 
assisted TasA fibre polymerization in vitro. Interestingly, TapAΔ50-57 failed to 
assist in polymerisation when studied in the same assay (Romero et al., 2014).  
 
The aim here was to take an independent genetic approach to determine 
sequence features of tapA that are needed for TapA function. Natural variants 
of tapA found in related Bacillus species initially served as a source of genetic 
diversity for the interrogation of the B. subtilis sequence. Protein sequence 
comparisons illuminated highly conserved regions and redundant regions which 
became the focus of further investigation. This ultimately resulted in the 
identification of the minimal functional genetic unit of tapA which was found to 
encode the first 57 amino acids of the protein (TapA1-57). Finally, the 
requirement of a signal sequence for the activity of TapA in the biofilm, as 




3.3.1. The tapA coding sequence from related Bacillus species can 
restore biofilm architecture to 3610 ΔtapA biofilms 
As a starting point for investigating important features of TapA, the biofilm 
activity of TapA variants from related Bacillus species were analysed. The 
ability of B. pumilis (tapAB_pum), B amyloliquefaciens (tapAB_amy) and B. 
paralicheniformis (tapAB_para) tapA ORFs to restore biofilm formation in 3610 
ΔtapA (NRS3936) was tested. The tapA operon from each of these species is 
very well conserved, with the tapA gene being the most variable ORF within the 
operon (Appendix: Figures S1-S5 and Table S1). The tapA homologs were 
integrated at the amyE locus under the control of an IPTG inducible promoter. 
The strains were grown on MSgg media, in the presence of IPTG, for 48 h to 
promote biofilm formation. As shown previously, the biofilm formed by the 
parental 3610 strain displayed a wrinkled morphology (Figure 23A) and the 
ΔtapA (NRS3936) biofilm exhibited a smooth surface (Figure 23A). Biofilm 
complexity was restored to the ΔtapA + pIPTG-tapA (NRS5045) strain when the 
B. subtilis tapA variant was induced by the presence of IPTG. Heterologous 
expression of the tapA homologs was shown to restore biofilm architecture to 
ΔtapA + pIPTG-tapAB_pum, ΔtapA + pIPTG-tapAB_amy and ΔtapA + pIPTG-
tapAB_para biofilms (Figure 23A). This result demonstrated that tapA homologs 
from related Bacillus species encode TapA homologs which are functional in the 
B. subtilis 3610 ΔtapA strain. To examine important sequence features in 




3.3.2. The conserved region 111-SKWKWELHK-120 is not needed for 
TapA function in the biofilm 
A clustal omega protein sequence alignment of TapA homologs is shown in 
Figure 23B. It was observed that there is a well conserved region between 
residues 111-120 (Figure 23B, Red box). This suggested that the conservation 
of this region in the functional TapA homologs tested, may be indicative of an 
important role for this region in conveying biological activity to TapA in the 
biofilm. Therefore, a tapA variant which encoded full-length TapA with residues 
113-118 changed to alanine was constructed. The variant TapA111-SKAAAAAAKL-120
 
is hereafter called TapAΔcons for convenience. The gene encoding the TapAΔcons 
variant was introduced at the amyE locus under the control of an IPTG-inducible 
promoter to make the strain ΔtapA + pIPTG-tapAΔcons (NRS5794). To test the 
functionality, the strain was grown on MSgg media for 48 h to promote biofilm 
formation. The biofilm formed by the parental 3610 strain exhibited complex, 
wrinkled morphology (Figure 23C) and as expected the ΔtapA (NRS3936) 
biofilm was flat and featureless (Figure 23C). The induction of tapA in strain 
ΔtapA + pIPTG-tapA (NRS5045) restored wild-type biofilm architecture. 
Interestingly, growing the strain ΔtapA + pIPTG-tapAΔcons (NRS5794) in the 
presence of IPTG also restored biofilm complexity (Figure 23C). This result 
indicated that this conserved region is not required for TapA activity in the 
biofilm.  
To observe the TapAΔcons variant in vivo, biofilm lysates were analysed by 
αTapA immunoblot. The stained SDS-PAGE, which serves as a loading control 
for this experiment, is shown in Figure 23D. As discussed earlier, the αTapA 
antibody recognises 3 bands with the lowest molecular weight band being 
confirmed as TapA and the 2 higher bands being TasA-dependent. Only the low 
124 
 
molecular weight TapA band was observed in the ΔtasA sample (Figure 23E). 
As before, the 3 bands were observed in the 3610 biofilm lysates but absent in 
the ΔtapA lysate (Figure 23E). The 3 bands could be observed in lysates 
originating from the strain ΔtapA + pIPTG-tapA (NRS5045) in an IPTG-
dependent manner. Interestingly, the lower 2 bands were absent in the ΔtapA + 
pIPTG-tapAΔcons (NRS5794) lysate even in the presence of IPTG (Figure 23E). 
However, the TasA-dependent band at ~30 kDa was present on induction with 
IPTG, moreover, the biofilm presented a wild-type phenotype. This result was 
unexpected given that the αTapA antibody detected TasA (non-specifically) yet 
was unable to detect the TapAΔcons variant. Taken together these results 
indicated that this region is important for antibody recognition but that it was not 
required for biofilm formation. Next, the question was raised as to whether there 
are distinguishable features between the tapA homologs that may help 




Figure 23: Homologous TapA proteins from related Bacillus species display acitvity in 
the 3610 biofilm. (A) The morphology of ΔtapA biofilms with the induction of tapA homologs: 
3610, ΔtapA (NRS3936), ΔtapA + pIPTG-tapA (NRS5045), ΔtapA + pIPTG-tapAB_pum 
(NRS5046), ΔtapA + pIPTG-tapAB_amy (NRS5047), ΔtapA + pIPTG-tapAB_para (NRS5743). n>3. 
(B) A clustal omega alignment of TapA protein sequences derived from Bacillus subtilis and 
related Bacillus species. Highlighted in black are residues with 100% conservation between the 
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4 sequences. A red box is used to demark the conserved region from amino acids 111-120. (C) 
Biofilms of 3610, ΔtapA, ΔtapA + pIPTG-tapA (NRS5045) and ΔtapA + pIPTG-tapAΔcons 
(NRS5794) grown in the presence of 25 µM IPTG for 48 h. n=3. (D) Biofilm lysates of the same 
set of strains as shown in (C) analysed by SDS-PAGE on a 12% acrylamide gel, 72 µg of 
protein was loaded for each sample, this gel stained with InstantBlue serves as a loading 
control for (E). n=3. (E) αTapA immunoblot of biofilm lysates. n=1 (E). - = 0 µM IPTG + = 25 µM 
IPTG. Arrow 1 corresponds to TasA (30 kDa band), arrow 2 indicates a TasA/TapA-dependent 
band (~18 kDa) and arrow 3 is TapA (16 kDa). Scale bars = 0.5 cm. 
 
3.3.3. The minimal genetic unit required for TapA function encodes the 
first 57 amino acids of the protein  
Revisiting the TapA sequence alignment it was found that B. pumilis TapA, at 
only 175 amino acids, is the shortest of the homologs tested in this study. 
Strikingly, the TapA homolog from B. pumilis was shown to be functional in B. 
subtilis. Given this result, the aim of the next set of experiments was to 
determine whether the C-terminus of TapA is necessary for biofilm function. To 
test this, a B. subtilis tapA variant was constructed encoding amino acids 1-193 
(TapAB_sub1-193). This construct is designed to mimic the truncated C-terminus 
observed in B. pumilis TapA. Biofilm formation was analysed by growth of the 
bacterial strains on MSgg media for 48 h before image capture. The 3610 
biofilm exhibited a typical rugose, complex appearance while the ΔtapA strain 
was featureless and smooth (Figure 24A). The ΔtapA + pIPTG-tapA (NRS5045) 
and ΔtapA + pIPTG-tapA1-193 (NRS5744) strains were found to form wild-type 
biofilms when expression was induced with IPTG (Figure 24A). This result 
demostrated that tapA1-193 encodes a functional product and that the portion of 
the C-terminus from amino acids 193-253 is not needed for activity in the 
context of biofilm formation. This is consistent with a previous report that amino 
acids 194 to 237 can be removed without impacting TapA function (Romero et 
al., 2014).  
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The result of this experiment, in combination with th role of exoproteases in 
TapA processing, raised the question of how much of the C-terminus is required 
for its activity in the biofilm. To address this, a series of truncated forms of the 
tapA ORF were designed to determine the minimal coding region that was 
needed to yield an active gene product (termed the minimal functional unit: 
mfu). Through the systematic analysis of 22 constructs the ΔtapA biofilm defect 
was found to be rescued upon provision of a very short region of the gene 
encoding amino acids 1-57. This was demonstrated with the strain ΔtapA + 
pIPTG-tapA1-57 (NRS6041) forming wild-type biofilms (Figure 24A). In this case 
biofilm formation was considered complemented when rugose structure was 
restored to the colony in the presence of IPTG. In fact, all of the constructs 
encoding TapA variants from amino acids 57 up to 253 in length restored 
complexity to the biofilm (Figure 24A). In contrast, the biofilms formed by the 
strain ΔtapA + pIPTG-tapA1-56 (NRS6025) displayed only partial structuring. 
Moreover, increasing the IPTG concentration, from 25 µM to 1 mM, to boost 
transcription of the coding region, did not restore wild-type morphology to ΔtapA 
+ pIPTG-tapA1-56 biofilms (Figure 24A). Biofilms formed by ΔtapA + pIPTG-
tapA1-50 (NRS6002) phenocopied the appearance of ΔtapA biofilms indicating 
that tapA1-50 does not encode a functional form of the protein (Figure 24A). 
Taken together these results confirm that the minimal functional unit of tapA 
which is sufficient to convey biofilm activity is that which is encoded by tapA1-57. 
It was surprising that such a limited part of the protein was needed given the 
level of amino acid conservation between TapA orthologues in the core of the B. 
subtilis sequence from amino acids 58-195, which is shown here to be 
redundant in regards to the biofilm activity of TapA. For comparison an 
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illustration of WT TapA (Figure 24B) and TapA1-57 (Figure 24C) are depicted to 
convey the strikingly small proportion of TapA that is needed for activity.  
 
 
Figure 24: The minimal functional unit of tapA encodes the first 57 amino acids of the 
protein. (A) Biofilm morphology of ΔtapA biofilms producing truncated TapA variants with tapA 
expressed from the amyE locus in an IPTG-dependent manner. Strains harbouring IPTG-
inducible promoters are grown as biofilms in the presence of 25 µM IPTG unless otherwise 
stated. The following strains are shown: 3610, ∆tapA (NRS3936), ∆tapA + pIPTG-tapAwt 
(NRS5045), ΔtapA + pIPTG-tapA-Bs_tapA1-193 (NRS5744), ΔtapA + pIPTG-tapA-Bs_tapA1-188 
(NRS5789), ΔtapA + pIPTG-tapA-Bs_tapA1-183 (NRS5790), ΔtapA + pIPTG-tapA-Bs_tapA1-178 
(NRS5791), ΔtapA + pIPTG-tapA-Bs_tapA1-163 (NRS5814), ΔtapA + pIPTG-tapA-Bs_tapA1-153 
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(NRS5813), ΔtapA + pIPTG-tapA-Bs_tapA1-143 (NRS5806), ΔtapA + pIPTG-tapA-Bs_tapA1-133 
(NRS5805), ΔtapA + pIPTG-tapA-Bs_tapA1-123 (NRS5819), ΔtapA + pIPTG-tapA-Bs_tapA1-113 
(NRS5988), ΔtapA + pIPTG-tapA-Bs_tapA1-103 (NRS5989), ΔtapA + pIPTG-tapA-Bs_tapA1-95 
(NRS6005), ΔtapA + pIPTG-tapA-Bs_tapA1-88 (NRS6004), ΔtapA + pIPTG-tapA-Bs_tapA1-71 
(NRS6003), ΔtapA + pIPTG-tapA-Bs_tapA1-65 (NRS6005), ΔtapA + pIPTG-tapA-Bs_tapA1-60 
(NRS6044), ΔtapA + pIPTG-tapA-Bs_tapA1-59 (NRS6043), ΔtapA + pIPTG-tapA-Bs_tapA1-58 
(NRS6042), ΔtapA + pIPTG-tapA-Bs_tapA1-57 (NRS6041), ΔtapA + pIPTG-tapA-Bs_tapA1-56 
(NRS6025) and ΔtapA + pIPTG-tapA-Bs_tapA1-50 (NRS6002). Bs_tapA = B. subtilis tapA. Scale 
bar = 0.5 cm. Images representative of at least 3 independent replicates. (B) The full-length 
TapA protein and (C) the TapA1-57 minimal functional unit. These schematics show the TapA 
protein, highlighting regions of interest such as the signal sequence (grey), the mature protein 
after signal cleavage (blue) and the predicted β-sheet structure found in the core of the protein.  
 
3.3.4. Truncated forms of TapA are not detected with the αTapA antibody 
It is demonstrated above that tapA variants encoding proteins truncated at the 
C-terminus are still functional, even when only the first 57 amino acids of the 
protein are encoded. To detect the functional component of the TapA protein an 
αTapA immunoblot of biofilm lysates was conducted. Biofilms were grown as 
described before and lysed to facilitate the extraction of protein. These extracts 
were then analysed by immunoblot. As before 3 bands were observed in the 
3610 strain which were absent in ΔtapA (NRS3936) lysates but recovered on 
induction of tapA in the strain ΔtapA + pIPTG-tapA (NRS5045) (Figure 25A). 
Biofilm lysates originating from the strain ΔtapA + pIPTG-tapA1-193 (NRS5744) 
gave the same banding pattern as wild-type lysate when grown in the presence 
of IPTG (Figure 25A). Low molecular weight TapA is detected in ΔtapA + 
pIPTG-tapA1-193 (NRS5744) biofilms with the same apparent molecular weight 
(16 kDa) as is observed in wild-type lysates (Figure 25A). It is interesting to 
note that TapA1-193 is predicted to have a molecular weight of 17.31 kDa after 
cleavage of a signal peptide at amino acids 1-43 to give TapA44-193. This 
indicated that TapA44-193 maybe similar to the form present in vivo or that both 
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TapA and TapA44-193 undergo further processing to produce the 16 kDa TapA 
band. To test this prediction, biofilm lysates of 3610, ΔtapA (NRS3936), ΔtasA 
(NRS5267), ΔtapA + pIPTG-tapA1-188, ΔtapA + pIPTG-tapA1-183 and ΔtapA + 
pIPTG-tapA1-178 were obtained and analysed by αTapA immunoblot as before. 
Use of the αTapA antibody led to the detection of 3 bands in the 3610 sample 
and these were absent in ΔtapA (Figure 25B). The low molecular weight form 
of TapA was not detected in the lysates of ΔtapA + pIPTG-tapA1-188, ΔtapA + 
pIPTG-tapA1-183 or ΔtapA + pIPTG-tapA1-178 (Figure 25B). This is despite biofilm 
architecture being restored to wild-type levels when these strains are grown in 
the presence of IPTG. These results support the conclusion that TapA44-193 is 
similar to the low molecular weight form detected in 3610 biofilms. A band with 
an intermediate apparent molecular weight between the 18 kDa and 16 kDa 
bands was present in ΔtapA + pIPTG-tapA1-188 (Figure 25B). The 18 kDa band 
was shown in the first results chapter to be dependent on the presence of both 
tasA and tapA and is absent in both ΔtasA and ΔtapA mutants (Figure 25B). 
Therefore, it is not possible to confirm whether the band detected in ΔtapA + 
pIPTG-tapA1-188 represents an alternatively processed form of TapA or TasA. 
However, it can be concluded that the αTapA antibody is recognising a portion 
of the protein which is absent in the minimal functional forms. Additionally, the 
αTapA antibody still detected a band of 30 kDa representing TasA in the strains 
expressing genes encoding truncated forms of TapA (Figure 25A and B, Arrow 
1). Given these findings it is likely that the low molecular weight, 16 kDa, form of 





Figure 25: The αTapA antibody does not recognise the functional portion of the TapA 
protein. (A) αTapA immunoblot of biofilm lysates of 3610, ΔtapA (NRS3936), ∆tapA + pIPTG-
tapAwt (NRS5045) and ΔtapA + pIPTG-tapA-Bs_tapA1-193  (NRS5744). n=1 (B) αTapA 
immunoblot of biofilm lysates of the strains: 3610, ΔtapA (NRS3936), ΔtasA (NRS5267), ΔtapA 
+ pIPTG-tapA1-188 (NRS5789), ΔtapA + pIPTG-tapA1-183 (NRS5790) and ΔtapA + pIPTG-tapA1-178 
(NRS5791). n=1. Arrow 1 corresponds to TasA (30 kDa band), arrow 2 indicates a TasA/TapA-
dependent band (~18 kDa) and arrow 3 is TapA (16 kDa). - = 0 µM IPTG, + = 25 µM IPTG. 
3.3.5. Minimal forms of TapA orthologues display a varying level of 
functionality 
Since it was possible to identify a minimal functional form of B. subtilis TapA, it 
was postulated that determining the minimal units for the TapA orthologues may 
lead to important insight into key amino acid features needed for function. To 
address this, B. amyloliquefaciens (Bamy), B. pumillis (Bpum) and B. 
paralicheniformis (Bpara) TapA variants were designed to mimic B. subtilis 
truncations from amino acids 1-57, 1-58, 1-59 and 1-60 (this numbering denotes 
the length of these orthologue truncations with relation to the B. subtilis TapA 
sequence). The genes encoding the truncated tapA orthologues were then 
integrated at the amyE locus of the 3610 ΔtapA (NRS3936) strain and 
expression was induced with the inclusion of IPTG in the growth substrate. 
Biofilms were grown for 48 h before images were captured. 3610 biofilms were 
observed to have a wrinkled appearance and ΔtapA biofilms displayed a flat 
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biofilm lacking the characteristic corrugations of the wild-type colony (Figure 
26A). The ΔtapA + pIPTG-Bsub_tapAWT (NRS5045) strain displayed wild-type 
biofilm appearance and was included as a control to demonstrate the assay 
was functioning as expected (Figure 26B).  As shown previously, biofilms 
formed by strains expressing minimal forms of the B. subtilis tapA: ΔtapA + 
pIPTG-Bsub_tapA1-57 (NRS6041), ΔtapA + pIPTG-Bsub_tapA1-58 (NRS6042), 
ΔtapA + pIPTG-Bsub_tapA1-59 (NRS6043) and ΔtapA + pIPTG-Bsub_tapA1-60 
(NRS6044) all had the rugose surface appearance of wild-type colonies (Figure 
26B). The ΔtapA + pIPTG-Bamy_tapA1-57 (NRS6504) and ΔtapA + pIPTG-
Bamy_tapA1-58 (NRS6505) strains were observed to regain some level of 
structure when expression was induced, however these were judged 
qualitatively to have reduced activity when compared to WT B. subtilis TapA 
(Figure 26B). The ΔtapA + pIPTG-Bamy_tapA1-59 (NRS6504) and ΔtapA + 
pIPTG-Bamy_tapA1-60 (NRS6505) strains were shown to have more activity, re-
instating biofilms to wild-type in appearance (Figure 26C). In contrast, biofilms 
formed by ΔtapA + pIPTG-Bpum_tapA1-57 (NRS6508), ΔtapA + pIPTG-
Bpum_tapA1-58 (NRS6509), ΔtapA + pIPTG-Bpum_tapA1-59 (NRS6510) and 
ΔtapA + pIPTG-Bpum_tapA1-60 (NRS6511) resembled ΔtapA biofilms in 
appearance (Figure 26D). This indicated that these forms of B. pumilis TapA 
are either not functional or unstable. Finally, the  ΔtapA + pIPTG-Bpara_tapA1-57 
(NRS6512), ΔtapA + pIPTG-Bpara_tapA1-58 (NRS6513), ΔtapA + pIPTG-
Bpara_tapA1-59 (NRS6514) and ΔtapA + pIPTG-Bpara_tapA1-60 (NRS6515) 
strains displayed biofilms in which structure was only partially re-instated, 
indicating that these TapA variants retained partial activity (Figure 26E). A 
summary of the phenotypes shown in Figure 26 are presented in Table 12.  
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To summarise, a minimal functional form of B. amyloliquefaciens tapA could be 
determined as that which encodes the first 59 amino acids of the protein. 
However, minimal functional forms of the B. pumilis tapA and B. 
paralicheniformis tapA genes could not be identified using the minimal 
functional unit of B. subtilis tapA as a basis for their construction. The 
percentage sequence identity is highest between B. subtilis TapA and B. 
amyloliquefaciens TapA (48.89%) than it is between B. subtilis TapA and B. 
pumilis TapA or B. paralicheniformis TapA (41.48% and 39.11%, respectively). 
This may explain why B. amyloliquefaciens TapA displays the most functionality 
within the B. subtilis ΔtapA system deployed here. Furthermore, it was noted 
that based upon secondary structure analysis that there is a β-strand predicted 
to be present in the region of the protein for each of the TapA homologs from 
amino acids 51 to 56 (based on the numbering in B. subtilis TapA) (Figure 
26F). This region is conserved most strongly between B. subtilis TapA and B. 





Figure 26: Biofilm morphology of ΔtapA biofilms producing truncated version of TapA 
homologs demonstrate varying degrees of activity. (A) Images of wild-type 3610 and ΔtapA 
biofilms. The image of the ΔtapA biofilm was taken as part of a different biological repeat of the 
same experiment. (B) B. subtilis tapA variants encoding truncated proteins produced in a ΔtapA 
strain background. (C) B. amyloliquefaciens tapA variants encoding truncated proteins. (D) B. 
pumilis tapA variants encoding truncated proteins. (E) B. paralicheniformis tapA variants 
encoding truncated proteins. (F) The sequences of the TapA homologs are shown. The 
predicted signal sequence is highlighted in bold and underlined text and shown in grey is a 
conserved β-strand region which was predicted by the JPRED 4 server. The number to the right 
of the sequences refers to the amino acids (Drozdetskiy et al., 2015). See Table 12 for a 
complete list of the strains used in this experiment with strain numbers. 25 µM IPTG was 





tapA varianta Biofilm phenotypeb Strain number 
Bsub_tapAWT* WT NRS5045 
Bsub_tapA1-57* WT NRS6041 
Bsub_tapA1-58* WT NRS6042 
Bsub_tapA1-59* WT NRS6043 
Bsub_tapA1-60* WT NRS6044 
Bamy_tapAWT** WT NRS5047 
Bamy_tapA1-57** partial NRS6504 
Bamy_tapA1-58** partial NRS6505 
Bamy_tapA1-59** WT NRS6506 
Bamy_tapA1-60** WT NRS6507 
Bpum_tapAWT*** WT NRS5046 
Bpum_tapA1-40 (Bsub 1-57)*** defect NRS6508 
Bpum_tapA1-41 (Bsub 1-58)*** defect NRS6509 
Bpum_tapA1-42 (Bsub 1-59)*** defect NRS6510 
Bpum_tapA1-43 (Bsub 1-60)*** defect NRS6511 
Bpara_tapAWT**** WT NRS5741 
Bpara_tapA1-57**** partial NRS6512 
Bpara_tapA1-58**** partial NRS6513 
Bpara_tapA1-59**** partial NRS6514 
Bpara_tapA1-60**** partial NRS6515 
 
Table 12: Qualitative descriptions of the biofilm phenotypes of orthologous TapA C-
terminal truncations as determined by production in the background strain 3610 ΔtapA 
as an experimental system. a The numbering of amino acids is the same for all TapA variants 
except B. pumilis and the equivalent number for TapA B. subtilis residues is shown within 
parenthesis in the first column of the table. b Biofilm phenotypes are described qualitatively as: 
WT- prominent corrugations resembling WT B. subtilis biofilms, partial– failure to form 
prominent wrinkles and defect– flat, featureless biofilms resembling a ∆tapA mutant biofilm 
phenotype. *Allele of tapA amplified from NCIB 3610 (B_sub), **Allele of tapA amplified from 
Bacillus amyloliquefaciens strain FZB42 (B_amy), ***Allele of tapA amplified from Bacillus 
pumilis strain SAFR-032 (B_pum) and ****Allele of tapA amplified from Bacillus 
paralicheniformis (B_para).  
3.3.6. Mutational analysis on the minimal functional unit of TapA identifies 
key residues for TapA function 
The aim of the next set of experiments was to understand the functional 
components of TapA1-57
 and the role of specific amino acids in conveying 
function. We focussed this analysis on the region after the signal peptide 
cleavage point. To begin with, the residues F45 and D47 were chosen for 
examination as they are conserved between the B. subtilis, B. 
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amyloliquefaciens, B. pumilis and B. paralicheniformis TapA homologs. Next, 
the potential β-strand structure from amino acids 51 to 56, which was identified 
in the previous section, was chosen for further examination. This region is 
constituted by alternating polar and hydrophobic residues and is a conserved 
feature between the minimal functional units of B. amyloliquefaciens TapA and 
B. subtilis TapA. Given a β-strand conformation the hydrophobic side chains of 
the amino acids would be orientated in the same direction and the polar side 
chains pointed in the opposite direction giving rise to distinct hydrophobic and 
polar faces (Figure 27).  
 
Figure 27: The tapA minimal functional unit encodes a β-strand from amino acids 51-56. 
Analysis of the TapA protein sequence using the secondary structure prediction software, Jpred 
4, led to the discovery of a potential β-strand region constituted by amino acid residues 51-56. A 
schematic of the predicted β-strand structure 51-FDVSLQ-56 demonstrating the hydrophobic 
(blue circles) and polar (green circles) faces created by the side chains of the amino acids is 
shown. 
 
Site-directed mutagenesis was used to generate tapA1-57 ORFs encoding 
variants with amino acid substitutions at the desired positions. To elucidate the 
function of both conserved amino acids and the β-strand region found within 
TapA1-57. A summary of the full-set of amino acid substitutions carried out is 
shown in Figure 28A. As before, the tapA variants generated were introduced 
to the amyE locus in the ΔtapA mutant background. The strains generated were 
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then grown under biofilm promoting conditions for 48 h to induce the expression 
of the tapA variants. For the purposes of comparison a number of control strains 
were grown and the biofilms formed as previously described (Figure 28B, C, D, 
E and F). The ΔtapA + pIPTG+tapA1-57(F45A) strain formed flat, featureless 
biofilms which resembled the ΔtapA mutant (Figure 28G). Biofilms formed by 
ΔtapA + pIPTG+tapA1-57(D47A) cells displayed partial recovery of structure 
(Figure 28H). In short, the amino acid substitutions of these 2 conserved 
residues perturbed the function of TapA, with a more profound effect observed 
when F45 was substituted with alanine.   
The residues F51, D52, V53, S54, L55, Q56 and T57 are predicted to form a β-
strand in which alternating residues point in the same direction to form a 
hydrophobic face (F, V and L) and a polar/charged face (D, S and Q) (Figure 
27). Initially, an alanine scan was carried out targeting these residues and 
subsequent substitutions were assessed for selected amino acids. The strains 
∆tapA + pIPTG+tapA1-57(F51A) (Figure 28I) and ∆tapA + pIPTG+tapA1-57(D52A) 
(Figure 28J) formed biofilms with only partial structuring. As D52 is a negatively 
charged polar amino acid it was judged that substituting this residue with the 
uncharged, polar asparagine would indicate whether the charge of the residue 
was important for function. The strain ∆tapA + pIPTG+tapA1-57(D52N) formed 
biofilms with partial structure with some level of wrinkling re-instated (Figure 
28K). This is consistent with the previous result where ∆tapA + pIPTG+tapA1-
57(D52A) did not display observable wrinkles. Taken together this indicated that 
the removal of the side chain (D52A) has more impact than removing the 
charge but retaining polar properties (D52N). In the cloning process a D52L 
mutant arose by chance and so it was carried forward for phenotyping. Biofilms 
of ΔtapA + pIPTG+tapA1-57(D52L) had only partial structure which demonstrates 
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that substitution of a polar amino acid with a hydrophobic amino acid is 
detrimental to TapA activity (Figure 28L). The ΔtapA + pIPTG+tapA1-57(V53A) 
biofilms showed partial structuring (Figure 28M). However, changing V53 to K, 
which is a charged polar residue, resulted in biofilms resembling ΔtapA in 
morphology (ΔtapA + pIPTG-tapA1-57(V53K)) (Figure 28N). These results implied 
that replacing hydrophobic valine with the charged and polar lysine was 
detrimental to the activity of the TapA protein encoded, even more so than 
removing the side chain (V53A). Replacing valine with an alternative 
hydrophobic amino acid in isoleucine results in biofilms with wild-type 
morphology as displayed by the ΔtapA + pIPTG-tapA1-57(V53I) strain (Figure 
28O). These results indicated that the hydrophobic side chain of valine is 
important for the function of TapA1-57. Biofilms formed by ΔtapA + pIPTG- tapA1-
57(S54A) resembled wild-type biofilms (Figure 28P). This result indicated that the 
polar nature of the serine side chain is not important for the function of TapA1-57, 
however, like serine, alanine has a small R group the size of which may be 
important for function. Leucine at position 55 was changed to alanine and 
lysine, in both cases this resulted in the loss of TapA biofilm activity as 
demonstrated by the flat, featureless biofilms formed by ΔtapA + pIPTG+tapA1-
57(L55A) (Figure 28Q) and ΔtapA + pIPTG+tapA1-57(L55K) (Figure 28R). However, 
substitution of leucine with the similarly hydrophobic isoleucine resulted in a 
functional variant of TapA1-57 as displayed by the restoration of complexity in 
ΔtapA + pIPTG-tapA1-57(L55I) biofilms (Figure 28S). This result suggested that it 
is the hydrophobic nature of leucine which is important for the function of TapA1-
57. Changing T57 and Q56 to alanine, separately, did not impact TapA activity in 
restoring biofilm formation, as shown by ΔtapA + pIPTG+tapA1-57(Q56A) (Figure 
28T) and ΔtapA + pIPTG+tapA1-57(T57A) (Figure 28U) biofilm phenotypes. This 
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indicated that it is likely to be the length of the protein that is important for 
function and not the biochemical properties of these 2 residues since TapA1-56 is 
only partially functional (Figure 28F). A summary of the qualitative descriptions 
of the biofilm phenotypes for this experiment are shown in Table 13. 
In summary, changing T57 or Q56 to alanine did not impact biofilm formation 
indicating that it is the length of the protein that is important for function and not 
the biochemical properties of these 2 residues given that TapA1-56 is not 
functional. The hydrophobic character of V53 and L55 was shown to be 
important for the function of TapA1-57. The residues F51 and D52 were shown to 
be key residues as changing these residues perturbed TapA activity. S54 
appeared to be the most dispensible of the amino acids analysed as removing 
the side chain properties by replacement with alanine (S54A) did not perturb the 
biofilm acitivity of TapA.  
It should be noted that the antibody cannot detect truncated forms of TapA and, 
therefore, we cannot distinguish a lack of protein production from a loss of 
function. However, these results indicate support for the hypothesis that the 
hydrophobic face of a potential β-strand structure within the TapA minimal 




Figure 28: Mutational analysis of the tapA minimal functional unit. (A) A summary of the 
amino acid substitutions of the TapA1-57 which are carried out as part of this experiment. Shown 
is the B. subtilis TapA sequence and in yellow is the predicted signal peptide. Highlighted in 
grey is the β-strand region. The letters shown above the sequence are the amino acids which 
were substituted in place of those found in the TapA sequence. The amino acid numbering is 
shown below and the N- and C-termini are labelled in bold. Biofilms formed by a range of strains 
are shown in: (B) 3610, (C) ∆tapA (D) ΔtapA + pIPTG-tapAwt (E) ΔtapA + pIPTG-tapA1-56 
(NRS6025) (F) ΔtapA + pIPTG-tapA1-57 (NRS6041) (G) ΔtapA + pIPTG+tapA1-57(F45A)  (H) ΔtapA 
+ pIPTG+tapA1-57(D47A) (I) ∆tapA + pIPTG+tapA1-57(F51A)  (J) ∆tapA + pIPTG+tapA1-57(D52A)  (K) 
∆tapA + pIPTG+tapA1-57(D52N)  (L) ΔtapA + pIPTG+tapA1-57(D52L) (M) ΔtapA + pIPTG+tapA1-57(V53A)  
(N) ΔtapA + pIPTG-tapA1-57(V53K) (O) ΔtapA + pIPTG-tapA1-57(V53I)  (P) ΔtapA + pIPTG- tapA1-
57(S54A) (Q) ΔtapA + pIPTG+tapA1-57(L55A) (R) ΔtapA + pIPTG+tapA1-57(L55K) (S) ΔtapA + pIPTG-
tapA1-57(L55I)  (T) ΔtapA + pIPTG+tapA1-57(Q56A) (U) ΔtapA + pIPTG+tapA1-57(T57A). Blue boxes 
signify amino acid positions which are hydrophobic in the WT protein sequence and green 
boxes indicate amino acid positions which are polar in the WT sequence. See Table 13 for full-
details of the strains used and the corresponding strain numbers. Strains carrying inducible 
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tapA variants were grown in the presence of 25 µM IPTG. Bs_tapA = B. subtilis tapA. Scale bar 
= 0.5 cm. For figure (B)-(U) n=3. 
tapA varianta Biofilm phenotypeb Strain number 
Bs_tapA1-56  Partial/defect NRS6025 
Bs_tapA1-57  WT NRS6041 
Bs_tapA1-57(T57A)  WT NRS6384 
Bs_tapA1-57(Q56A)  WT NRS6385 
Bs_tapA1-57(L55I)  WT NRS6386 
Bs_tapA1-57(L55K)  Defect (ΔtapA phenotype) NRS6387 
Bs_tapA1-57(L55A)  Defect (ΔtapA phenotype) NRS6472 
Bs_tapA1-57(S54A)  WT NRS6388 
Bs_tapA1-57(V53I)  WT NRS6389 
Bs_tapA1-57(V53K)  Defect (ΔtapA phenotype) NRS6502 
Bs_tapA1-57(V53A)  Partial/defect (like Bs_TapA1-
56) 
NRS6473 
Bs_tapA1-57(D52A)  Partial NRS6476 
Bs_tapA1-57(D52L)  Partial/defect (like Bs_TapA1-
56) 
NRS6477 
Bs_tapA1-57(D52N)  Partial (wrinkling can be 
observed) 
NRS6516 
Bs_tapA1-57(F51A)  Partial NRS6390 
Bs_tapA1-57(D47A)  Partial NRS6475 
Bs_tapA1-57(F45A)  Defect (ΔtapA phenotype) NRS6474 
Table 13: Biofilm phenotypes with qualitative description of the results of mutational 
analysis of the B. subtilis tapA minimal functional genetic unit. a Origin strain of the tapA 
sequence used is denoted as follows: Bs_tapA = tapA from B. subtilis. b Biofilm phenotypes are 
described qualitatively as: WT- prominent corrugations resembling WT B. subtilis biofilms, 
partial– failure to form prominent wrinkles and defect– flat, featureless biofilms resembling a 
∆tapA mutant biofilm phenotype. 
3.3.7. The tapA variants encoding non-functional TapA1-57 variants do not 
appear to display a dominant negative effect  
It was then investigated whether the tapA variants judged to encode non-
functional products (tapA1-57(F45A), tapA1-57(L55K) and tapA1-57(L55A)) had a dominant 
negative effect on biofilm formation when expressed from the amyE locus in 
wild-type 3610 biofilms. Biofilm formation was observed as described 
previously. The wild-type 3610 biofilm was included as a positive control and 
displayed complex, rugose morphology and the ΔtapA mutant exhibited a flat, 
featureless appearance (Figure 29). The strains 3610 + pIPTG- tapA1-57(F45A), 
3610 + pIPTG- tapA1-57(L55K) and 3610 + pIPTG- tapA1-57(L55A) were grown on 
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MSgg agar containing IPTG to induce expression of the tapA variants (Figure 
29). All of the biofilms displayed wild-type morphology. This result does not 
support the hypothesis that these forms of TapA exert an inhibitory effect on the 
native TapA protein. However, the presence of these truncated TapA variants in 
vivo has not been proven and they may be degraded by the cells during biofilm 
formation. 
 
Figure 29: Biofilm morphology of 3610 strains expressing versions of the tapA gene 
encoding variants of the minimal functional unit. Expression of tapA variants was induced in 
the presence of 25 µM IPTG. The following strains were used: 3610, ΔtapA (NRS3936), 3610 + 
pIPTG-tapA1-57(F45A) (NRS6522), 3610 + pIPTG-tapA1-57(L55K) (NRS6520) and 3610 + pIPTG-
tapA1-57(L55A) (NRS6521). Scale bar = 0.5 cm. n=1. 
 
3.3.8. Determining the functional form of TapA in vivo 
It has been shown above that TapA1-57 is functional, additionally, TapA is 
predicted to have a cleavable signal peptide consisting of amino acids 1-43, this 
suggested that TapA may function as a short, secreted peptide consisting of 
amino acids 44-57 (Figure 30). To test this hypothesis 2 approaches were 
taken. Firstly, the ability of the TapA44-57 peptide supplied exogeneously to 
restore wild-type morphology to ΔtapA mutants was tested. Secondly, a genetic 
construct encoding a hybrid protein consisting of the known signal peptide of 
TasA fused to the TapA44-57 peptide region was constructed and tested for 




Figure 30: A schematic of a potential TapA peptide. Shown is the amino acid sequence of 
TapA1-57 encoded by the tapA minimal functional unit. Bold and underlined is the TapA signal 
sequence which is proposed to be cleaved. In light blue is TapA44-57 which would theoretically 
be released upon cleavage of the signal sequence. 
3.3.9. The TapA44-57 peptide does not demonstrate activity when added 
exogeneously to ΔtapA biofilms  
The TapA44-57 peptide was synthesised and the ability to restore structure to 
ΔtapA (NRS3936) biofilms was determined. Approximately 80 µg of the TapA44-
57 peptide was added to the culture before spotting of the cells onto biofilm 
promoting MSgg media. 3610 biofilms formed complex, structured biofilms on 
the provision of purification buffer (+buffer) or TapA44-57 (+peptide) (Figure 31A). 
As expected the ΔtapA + pIPTG-tapA (NRS5045) strain biofilms resembled 
wild-type on induction of tapA expression with IPTG (Figure 31A). In short the 
biofilms formed as normal regardless of the provision of buffer or peptide.  In 
the case of ΔtapA biofilms, the provision of purification buffer or exogeneous 
peptide had no impact on the gross biofilm features (Figure 31A).  
There are many reasons why exogeneous provision may not rescue biofilm 
formation. For example, since the peptide is being added exogeneously the 
correct localisation may not be achieved by comparison with the endogeneously 
produced TapA. Therefore a second approach was taken to examine whether 
TapA functions as a peptide. 
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3.3.10. The hybrid protein TasAsp-TapA44-57 does not display 
biological activity in the biofilm 
To test whether a cleavable signal peptide was needed for the export and 
function of the TapA protein, the following experiment was carried out. The 
known SipW-cleaved signal peptide of TasA (TasA1-27) was fused to the region 
of tapA encoding amino acids 44-57 (Figure 31B). When this artificial construct, 
encoding TasA1-27TapA44-57, was analysed in silico by SignalP4.1 it resulted in a 
predicted cleavage point, directly after amino acid 27, with a higher score (D= 
0.644), than that obtained for WT TapA (D = 0.527). When the construct 
encoding this protein was induced, in the strain ΔtapA + pIPTG-tasA1-27tapA44-
57, no activity was observed with the resulting colonies resembling the flat ΔtapA 




Figure 31: The peptide TapA44-57 does not restore complexity to ΔtapA biofilms. (A) 
Bacterial cultures were grown for 3-4 h before cells were collected by centrifugation to 
concentrate and then mixed 1:1 (vol:vol) with purification buffer (+buffer) or with peptide 
dissolved in purification buffer (+ peptide). Biofilms were spotted onto MSgg agar with or without 
the presence of 25 µM IPTG and grown for 48 h at 30oC. Strains 3610, ΔtapA (NRS3936) and 
ΔtapA + pIPTG-tapA (NRS5045) were used as controls. n=1. (B) A schematic outlining the 
protein encoded by the tasA1-27tapA44-57 construct. Shown in bold, black font is the TasA signal 
peptide. In blue is the region of TapA from amino acids 44-57. (C) Biofilm morphology of ΔtapA 
strains expressing IPTG-inducible constructs encoding tasA-tapA hybrid sequences, imaged at 
48 h. The TasA signal sequence was fused to the N-terminus of the predicted mature (post-
signal peptide cleavage) form of TapA from amino acids 44-57. n=2. Strains: 3610, ΔtapA 
(NRS3936) ΔtapA + pIPTG-tapA (NRS5045), ΔtapA + pIPTG-tapA1-57 (NRS6041) and ΔtapA + 
pIPTG-tasA1-27tapA44-57 (NRS6478). Scale bar = 0.5 cm. 
Controls demonstrated that the IPTG-dependent induction of gene expression 
was functioning in the assay with both ΔtapA + tapA (NRS5045) and ΔtapA + 
tapA1-57 (NRS6041) forming biofilms resembling wild-type in appearance. These 
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results cast doubt on whether the N-terminus of TapA forms a cleavable signal 
peptide. 
3.3.11. The extracellular processing of TapA is not dependent on 
SipW-mediated export 
A cleavable signal sequence from amino acids 1-43 is predicted in silico for 
TapA. SipW has been reported to be the cognate signal peptidase that carries 
out cleavage of both TapA and TasA signal peptides (Stöver and Driks, 1999a, 
c). However, attempts to demonstrate the functionality of the peptide TapA44-57 
remaining after the anticipated cleavage of the TapA1-57 have so far been 
unsuccessful. A possible explanation for this could be that amino acids 1-43 are 
not removed from, but instead part of the functional TapA form in vivo. To 
address this possibility 2 approaches were taken, first the sipW gene was 
deleted and the impact of this on biofilm formation and TapA export examined. 
Second, a form of TapA was constructed in which the cleavage site is changed 
to block the action of the B. subtilis signal peptidases (of which there are 5). The 
second approach is based on the report that proline residues are not tolerated 
in the +1 position, in relation to the cleavage site, targeted by signal peptidase 
enzymes (Barkocy-Gallagher and Bassford, 1992). For this reason a tapA 
variant was constructed to encode the full-length TapA protein with a proline 
residue at amino acid position 44, in place of, the native alanine (tapAA44P). 
Biofilms were grown as described previously. The biofilms formed by the ΔsipW 
(NRS5488) strain resembled the flat, featureless appearance of ΔtapA biofilms, 
in contrast to the rugose, complex colonies formed by the parental strain 3610 
(Figure 32A). As expected, induction of the wild-type tapA coding region in the 
strain ΔtapA + pIPTG-tapA (NRS5045) (Figure 32B) restored biofilm formation 
to that displayed by the 3610 strain (Figure 32A). Interestingly, when the ΔtapA 
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+ pIPTG-tapAA44P (NRS6059) strain was grown in the presence of IPTG, biofilm 
architecture was also re-instated to wild-type levels (Figure 32B). By contrast, 
in the absence of IPTG, ΔtapA + pIPTG-tapAA44P (NRS6059) biofilms were flat 
and featureless (Figure 32B). These findings reveal that a change of alanine 44 
to proline does not impact TapA activity. 
Next it was tested whether TapA processing is perturbed in either the ΔsipW or 
ΔtapA + pIPTG-tapAA44P (NRS6059) strains. To test this, the biofilm lysates of 
these strains were analysed and probed with the αTapA antibody. As shown 
previously 3 bands were detected by the αTapA antibody in the 3610 biofilm 
lysates, all of which were absent in the ΔtapA sample (Figure 32C). The 3 
bands were restored on induction of tapA in ΔtapA + pIPTG-tapA (NRS5045) 
(Figure 32C). In the ΔsipW lysates only the bottom 2 bands were detected, 
these correspond to the low molecular weight form of TapA (16 kDa) and the 
TasA/TapA-dependent band (18 kDa) (Figure 32C). All three bands were 
present in the ΔtapA + pIPTG-tapAA44P lysate originating from biofilms grown 
with IPTG present (Figure 32C). The 3 bands were also found in the ΔtapA + 
pIPTG-tapAA44P grown without IPTG (Figure 32C). The IPTG-inducible Pspank 
promoter used in this study is known to drive residual levels of expression in the 
absence of IPTG which explains this finding. In both cases these results 
indicated that TapA still achieved export to an extracellular location in order to 
be processed to low molecular weight forms by the action of exoproteases, as 
proposed in section 3.1.16. Additionally, it was interesting to note that the non-
specific TasA band normally detected by the αTapA antibody was no longer 
observed in the ΔsipW lysates. This is likely to be due to the role of SipW in 
regulating the export of TasA (Stöver and Driks, 1999c). To validate these 
findings an αTasA immunoblot was carried out on 3610, ΔtapA (NRS3936), 
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ΔtasA (NRS5267) and ΔsipW (NRS5488) biofilm lysates (Figure 32D). TasA 
was detected as a strongly reacting band of ~30 kDa in 3610 lysates, with a 
number of lower molecular weight forms found below (Figure 32D). As 
expected, TasA levels were reduced in the ΔtapA mutant and absent in the 
ΔtasA lysates. However, only a limited amount of TasA could be detected in 
ΔsipW biofilms (Figure 32D). It may be that TasA could not be exported without 
SipW and was then subjected to intracellular degradation. These results are 
consistent with a role for SipW in processing the signal peptide of TasA (Stöver 
and Driks, 1999c). 
To summarise, SipW may not be required for the export of TapA to an 
extracellular location. Furthermore, attempts to block signal peptide cleavage of 
TapA by any of the signal peptidases encoded by B. subtilis did not impact 
biofilm formation or TapA processing. In conclusion, it still remains unclear 
whether TapA functions as a peptide (TapA44-57) or whether amino acids 1-43 
are a present in the mature, functional form of TapA. 
 
Figure 32: TapA localization does not appear to be dependent on an N-temrinal signal 
peptide. (A) Biofilm formation was assessed in the following strains: 3610, ΔtapA (NRS3936), 
ΔsipW (NRS5488) (n=>3), (B) ΔtapA + pIPTG-tapA (NRS5045) and ΔtapA + pIPTG-tapAA44P 
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(NRS6059). n=1. (C) Biofilm lysates (50 µg) of strains shown in (A) and (B) were separated on a 
14% acrylamide gel by SDS-PAGE, transferred to a membrane and probed with the αTapA 
antibody for immunoblot. n=1. (D) αTasA immunoblot of biofilm samples: 3610, ΔtapA, ΔtasA  
and ΔsipW biofilm lysate. n=2. Scale bar = 0.5 cm. - = 0 µM IPTG + = 25 µM IPTG. 
3.3.12. Summary 
This results chapter has outlined a genetic approach which was undertaken to 
understand the function of TapA. It was found that homologous tapA genes 
originating from B. pumilis, B amyloliquefaciens and B. paralicheniformis 
encoded functional products when studied in the context of B. subtilis  3610. 
Strikingly, a very well conserved region of the protein from amino acids 111-120 
was not needed for the biofilm activity of TapA. Furthermore, it was identified 
that most of the C-terminal portion of the protein was not needed for the 
function of TapA. On further analysis, it was found that a minimal functional unit 
of tapA encoding just the first 57 amino acids of TapA (TapA1-57) was sufficient 
to restore biofilm formation to a ΔtapA mutant.  
A site-directed mutagenesis approach highlighted amino acid residues of 
importance present in TapA1-57, and a potential β-strand region of interest was 
investigated further. Given the prediction of an N-terminal signal peptide from 
amino acids 1-43 this indicated that TapA may function as a peptide consisting 
of amino acids 44-57. A functional study of the TapA peptide did not confirm 
activity and a re-assessment of the TapA signal peptide indicated that it may 





4. Discussion  
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Each component of the matrix operon (tapA-sipW-tasA) has been shown to be 
essential for complex biofilm formation in B. subtilis (Branda et al., 2006; 
Hamon et al., 2004; Romero et al., 2011; Terra et al., 2012). The current work 
focussed on the secreted matrix protein TapA, which is reported to facilitate 
fibre formation by TasA and to anchor these fibres onto the surface of the cell. 
We wanted to better understand the function of TapA and how it interacts with 
TasA to facilitate fibre formation. Additionally, we wanted to determine the 
composition of the functional form of TapA in vivo. 
Using a de novo αTapA antibody we found that TapA is processed to a low 
molecular weight form in the biofilm (Figure 13). Furthermore, we found that 
processing is dependent on the action of the natively encoded exoproteases 
(Figure 20). We also demonstrated that the presence of the tapA gene is not 
necessary for the biological function of TasA fibres formed in vitro (Figure 22). 
Next, we identified that the minimal functional form of tapA encoded the first 57 
amino acids of TapA (TapA1-57) (Figure 24). This form of the protein is shown in 
relation to the predicted 3D structure of TapA (Figure 33A) and schematically 
(Figure 33C) in relation to full-length TapA (Figure 33B and Figure 33C). It 
was found that the αTapA antibody did not recognise the minimally functional 
form of the TapA protein (Figure 25). Therefore, it is likely that the low 
molecular weight form of TapA, detected by immunoblot, is similar to the core of 
the protein (predicted to be a structured β-strand rich region Figure 33A) which 
is absent in the minimal functional form (Figure 33C). In support of this 
conclusion, it was found that when a well conserved motif between amino acids 
111-120, which resides within this core region, was changed, then the low 
molecular weight forms of TapA could no longer be detected (Figure 23E). The 
core of the protein was shown to be resistant to proteolysis by exoproteases 
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found in supernatant and stable over time when TapA44-253 was stored at 4
oC. 
These forms are shown schematically (Figure 33D and E), note that they 
largely overlap with the region thought to contain the β-strand rich domain. The 
stability of this part of the protein may explain why it was readily detectable in 
vivo. We then went on to highlight a predicted β-strand structure, within the 
minimally functional region, which appears to be key for the function of TapA1-57 
(Figure 28), this is shown in the context of the predicted tertiary structure for 
TapA (Figure 33A). Finally, we re-assessed the role of the signal peptidase, 
SipW, in the processing of TapA and re-investigated the existence of an N-
terminal TapA signal peptide. 
 
Figure 33: The 3D structure of TapA annotated with functionally and structurally 
important features (A) The 3D structure of TapA as predicted using the RaptorX server and 
visualised using PyMol. The N- and C-termini are labelled. The form of the minimal functional 
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unit (mfu) is shown on this structure with the predicted β-strand secondary structure element 
shown as a grey arrow. The structured β-strand rich domain is also shown. Schematics illustrate 
different forms of the TapA protein important in the current study. The full-length protein (B), 
minimal functional form (C), the stable form which persists on storage at 4oC (D) and the 
supernatant processed form (E) are shown. In all cases numbers are in relation to the amino 
acid numbering of the WT, full-length protein. In the schematic representations, the signal 
sequence (ss) is shown in blue and the mature region of TapA is shown in orange.  
4.1.1. Re-evaluating the functional form of TapA 
Using a custom made αTapA antibody it was found that TapA is processed in 
the biofilm environment, migrating as a low molecular weight band of 16 kDa, 
when analysed by immunoblot (Figure 13B). This is in contrast to the higher 
molecular weight TapA bands detected by other groups (Romero et al., 2011, 
2014; Stöver and Driks, 1999a). It was also demonstrated that the development 
of an αTapA antibody is made problematic due to cross-reactivity of the 
antibody to the more abundant protein TasA. This result was consistent with the 
result observed when using the earlier published TapA anti-serum which was 
kindly gifted by Adam Driks at Loyola University (Figure 13C). Interestingly, 
when concentrated TasA fibres were probed with an αTapA antibody, 2 smaller 
bands migrating between the 15 kDa and 25 kDa markers are detected, which 
are reminiscent of the bands I observe (Romero et al., 2011) (Figure S5 ). 
Furthermore, the nature of the samples probed with αTapA antibodies vary 
between studies for example the current study utilises biofilms that are exposed 
to an enzymatic lysis buffer and sonication and contain intracellular proteins, 
membrane proteins and extracellular proteins. However, other studies utilize 
concentrated cell fractions to give localisation information for TapA.  
It was then shown that TapA is processed in an active manner which is 
dependent upon the activity of secreted proteases found in the biofilm (Figure 
20B). Generation of an exoprotease-free version of NCIB3610 comI, which did 
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not display exoprotease activity, as judged by growth on LB agar supplemented 
with milk (Figure 20A), resulted in the detection of unprocessed TapA (Figure 
20B). However, there was no biofilm defect observed in this strain (Figure 
20C). This was a suprising result given that exoprotease genes are known to be 
expressed within the biofilm (Marlow et al., 2014) and were shown to process 
TapA (Figure 20B). These results, however, indicate that the role of 
exoproteases may not be in facilitating the formation of architecturally complex 
colonies under these conditions. The possibility does remain that there is 
sufficient protease activity within the biofilm to generate a very small amount of 
a processed, functional form of TapA. This hypothesis is supported by the 
finding that the supernatant of 3610 comI-KO7 strain showed residual levels of 
TapA44-253 proteolytic activity (Figure 20D). An alternative role for exoproteases 
may be the breakdown of biopolymers to release energy for the maintenance of 
cellular processes and division. Our work does indicate that the low molecular 
weight form of TapA is dependent on the action of the exoprotease gene vpr. It 
is possible that low molecular weight TapA is generated by the proteolytic 
cleavage of the 18 kDa band, detected by the αTapA antibody. Therefore, the 
16 kDa and 18 kDa bands are both TapA, with the latter being dependent on 
the presence of TasA. Regardless of the identity of the 18 kDa band it appears 
that the presence of the 16 kDa band is dependent on the action of the 
exoprotease Vpr (Figure 20B and Figure 18B). However, this gene should be 
deleted independently to generate a ∆vpr single mutant to test this hypothesis 
further. This is because in the current work the vpr gene is deleted within the 
context of other exoprotease genes being deleted at the same time, so a 
combinatorial role between Vpr and another exoprotease such as Bpr, to 




4.1.2. An alternative approach to studying TapA validates amino acids 50-
57 as a key region for TapA function 
Findings from this project led to the conclusion that amino acids 51-57 of TapA 
are representative of a region which is crucial for bioactivity in the NCIB3610 
biofilm, as previously published (Romero et al., 2014). Importantly, this finding 
was elucidated using an independent approach. Previously, a functional role for 
this region was predicted based on the observation that it represented an 
imperfect repeat sequence which was found to be similar to a region at 
positions 194 to 237 in the protein. When amino acids 50-57 were deleted or 
replaced with a different set of amino acids then the protein was no longer 
functional (Romero et al., 2014). The approach taken in this study was to 
compare the protein sequence of B. subtilis TapA to orthologous TapA proteins 
from related Bacillus species to identify key sequence features. It was found 
that the expression of homologous tapA genes from B. pumilis, B. 
amyloliquefaciens, and B. paralicheniformis restored wild-type biofilm formation 
to a ΔtapA strain (Figure 23A). This result is in agreement with reports that B. 
amyloliquefaciens tapA can restore architecture to a B. subtilis ΔtapA mutant 
(Romero et al., 2014). It was noted that Bacillus pumilis TapA lacked a large 
part of the C-terminus but was still functional. Given that TapA was found to be 
processed in vivo and that parts of the sequence were not needed for function 
we looked to identify the minimal functional unit of tapA. We designed a range 
of tapA gene variants which encoded truncated TapA which lacked an 
increasing number of amino acids from the C-terminus. The result of this was 
the identification of the minimal functional genetic unit (mfu) determined to 
encode amino acids 1-57 (Figure 24A). This is in agreement with the finding 
156 
 
that amino acids 50-57 are key for the function of TapA (Romero et al., 2014). 
However, here we extend this finding to show that a region consisting of TapA 
from amino acids 1-57 is necessary and sufficient for activity within the biofilm. 
4.1.3. Determining the minimal functional unit of TapA orthologues 
We suggested that determining the minimal functional forms of the TapA 
orthologues could give insight into the essential, conserved features of TapA. 
The B. pumilis, B. amyloliquefaciens, and B. paralicheniformis TapA homologs 
equivalent in length to B. subtilis TapA1-57 all had predicted β-strands within this 
region (Figure 26F). Constructs were also designed which encoded additional 
amino acids on the C-terminal side of what is equivalent to the Bsub1-57 mfu. 
This is because it was not known whether the mfu for the tapA homologs is 
greater in length than the B. subtilis version. It was not possible to determine a 
minimal functional unit for B. paralicheniformis (Figure 26E) or B. pumilis 
(Figure 26D) based on the experiments conducted here. The B. 
paralicheniformis short forms of TapA did appear to have partial activity but did 
not restore wild-type biofilm formation (Figure 26E). However, B. 
amyloliquefaciens had a minimal functional form similar in length to that of B. 
subtilis TapA (Figure 26C). It should be noted that these genes are being 
expressed in a B. subtilis ΔtapA mutant which is not the system in which they 
have evolved. This may be why the B. amyloliquefaciens TapA truncations 
displayed more biological activity, as the sequence identity is highest between 
B. amyloliquefaciens and B. subtilis TapA. In support of this, we have published 
that recombinant B. amyloliquefaciens fTasA, added exogeneously to ΔtasA 
sinR (NRS5248) biofilms restored rugosity (Erskine et al., 2018). Interestingly, 
the B. amyloliquefaciens fibres were found to form a distributed mesh of thin 
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fibres, whereas, B. subtilis TasA fibres assembled in to bundles composed of 
fibres with a greater diameter (Erskine et al., 2018). 
4.1.4. Mutational analysis of TapA 51-57 and conserved residues  
The TapA amino acid sequence was analysed using the secondary structure 
prediction programme Jpred 4 (Drozdetskiy et al., 2015). This highlighted a 
possible 6 residue β-strand composed of amino acids 51-56 inclusive. It was 
hypothesised that the functionality of the TapA1-57 variant is dependent on this 
secondary structure feature. If the prediction is accurate then it would result in 
alternating hydrophobic and polar residues, meaning that one face of the strand 
is hydrophobic and the opposite face polar. To test this, a range of mutant tapA 
forms were generated which encoded the first 57 amino acids of the protein with 
specific amino acid changes in the region of interest. Changing T57 to alanine 
and Q56 to alanine had no impact on biofilm integrity. This indicates that these 
residues play an important function in conveying length to the protein and that 
the biochemical properties of the residues are less important, this is due to the 
observation that TapA1-56 has noticeably reduced function. However, it should 
be noted that threonine is similar to alanine in that it has a small and 
hydrophobic side chain. Carrying out an alanine scan, targeting the polar face, 
allowed us to identify the importance of residue D52 (Figure 28: J, K and L), 
however, the change of S54A and Q56A (as discussed above) had no impact 
on TapA1-57 function (Figure 28: P and T). Changing the hydrophobic residues 
to alanine or to a positively charged lysine residue reduced or abolished TapA1-
57 activity (Figure 28: I, J, M, N, O, Q, R and S). This indicated that the 
hydrophobicity of these residues is important, however, the small, hydrophobic 
amino acid alanine cannot substitute in their place. These results are 
summarised in Figure 34. In conclusion, the hydrophobic properties of amino 
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acids 51, 53 and 55 are important. This hydrophobic face may be important for 
TasA interaction or for interaction with other matrix components. Additionally, 
conserved residues F45 and D47 were also shown to be needed for TapA1-57 
function (Figure 28: G and H). Aromatic amino acids such as phenylalanine 
(F45) have been shown to form stacking interactions which can be important for 
protein structure and function.  
 
Figure 34: A model for the secondary structure for the region of TapA from amino acids 
51-56 inclusive which are predicted to adopt a β-strand conformation (grey arrow). 
Hydrophobic residues are shown as blue circles and polar residues are shown as green circles. 
The amino acids which were shown to be key for the function of TapA1-57 are indicated with a 
black circle. 
 
It was reported that TapAΔ50-57 had a dominant negative effect preventing 
normal biofilm formation (Romero et al., 2014). Additionally, this TapA variant 
was shown to be defective in assisting polymerisations of TasA fibres in vitro 
(Romero et al., 2014). It was therefore hypothesised that the non-functional 
TapA1-57 variants generated in this project may have a similar effect. To test this 
Bs_tapA1-57(L55K), Bs_tapA1-57(L55A) and Bs_tapA1-57(F45A) were expressed from the 
amyE locus under the control of the Pspank promoter in the NCIB3610 strain 
background. These strains formed complex colonies resembling wild-type 
(Figure 29). This indicates that they encode products which do not have a 
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dominant negative effect. It should be noted that the TapAΔ50-57 form was a full-
length form of TapA, unlike the truncated forms analysed in this work. 
Ideally, when carrying out the genetic analysis of the tapA sequence, which are 
designed to encode variants of the TapA protein, and testing them for function, 
then an αTapA immunoblot should be carried out. This is to determine that the 
protein is still being made and is found at similar levels to native TapA. 
However, as demonstrated, the αTapA antibody utilised does not recognise 
truncated forms of the protein. To remedy this, an antibody could be generated 
to recognise the minimal functional form of the protein. Alternatively, the 
translational fusion of TapA variants with an epitope tag may allow for detection 
with an alternative antibody. It has been shown that the C-terminus of full-length 
TapA could be tagged with yellow fluorescent protein (YFP) and detected in the 
cell wall fraction of biofilm cells (Romero et al., 2011). It is unclear how this was 
successful given the in vivo processing of TapA, which we have demonstrated. 
However, it could be that there is a small amount of full-length TapA that we can 
not detect directly with the αTapA antibody. Alternatively, the C-terminus of 
TapA may be cleaved from the functional N-terminus and interact with the cell 
wall. Attempting to fuse the full-length TapA, TapA1-193, and TapA1-57 to a C-
terminal His-tag did not appear to be successful (data not shown). Although it is 
interesting to note that TapA1-57_6His was still functional given that there is an 
additional 6 amino acids added to the protein. It could indicate that the length of 
the protein is more important than the biochemical properties of the amino acids 
after threonine-57. Consistent with this, changing amino acids 56 and 57 to 
alanine did not impact function. Finally, an αTasA immunoblot could be carried 
out to elucidate whether TapA variants retain the property of facilitating TasA 
stability/production. The role of TapA in TasA stability was a phenomenon that 
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we observed (Figure 11E) and has been reported separately (Romero et al., 
2011) 
4.1.5. TapA is not needed for ex vivo TasA fibre function 
The restoration of biofilm architecture to a ΔtasA sinR strain by ex vivo provision 
of in vitro, self-assembled TasA fibres was shown not to be dependent on the 
presence of the tapA gene (Figure 22B) (Erskine et al., 2018). This is in 
addition to our observation that exogenous provision of 20 µg of fTasA is unable 
to restore complex architecture to the tasA mutant (Figure 21B) (Erskine et al., 
2018). In contradiction to this result, it has been reported that the addition of 40 
µg of recombinant TasA fibres to ΔtasA pellicles can restore structure to a level 
indistinguishable from wild-type (Branda et al., 2006), and this result has been 
reproduced in a separate study (Diehl et al., 2018). Additionally, a preparation 
of native TasA was also shown to have biological activity when added to a 
ΔtasA mutant (Chai et al., 2013), again this was not found to be the case in our 
hands (Erskine et al., 2018). The disparity between our results and those 
reported could be due to working with different forms of TasA. This could be 
impacted by purification conditions (pH, protein concentration and buffer 
properties) and the storage and handling of the protein used in the assays. It 
has been reported that TasA adopts multiple oligomeric forms in vitro, but TasA 
undergoes a change to only one of these forms within the biofilm to form fibres 
(Diehl et al., 2018).   
4.1.6. Analysis of the TapA signal sequence 
Using the online SignalP 4.1 server to analyse the TapA protein sequence in 
silico it is predicted that TapA has a signal sequence which is cleaved between 
amino acids 43 and 44 (Petersen et al., 2011). The B. subtilis genome encodes 
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5 type I signal peptidases (Tjalsma et al., 1998). Most signal peptides in B. 
subtilis are cleaved by the action of the serine-lysine type signal peptidases, 
namely, SipS and SipT (Tjalsma et al., 1999). However, it is SipW that is 
reported to cleave the signal sequences of both TasA and TapA (Stöver and 
Driks, 1999a, c). The tapA, sipW and tasA genes are co-located in an operon. 
The SipW signal peptidase is of the serine-histidine dyad type (Tjalsma et al., 
2000b). At the -1 and -3 positions relative to the start site TapA has a threonine 
and alanine residue respectively which fits with the idea that you need small 
uncharged amino acids at these positions (Fikes et al., 1990; Shen et al., 1991). 
It has been reported using E. coli as a model system that prolines are not 
tolerated in the +1 position relative to the cleavage site (the residue that would 
form the N-terminus of the mature protein) (Barkocy-Gallagher and Bassford, 
1992). Furthermore, through global analysis of predicted B. subtilis signal 
peptides it was shown that prolines are never found in the +1 position (Tjalsma 
et al., 2000a). This work showed that changing alanine at (the predicted) 
position +1 to proline in the full-length TapA sequence did not alter biofilm 
morphology and TapA was still processed to lower molecular weight forms 
(Figure 32: B and C). This indicates that TapA still achieves an extracellular 
location, in the case of TapAA44P, as processing is exoprotease-dependent. 
Signal sequences which are not cleaved can result in a membrane anchored 
protein (Dalbey and Wickner, 1985; Fikes et al., 1987). It is possible that the 
predicted TapA signal peptide is actually uncleaved in vivo resulting in the 
anchoring of the protein to the membrane. In this model, the C-terminus is 
found in the periplasmic space or in association with the cell wall. In support of 
this hypothesis, fusion of the known TasA signal peptide in place of the first 43 
amino acids of the TapA sequence, of the minimal functional unit, to encode 
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TasAsp-TapA44-57, could not facilitate wild-type biofilm formation. The 
discrimination score (D) for the TapA signal sequence is 0.527, given by 
SignalP4.1, it is very close to the cut-off of 0.45 indicating that the probability of 
it being a signal peptide is relatively low with scores above 0.7 indicating a high 
confidence of a correct prediction (Petersen et al., 2011). Finally, deletion of 
sipW did not impact the extracellular processing of TapA as judged by an 
αTapA immunoblot (Figure 32C). This is in contradiction to the report that SipW 
cleaves the signal peptide of TapA (Stöver and Driks, 1999a).  
4.1.7. The role of exoproteases in biofilm formation 
Exoproteases are known to be produced during biofilm formation (Cairns et al., 
2014; Marlow et al., 2014). The findings of the current work, specifically that 
TapA is processed by secreted proteases, is novel and interesting (Figure 
20B). It was discovered that even in the absence of secreted proteases B. 
subtilis still formed structurally complex biofilms (Figure 20C). In reality, the 
functional role of proteases in the B. subtilis biofilm is an under explored topic.  
Uncovering the role of exoproteases may require a more sophisticated 
approach than macroscopic observations of biofilm morphology. One 
explanation could be that proteolytic cleavage of TapA serves as an additional 
regulatory role in governing biofilm formation, but that under the artificial 
conditions tested the impact of perturbing this process (by deleting exoprotease 
genes) is not readily observable. 
4.2.  A model for the function of TapA  
Given all of the information above and the published information regarding 
TapA, I propose the following outline for how TapA functions. The TapA protein 
is transported to the membrane where the signal sequence is cleaved to 
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generate the mature form of the protein TapA44-253. The work here demonstrates 
that TapA export does not seem to be SipW-dependent, as TapA is still subject 
to extracellular degradation when the sipW gene is deleted (Figure 32C). More 
importantly, the observed processing of TapA by extracellular proteases 
(Figure 20B) is in support of the hypothesis that TapA is indeed a secreted 
protein, as predicted in silico. TasA fibres then form by the polymerisation of 
monomeric TasA (mTasA) subunits in a TapA-dependent manner (Figure 35A). 
The mature TapA44-253 protein contains the essential β-strand51-56 which has 
been the subject of investigation in the current work. It may be that the β-
strand51-56 is a nucleation point for the formation of TasA fibres from monomeric 
subunits. Consistent with this suggestion is the published finding that TapA 
aides the polymerisation of TasA in vitro but that TasA polymerisation is 
inhibited by TapA∆50-57 in which the genetic region corresponding to the β-strand 
region has been deleted (Romero et al., 2014). 
 
Our own published findings show that TasA rendered monomeric (mTasA) is 
subject to exoprotease degradation but that the fibrous form is resistant to 
proteolysis (Erskine et al., 2018). It may be that in the absence of TapA, TasA 
remains monomeric and is broken down almost completely, with fibres only 
forming in the presence of TapA (Figure 35B). Therefore, degraded forms of 
TasA are present in wild-type biofilms because the degradation of TasA is 
reduced and incomplete. We have found that recombinant TasA will form fibres 
spontaneously in vitro (Erskine et al., 2018). The reason that TasA fibres form in 
vivo may be due to TapA interacting with TasA to keep the localised 
concentration higher. This is the same reason proposed for TasA formation in 
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vitro since purified recombinant TasA is stored as a high concentration solution 
in our work. 
 
It was hypothesised, as part of the current work, that TapA function was 
regulated by proteolysis mediated by exoproteases. Although TapA processing 
was perturbed in the absence of exoproteases (Figure 20B), it was found that 
unprocessed TapA is still functional (Figure 20C). It is not clear whether we are 
actually detecting the unprocessed form of TapA by αTapA immunoblot or an 
alternatively processed form of TasA due to the non-specific nature of the 
antibody. The actual form of the mature TapA protein that is functional is 
unclear, but to summarise we have shown that unprocessed TapA may 
resemble TapA44-253 (Figure 35A). Importantly we also showed that TapA1-57 is 
functional (Figure 35A). It could be that the functional form, in WT biofilms, is 
TapA44-253 and once it has carried out its function it is unstable and degraded by 
exoproteases. Importantly, both TapA44-253 and TapA1-57 contain the β-strand51-
56 shown in this work to be key for function (Figure 28). At this point, it is not 
clear whether TapA functions by nucleating/assisting TasA fibre formation or 






Figure 35: A model for TapA function. (A) In the presence of TapA44-253 or TapA1-57 the 
formation of fibrous TasA (fTasA) is supported from monomeric TasA (mTasA) subunits. It is not 
clear whether TapA functions to nucleate fibre assembly or acts as a chaperone that prevents 
the degradation of TasA. (B) In the absence of TapA, TasA remains monomeric, and is 
unstable. 
 
Alternative explanations for the function of TapA 
Given that there are many unanswered questions as to how TapA functions in 
the development of complexity in the B. subtilis biofilm, I here propose some 
alternative roles.  
The current published model for TapA function describes TapA as anchoring 
TasA fibres to the cell wall with TasA fibres extending from the surface of the 
cell into the extracellular environment. There is an additional role proposed for 
TapA in the assembly of TasA fibres as suggested by a number of different 
experimental approaches both in vitro and in vivo. However, we found that the 
presence of tapA was not needed for the biological function of TasA fibres 
added exogeneously to biofilms, therefore, suggesting that a TapA-dependent 
attachment point is not critical for the function of TasA (Erskine et al., 2018). 
Moreover, the TapA and TasA sequences do not include any likely candidates 
for cell wall anchoring motifs, which normally exist in the sequence context, for 
Gram-positive bacteria, of LPXTG. As an example, the LPXTG motif is found in 
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the cell wall anchored (CWA) proteins of Staphylococcal aureus which are 
important for the attachment of cells to a surface in order to initiate biofilm 
formation (Foster et al., 2013). They are also important for binding of ligands 
found in the human host (Hobley et al., 2015). Additionally, in S. aureus biofilms 
the surfaces of cells are decorated with fibres formed by monomers called 
phenol soluble modulins (Periasamy et al., 2012). It is unclear how these fibres 
are attached to the surface of the cell but this could be by electrostatic 
association with the cell wall. It could be that an association of TasA and TapA 
with the cell wall is mediated by electrostatic interactions.  
A previous publication (Tjalsma et al., 2000b), describes the growth of Bacillus 
subtilis in TY media and controlled sipW expression with a constitutively active 
promoter. They found that after 4h TasA remained unprocessed even though 
sipW was expressed. The authors suggest that this indicates there is an as yet 
unidentified factor which is present at the later time points where TasA was 
observed in a processed form. It is possible that this additional factor is TapA. It 
should be noted that the authors could not detect TapA in these growth 
conditions but this could be related to issues with the αTapA antibody, which I 
have discussed. It is difficult to explain how TapA would become subject to 
extracellular proteolysis given this model. It could be that TapA is also exported 
as part of this process or TapA may only reach an extracellular location 
because of cell lysis. Curli fibres of E. coli are the most abundant proteinaceous 
component in E. coli biofilms (and other related species) (Evans and Chapman, 
2014). In this case, fibres are formed by the subunit CsgA and the nucleation of 
fibrils is carried out by CsgB. Nucleation by CsgB is depedent upon CsgF which 
is associated with the outer membrane from which fibres form (Hobley et al., 
2015). CsgF interacts with the Curli specific transport apparatus CsgG (Hobley 
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et al., 2015). It could be that TapA operates in a dual role by nucleating fibres 
(like CsgB) but also associating with the outer surface of the membrane (like 
CsgF) to facilitate TasA export. Alternatively, TapA may act as a chaperone to 
keep TasA in an unfolded state for Sec-dependent transport. In this case, when 
the tapA gene is absent then TasA is degraded by intracellular proteases. 
 
It may be that the TapA signal peptide is cleaved off by an alternative signal 
peptidase, other than SipW, with the mature TapA undergoing further 
processing to generate a secreted peptide consisting of the intervening amino 
acids from 44-57. It is anticipated that this would appear to be the case for the 
minimal functional form of TapA1-57. This peptide could nucleate the formation of 
TasA fibres in the extracellular environment. RbmA is an example of a secreted, 
matrix protein of Vibrio cholerae which is needed for the rugosity of biofilms 
(Fong et al., 2010). It is exported via a Type II secretion system into the 
extracellular environment where it is thought to function by binding to 
carbohydrates (Johnson et al., 2014). Alternatively, the TapA peptide may 
anchor fibres to the cell surface as has been previously postulated (Romero et 
al., 2011). 
Finally, it is possible that the low scoring in silico predicted TapA signal peptide 
is indicative of an uncleaved membrane anchoring domain. In this model TapA 
is a membrane protein with a single pass N-terminal transmembrane helix and 
the C-terminus of the protein would be localised externally to the cell exposing it 
to the protease activity of the extracellular environment. This membrane 
anchored TapA could function in a similar way to that described previously for 
TapA by anchoring TasA fibres to the cell surface. 
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4.3. Future outlook 
It remains unclear what the role of the stable core of the TapA protein and the 
C-terminus is but given that there are many very well conserved features, in the 
protein core, this indicates it may have a biofilm-independent function. 
Alternatively, it could be that the protein functions exclusively in biofilm 
formation and the tapA gene is conserved to encode an appropriately 
processed form of TapA. The alternative explanation may be the most likely 
given that the minimal functional form of TapA (TapA1-57) still conveys rugosity 
to the biofilm without the presence of the rest of the protein. 
The results of this work have shown that exoproteases are not needed for the 
structural complexity of B. subtilis biofilms. The artificial growth conditions 
implemented in laboratory studies only offer some insight into the real world 
lifestyle of microorganisms. Therefore, it would be interesting to study the ability 
of the exoprotease-free strain to form biofilms on plant roots. A number of plant 
models of B. subtilis biofilm formation are available including Aribidopsis and 
Tomato plant root colonization assays (Bais et al., 2004; Chen et al., 2012; 
Chen et al., 2013). It is possible that exoproteases function in a way to release 
energy from large biomolecules found in the rhizosphere. This may release 
amino acids for carbon metabolism and/or as a nitrogen source. The MSgg agar 
we utilise for biofilm formation assays contains 2 readily available carbon 
sources in the form of glycerol and glutamic acid, glutamic acid also serves as 
the sole nitrogen source in MSgg. This may explain the increased expression of 
exoprotease genes at later time points in biofilm formation experiments (Marlow 
et al., 2014), as resources are used up. It might be that exoproteases 




A TapA 3D-structure prediction shows an N-terminal α-helical domain and a β-
strand-rich core region (Figure 9B). It may be that loop regions connecting 
these structured domains are vulnerable to proteolysis during the in vivo 
processing of TapA. However, it is notoriously difficult to predict 3D structure 
from the amino acid sequence of a protein. Experimental investigation of TapA 
protein structure would be a necessary step in understanding this protein 
further. Further work may finally confirm the in vivo functional form of the protein 
and this may represent the form which is most suitable for crystallisation 
studies.  
The difficulty in isolating the functional form of TapA arises due to issues with 
the TapA antibodies used in this study, i.e. the novel αTapA that we generated 
and the TapA anti-serum kindly gifted by Adam Driks at Loyola University. 
These antibodies do not appear to detect the minimal functional forms of TapA 
and react non-specifically with the TasA protein. This may be unsurprising given 
that TasA is the most abundant protein in the biofilm so is present in higher 
concentration in biofilm lysates. It may be that the rabbit host, in which 
antibodies were raised, was naturally exposed to Bacillus subtilis (also known 
as the hay Bacillus or grass Bacillus) and therefore TasA, indirectly, prior to 
immunisation. To address this, assessment of the pre-immune serum could be 
tested for specificity against TasA and TapA. A possible solution could be to 
generate an antibody against the TapA44-57 peptide. The key issue that will need 
to be addressed, is determining the localisation of TapA, and alternative 
antibodies may help to tackle this. This will hopefully lead to a more informed 
model as to how TapA functions. 
Another method would be to bypass the use of an αTapA antibody. To achieve 
this goal, tagging the N-terminus of the TapA protein may allow for the isolation 
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of the functional form of TapA, if it is not cleaved by the action of a signal 
peptidase. The results presented here cast doubt on the role of SipW as 
processing the signal peptide of TapA. It should be further investigated whether 
another signal peptidase performs this role or whether the N-terminus is not 
cleaved. Finally, it could be determined whether TapA performs a chaperone 
role and is needed for TasA export by assessing the localisation of TasA 
(whether it is intracellular or extracellular) in a ΔtapA mutant. 
Bacillus cereus is a relative of B. subtilis and forms biofilms under similar 
conditions but it has been reported that it does not encode a TapA homologue. 
Interestingly, the B. cereus genome has 2 orthologues of tasA, named tasA and 
calY (Figure 36). In the case of B. cereus, TasA was shown to develop more 
abundant fibres than CalY but neither were essential for biofilm formation in 
contrast to the critical role of TasA in B. subtilis biofilm formation (Caro-Astorga 
et al., 2014). It may be that B. cereus resembles the ancestral system that 
preceded the tapA-sipW-tasA system of Bacillus subtilis, although this remains 
an unexplored hypothesis. In this evolutionary model TapA may have arisen 
from an extra homolog of TasA and adopted a role as an additional regulatory 
control in TasA fibre formation in vivo. Phylogenetic analysis may be able to 
infer whether this was the case or not.  
 
Figure 36: The architecture of the B. cereus tapA operon by comparison with the B. 
subtilis tapA operon. The length of the ORFs are shown directly above the gene sequences in 
black text. B. cereus has 2 tasA homologs (termed tasA and calY), as part of this operon. 
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Between tasA and calY there is an ORF of unknown function. This ORF has some level of 
sequence identity with tapA (22.31) but was not found to be expressed in the same conditions in 
which other members of this operon were being expressed, namely when B. cereus was grown 
in LB. The percent sequence identity is shown in blue for B. cereus with reference to the B. 
subtilis sequences. 
 
I have discussed in some detail the real world socio-economic importance of 
biofilms both “good” and “bad”. More recently research groups are now trying to 
design biofilms by engineering them to have new properties. For example, E. 
coli biofilms have been engineered to create synthetic biological nanomaterials 
(Nguyen, 2017). It could be that the TasA system of B. subtilis offers an 
alternative model with different properties which may facilitate the creation of 
novel biological nanomaterials. Furthermore, by understanding biofilm formation 
in B. subtilis it may be possible to engineer improved biocontrol strains with 
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6. Appendix:  






shown  in blue. The end of  the  tapA ORF and  the start of  the sipW ORF overlaps by 17 bp, 29 bp and 4 bp  in B. subtilis, B. amyloliquefaciens and B. paralicheniformis, 
respectively.  There  is  a  gap  of  51  bp  between  tapA  and  sipW  in  B.  pumilis.  The  gap  between  tapA  and  tasA  is  63  bp,  64  bp,  72  bp  and  57  bp  in  B.  subtilis,  B. 
amyloliquefaciens, B. paralicheniformis and B. pumilis, respectively. Accession numbers: Bacillus subtilis CP020102.1, Bacillus amyloliquefaciens FZB42: CP000560, Bacillus 
paralicheniformis: MIZE01000002.1 and Bacillus pumilis SAFR2: CP000813.4. 






























B. subtilis  253   210  24.18  ‐  190  20.68  ‐  261  234  25.74  ‐ 
B. amyloliquefaciens 223  188  21.66  48.89  194  20.8  73.16  261  234  25.56  83.52 
B. paralicheniformis  242  199  22.51  38.31  194  21.02  64.74  264  237  26.25  71.21 
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Natural variations in the biofilm-
associated protein BslA from the 
genus Bacillus
Ryan J. Morris1, Marieke Schor1, Rachel M. C. Gillespie2, Ana Sofia Ferreira2, Lucia Baldauf1, 
Chris Earl1, Adam Ostrowski2, Laura Hobley3, Keith M. Bromley1, Tetyana Sukhodub2, Sofia 
Arnaouteli2, Nicola R. Stanley-Wall2 & Cait E. MacPhee1
BslA is a protein secreted by Bacillus subtilis which forms a hydrophobic film that coats the biofilm 
surface and renders it water-repellent. We have characterised three orthologues of BslA from Bacillus 
amyloliquefaciens, Bacillus licheniformis and Bacillus pumilus as well as a paralogue from B. subtilis 
called YweA. We find that the three orthologous proteins can substitute for BslA in B. subtilis and confer 
a degree of protection, whereas YweA cannot. The degree to which the proteins functionally substitute 
for native BslA correlates with their in vitro biophysical properties. Our results demonstrate the use of 
naturally-evolved variants to provide a framework for teasing out the molecular basis of interfacial self-
assembly.
Many bacterial species live in multi-cellular communities known as biofilms1, 2. The Gram-positive bacterium 
Bacillus subtilis forms biofilms with a characteristic wrinkled morphology and a surface that is highly hydropho-
bic. A critical component in generating the hydrophobicity of the biofilm is the amphiphilic protein BslA3. The 
structure of BslA contains a hydrophobic, surface-exposed ‘cap’ that sits atop a hydrophilic immunoglobulin-like 
domain, and is reminiscent of the fungal hydrophobins3–6. We recently characterised the mechanism by which 
BslA remains both stable and monomeric in aqueous environments and how its adsorbs to an interface7. We 
showed that the hydrophobic cap of BslA, in contrast to the hydrophobins, is structurally plastic; it undergoes an 
environmentally-responsive conformational change upon partitioning from an aqueous to a hydrophobic envi-
ronment. Once at an interface, BslA self-assembles into an ordered rectangular 2D lattice that macroscopically 
forms an elastic protein film3, 7, 8. Like the hydrophobins, BslA has been recognized as a ‘natural’ surface active 
agent that could find a range of applications in the food and personal care industries e.g. as surface modifier, coat-
ing agent, emulsifier, and/or foam stabiliser9–13.
Although the gross structural changes that lead to the surface-stabilising function of BslA are understood, we 
wished to tease out the mechanism by which BslA interacts with a hydrophilic-hydrophobic interface, i.e. what 
triggers the structural change between the conformational forms? Moreover, what interactions are critical for the 
formation of the regular 2D lattice? To address these questions, we have studied several BslA orthologues that are 
present in the genome of Bacillus species closely related to B. subtilis. In addition, we have investigated a paralogue 
of BslA called YweA. Using genetic modification and biophysical techniques, we characterize the behaviour of 
these variants both in vivo and in vitro. We find that key serine residues in the cap regions of the variants act as 
‘switches’ that drive conformational re-arrangement at an interface. We propose a classification system for BslA 
and its variants based upon the behaviour of the protein films under compression. This categorization allows us 
to tease out the interface-protein and protein-protein interactions and suggest amino acids important for the 
formation of stable, highly organised 2D films.
Results
Protein Alignment & Choice of BslA Variants. As previously reported by Kobayashi & Iwano, a number 
of Bacillus species possess well-conserved genes that encode for homologous proteins that fall into two groups: 
BslA-like and YweA-like8. Figure 1 shows a phylogenetic tree generated via maximum likelihood analysis of the 
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two paralogues YweA and BslA from various Bacillus species. The paralogue YweA shares 67% sequence simi-
larity with BslA and is distinguished from BslA by its lack of an N-terminal domain after the signal sequence in 
addition to the absence of 10 amino acids at the C-terminus that contain a conserved ‘CxC’ motif (Fig. 2A). In 
this work we have chosen to study the BslA orthologues produced by three species, Bacillus amyloliquefaciens 
(Ba_BslA), Bacillus licheniformis (Bl_BslA), and Bacillus pumilus (Bp_BslA), as well as the BslA paralogue YweA 
from B. subtilis. These particular Bacillus species were chosen as representatives of each distinct branch of the 
maximum likelihood tree (Fig. 1). The amino acid sequences of these proteins share a high degree of similiarity to 
B. subtilis BslA (Bs_BslA), while still possessing variations that may influence their behaviour both in vivo and in 
vitro (Fig. 2A; see Fig. S1 for the amino acid alignments for all species in the maximum likelihood tree).
In vivo characterization of BslA variants. First, we tested whether the orthologous genes, and therefore 
proteins, could substitute for Bs_BslA in vivo in B. subtilis. This was achieved using heterologous expression of 
complemented orthologous bslA genes (encoding for Ba_BslA, Bl_BslA, and Bp_BslA) in a mutant of B. subtilis 
possessing a bslA gene deletion (bslA−). Resultant biofilm formation was assessed by four criteria: complex col-
ony morphology, pellicle formation, colony surface hydrophobicity, and sporulation ability. Wild-type B. subtilis 
strain NCIB3610 produces characteristic biofilm and pellicle morphologies with a pronounced surface hydropho-
bicity, reflected in the high contact angle a water droplet makes with respect to the biofilm surface (Fig. 2D,E left 
column). The biofilms heterologously expressing Ba_BslA showed the greatest similarity to wild-type or Bs_BslA 
complemented biofilms, with a characteristic wrinkled morphology and pronounced surface hydrophobicity. The 
B. subtilis biofilms substituted with Bl_BslA were also highly hydrophobic and wrinkled, however, the wrinkles in 
the central ‘disc’ of the colony were less pronounced and the extent of wrinkling in the pellicle was reduced. For 
Bp_BslA, the colony surface showed marked hydrophobicity, however colony growth appeared diminished rela-
tive to NCIB3610 and the bslA− mutant genetically complemented with Bs_BslA. Moreover, like the bslA− mutant 
genetically complemented with Bl_BslA, the wrinkles in the central ‘disc’ of the colony were less pronounced. 
Finally, attempts to genetically complement the bslA− mutant with the yweA coding region did not reinstate either 
the characteristic wrinkled morphology or surface hydrophobicity of biofilms, consistent with YweA having only 
a minor role in the biofilm architecture (Fig. 3 and ref. 8).
The ability to sporulate is a sign of a mature biofilm matrix environment14. In B. subtilis, the sspB gene encodes 
for a small acid-soluble spore protein and expression is used as an indication of biofilm maturity. We utilized flow 
cytometry in conjunction with a PsspB:yfp transcriptional reporter fusion to assess the degree of sporulation within 
each of the heterologously complemented biofilms. All heterologously expressed BslA orthologues were found to 
confer high levels of sporulation relative to a negative control, albeit not to the degree exhibited by the wild-type 
strain (Table 1). Taken together, these data indicate that the orthologous proteins Ba_BslA, Bl_BslA, and Bp_BslA 
can at least partially fulfil the role of Bs_BslA within the B. subtilis biofilm, largely reinstating surface hydropho-
bicity and gross morphological characteristics. It is notable, however, that Bl_BslA and, especially, Bp_BslA do 
exhibit some differences in biofilm morphology. YweA, in contrast, does not recover wild-type biofilm morphol-
ogy or hydrophobicity (Figs 2 and 3). Nonetheless, YweA does appear to contribute to the surface hydrophobicity, 
exacerbating the impact of the bslA deletion on biofilm formation (Fig. 3).
Biophysical assessment of protein behaviour in vitro. Having studied the BslA variants in vivo, we 
next characterised their behaviour in isolation using in vitro biophysical techniques. BslA variant proteins were 
expressed using standard techniques (see Experimental Procedures). The resulting mature regions of the purified 
Figure 1. Maximum likelihood phylogeny of BslA and YweA protein sequences from Bacillus species. 
Abbreviations used are as follows: B_teq, Bacillus tequilensis; B_sub, Bacillus subtilis; B_pum, Bacillus pumilis; 
B_amy, Bacillus amyloliquefaciens; B_lic, Bacillus licheniformis; B_son, Bacillus sonorensis; B_moj, Bacillus 
mojavensis; B_vall, Bacillus vallismortis; B_atro, Bacillus atrophaeus; B_siam, Bacillus siamensis. The tree was 
rooted using the midpoint method. The bootstrap value shown in red indicates the support for each branch 
(from 0 to 1). YweA sequences for Bacillus siamensis and Bacillus pumilus could not be found using BlastP. 
Sequences highlighted in blue were used in this study.
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proteins were first analyzed using size exclusion chromatography and SDS-PAGE (Fig. 4). As demonstrated in 
previous work3, purified Bs_BslA is primarily composed of monomers and dimers, with a small sub-population of 
higher order oligomeric species (Fig. 4A,F). The orthologous BslA proteins showed similar monomer/dimer frac-
tions as Bs-BslA, but higher order oligomers were absent. YweA, in contrast, is almost entirely monomeric (Fig. 4E).
Kinetics of interfacial self-assembly of BslA variants. After protein purification, we assessed the inter-
facial activity of the BslA variants using pendant drop tensiometry. The dynamics of interfacial protein adsorption 
can often be characterized by three kinetic regimes: Regime I is a ‘lag time’ where there is no apparent change in 
the interfacial tension, Regime II is when a sufficient proportion of protein adsorbs to the interface to produce 
a decrease in interfacial tension, and Regime III is reached when the interfacial tension plateaus to a roughly 
constant final value15. Importantly, it should be stressed that once an elastic film has formed there is no longer 
an interfacial tension between the vapour and liquid phases and the concept of an ‘interfacial tension’ no longer 
applies. A good indication of when a film has formed is an increase in the error in the fit of the Young-Laplace 
equation to the drop shape16. Bromley et al. showed that the only sensible data that can be extracted from interfa-
cial tension measurements of Bs_BslA was the time at which the interfacial tension transitions between Regime I 
and Regime II (the ‘Regime I time’), since at any time after this transition an elastic film is present on the droplet 
Figure 2. Assessing biofilm formation of heterologously expressed bslA variants in B. subtilis. (A) Amino acid 
alignment of BslA variants found in other Bacillus species. Abbreviations used are as follows: B_sub, Bacillus 
subtilis; B_pum, Bacillus pumilis; B_amy, Bacillus amyloliquefaciens; B_lic, Bacillus licheniformis. Underlined 
and bolded amino acids signify the signal sequence, black represents 100% sequence identity. Blue amino 
acids represent the hydrophobic cap regions, where dark blue are conserved amino acids and light blue are 
conservative substitutions. The purple highlighted amino acids are glycine which are conserved across all 
species and always follow the amino acids comprising the caps. Aspartic acid is shown in red and serine 
residues within caps 1 and 2 are shown in green. Note that YweA is differentiated from Bs_BslA and the BslA 
orthologues by the fact it lacks both the N-terminal region following the signalling sequence and the C-terminal 
domain. The * symbols indicate the cap regions containing serine residues. Biofilms and pellicles were formed 
from the wild type strain (NCIB3610), a strain possessing a B. subtilis bslA gene deletion mutant (bslA−), strains 
that heterologously express the bslA gene of each species studied (B. subtilis, B_sub_bslA; B. amyloliquefaciens, 
B_sub_amy; B. licheniformis, B_lich_bslA; B. pumilus, B_amy_bslA) complemented into the bslA− mutant 
strain, and a strain expressing the yweA gene complemented into the bslA− mutant. Biofilm phenotypes were 
characterized by assessing (B) complex colony morphology; (C) pellicle formation; (D,E) colony surface 
hydrophobicity (see Table S3 for details on strains).
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surface7. Regime I times were determined in one of two ways: (1) the transition time between regimes I and II 
when the fit error was still low (<0.4 μm) or (2) when the fit error increased to a threshold value (>0.75 μm). 
Criterion (1) or (2) was chosen by whichever occurred first. We found that the Regime I times of the orthologues 
Ba_BslA and Bp_BslA were within error of Bs_BslA (Fig. 5A). In contrast, the Regime I time of Bl_BslA was 
nearly twice as long as those of the other orthologues while the Regime I time for YweA was faster than that of 
Bs_BslA by ~25%.
Relaxation dynamics of elastic films. The formation of an elastic film at a hydrophobic/hydrophilic 
interface is demonstrated by the observation of wrinkles following compression of the droplet (achieved by with-
drawing a small volume of fluid following equilibration). One way of characterizing these films is by monitoring 
the formation and subsequent disappearance of these wrinkles over time, reflecting relaxation of the interfacial 
protein film (Fig. 5B). We have assumed that wrinkle relaxation is due to the loss of protein into the subphase, 
although rearrangement of the protein at the interface cannot be ruled out. For these experiments an oil/water 
interface was used as the small difference in density between the two phases results in rounder droplets, allow-
ing for better imaging of the wrinkles that form. As found previously7, wrinkles formed under compression in 
a Bs_BslA film do not relax over the timescale of the experiment. In contrast, Ba_BslA and Bl_BslA exhibit very 
Figure 3. Characterization of biofilm phenotypes of yweA mutants. Biofilm phenotypes were characterized 
by assessing (A) complex colony morphology; (B) pellicle formation; (C,D) colony surface hydrophobicity for 
B. subtilis wild-type strain 3610, a bslA mutant, a yweA mutant, and a double mutant bslA yweA (see Table S3). 
Row C shows a representative sessile drop resting atop a biofilm formed from one of the strains used above. Row 
D are the average contact angles; ND means that a contact angle could not be determined from the images.
Strain
% Sporulation positivea
0 μM IPTG 25 μM IPTG
3610 PsspB-yfp 26.6 24.8 ± 1.63
bslA PsspB-yfp 5.9 ± 0.6 4.9 ± 0.8
bslA PIPTG-bslAB.sub PsspB-yfp 3.2 ± 0.2 14.1 ± 2.3
bslA PIPTG-bslAB.lic PsspB-yfp 5.6 ± 0.3 15.6 ± 1.2
bslA PIPTG-bslAB.amy PsspB-yfp 5.6 ± 0.4 13.0 ± 3.7
bslA PIPTG-bslAB.pum PsspB-yfp 5.2 ± 0.2 15.6 ± 1.2
Table 1. Sporulation frequency assessed by flow cytometry. aThe percentage sporulation was calculated using 
fluorescence form the PsspB-ypf fusion as a proxy after 48 hours incubated at 30 °C. NCIB3610 was used as 
the non-fluorescent control. For the full genotypes of the strains see Table S3. For each condition at least two 
independent samples were analysed. Expression of the variant gene was achieved using 25 μM IPTG. The value 
presented is the mean and the error is the standard deviation.
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slow relaxation, and Bp_BslA relaxes within a minute. Strikingly, relaxation of YweA is extremely rapid, occurring 
immediately upon compression.
Film organisation of BslA variants. Bs_BslA forms highly ordered 2D rectangular lattices at an air/water 
interface7. We investigated the structure of the films formed by BslA variants using transmission electron micros-
copy (TEM). Protein lattices were observed for all variants, but exhibited varying degrees of order. The films 
formed by Ba_BslA showed domains of ordered protein, but these were not widespread (Fig. 5C). As shown by 
the Fast Fourier Transform (FFT), weak peaks can be observed, indicating some level of ordering (Fig. 5C). The 
Bl_BslA films exhibited larger domains of ordered protein, and the FFT shows clear peaks (Fig. 5D). In contrast, 
Bp_BslA showed very weak ordering with only very small patches of organized structure, similar to those previ-
ously observed for the BslA L77K mutant3 (Fig. 5E). Thus amongst BslA orthologues, there appears to be some 
correlation between wrinkle relaxation and microscopic ordering: Bs_BslA films are highly ordered and wrinkles 
formed under compression do not relax, Ba_BslA and Bl_BslA show some degree of ordering and display slow 
wrinkle relaxation dynamics, whilst Bp_BslA films are not well ordered and wrinkles formed upon compression 
relax rapidly.
The paralogue YweA, however, does not conform to the trend observed for BslA orthologues. Indeed, YweA 
formed clearly defined and well ordered films similar to those formed by Bs_BslA, despite its rapid relaxation 
(Fig. 5B,F), calling into question the relationship between the microscopic organization of the protein within a 
film and film robustness.
CD spectroscopy of solution and interfacial states. Finally, circular dichroism (CD) spectroscopy was 
used to study the conformation of the BslA variants in aqueous solution and at an oil/water interface (Fig. 5G). 
Qualitatively, the spectra of the different BslA variants in aqueous solution are similar, with only Bp_BslA show-
ing the loss of a feature between 210 and 218 nm (Fig. 5G). When bound to refractive indexed matched emulsions 
(RIMEs; Fig. 5H) all of the proteins underwent a structural transition consistent with an increase in β-sheet 
structure, reflecting rearrangement of the hydrophobic cap upon insertion into the oil phase.
Effects of Bl_BslA cap mutations on the properties of in vitro protein films and in vivo bio-
film morphology. Pendant drop tensiometry showed that it takes Bl_BslA approximately twice as long 
as the other orthologues to become adsorbed at an interface (Fig. 5A). We have previously interpreted this 
slower-than-diffusion adsorption time in relation to the energy barrier between solution and interfacial confor-
mations of BslA7, implying that there is a larger energy barrier that must be overcome for Bl_BslA adsorption. 
Comparison of the amino acid sequence of Bs_BslA with that of Bl_BslA reveals two amino acid differences in 
the hydrophobic cap region (Fig. 2A). Specifically, the first difference resides in ‘Cap 1’ (residues L77, S78, and 
L79 of Bs_BslA) in which serine-78 in Bs_BslA is replaced by an alanine (A76 in Bl_BslA). The second difference 
is in ‘Cap 3’ (residues L153, S154, and I155 of Bs_BslA) in which S154 is replaced by a glycine (G152 in Bl_BslA). 
In contrast, these two serine residues are conserved in Ba_BslA and Bp_BslA, which have similar adsorption 
Figure 4. Size exclusion chromatography and SDS-PAGE analysis of Monomer-Dimer Formation. The 
bslA variant genes were cloned, overexpressed as a GST fusion and then purified. (A) Using size exclusion 
chromatography Bs_BslA was found to contain two primary peaks corresponding to monomer and dimer 
species, although there are higher-order additional peaks present. (B) Ba_BslA, (C) Bl_BslA, and (D) Bp_BslA 
all eluted in primarily two peaks. (E) YweA, in contrast, eluted in effectively one monomer peak. (F) SDS-PAGE 
analysis of recombinant protein without β-mercaptoethanol and (G) with β-mercaptoethanol.
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kinetics to the Bs_BslA. To investigate the role of these residues in the kinetics of adsorption and the properties 
of the resultant film, we produced two single amino acid mutants of Bl_BslA (A76S and G152S) and the dou-
ble mutant A76S/G152S in which the cap region is identical to that of Bs_BslA. If these cap regions, and their 
re-orientation at an interface, determine the kinetics of adsorption, one would predict that the Regime I time of 
Bl_BslA(A76S/G152S) would coincide with those of Bs_BslA and the other orthologues. This is in fact what is 
observed as shown in Fig. 6B. In contrast, both single mutants result in Regime I times that are shorter than those 
Figure 5. Biophysical characterization of BslA orthologues. (A) Regime I times were measured using pendant 
drop tensiometry. Plotted is the mean of 4 separate repeat experiments and the error bars correspond to the 
standard deviation. (B) Wrinkles were formed in the protein films by compressing the pendant droplet via 
removal of fluid. The relaxation of these wrinkles are plotted as a function of time: Bs_BslA(black squares); 
Ba_BslA (blue triangles), Bl_BslA (red circles); Bp_BslA (green diamonds); YweA (orange stars). Error bars 
represent standard deviation in relaxation times for at least N = 10 separate wrinkles across the drop. (C) Inset 
in each image is the FFT contained within the white box. Ba_BslA visually showed ordered domains, but was 
not widespread.The FFT displays weak peaks indicating some ordering. (D) Bl_BslA has perceptibly larger 
domains of order. The FFT contains obvious peaks indicating ordering of the protein. (E) TEM of Bp_BslA films 
showed very weak ordering with patchy organization, which is reflected in the isotropic FFT. (F) YweA formed 
the ordered films that were the most similar to Bs_BslA, as can be seen from the FFT. (G) Solution state circular 
dichroism spectra of BslA variants and (H) circular dichroism spectra of RIMEs: Bs_BslA (black); Ba_BslA 
(blue); Bl_BslA (red); Bp_BslA (green); YweA (orange). Note the RIME CD spectra were normalized assuming 
all protein is adsorbed to emulsion droplets.
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of Bs_BslA and Bl_BslA(A76S/G152S) but very similar to that of YweA. Interestingly, the ‘Cap 3’ region of YweA 
possesses the same S → G substitution as Bl_BslA (Fig. 2A). The fact that the single mutants are more ‘YweA-like’ 
in terms of adsorption indicates that residues 76 and 152 of Bl_BslA help shape the energetic landscape of cap 
re-organization at an interface. To further explore this hypothesis, we also studied the relaxation of the films 
formed by these mutant proteins (Fig. 6A). Notably, wrinkles formed under compression of a Bl_BslA(A76S/
G152S) droplet did not relax over the time scale of the experiment, unlike Bl_BslA which relaxes slowly, lending 
further support to a role for these cap residues in determining the stability and mechanical properties of the 
film. Consistent with this idea, the single cap mutants more closely recapitulate YweA-like behaviour, with films 
formed by these proteins exhibiting more rapid relaxation than both Bl_BslA and Bl_BslA(A76S/G152S) films. 
Indeed, films formed by Bl_BslA(A76S), the amino acid composition of which most closely resembles that of 
YweA, demonstrates the fastest relaxation rate of the cap mutants investigated. Intriguingly, the relaxation of 
wrinkles formed by this mutant appears to plateau to a non-zero value over the course of the experiment, indicat-
ing that wrinkles persist. We conclude from these results that the serine/glycine residue found in Cap 3 of BslA 
variants plays a prominent role in both the energetics of adsorption and the robustness of the resultant film.
Finally, we tested how the Bl_BslA cap mutations affect the structure and properties of the B. subtilis biofilm. 
When the genes encoding the Bl_BslA cap variants are heterologously expressed, the resultant biofilm morphol-
ogy and hydrophobicity are indistinguishable from both wild-type Bs_BslA (as determined using the parental 
NCIB3610 strain) and parental Bl_BslA constructs (Fig. 6C). Thus, while the in vitro films produced from these 
mutants show distinctive physical characteristics, we do not observe any differences in in vivo phenotype.
Discussion
While the structural metamorphosis of the hydrophobic cap has been identified as the mechanism that allows 
BslA to be stable in both aqueous and hydrophobic environments, many questions remain regarding how BslA 
self-assembles into 2D ordered lattices and what the key amino acids are that contribute to network formation at 
interfaces. We have previously demonstrated that single amino acid mutations can have marked consequences for 
both the kinetics and energetics of adsorption along with the spatial ordering of the protein at the interface7, 17. 
Instead of using a brute-force site-directed mutagenesis approach to further illuminate the biophysical properties 
of BslA at an interface, we have investigated the BslA variants found in three other Bacillus species, along with the 
B. subtilis BslA paralogue YweA. The aim of this strategy is to lead to more efficient targeting of important amino 
acids for future systematic mutagenesis studies of Bs_BslA. Such knowledge could be exploited to tailor both the 
kinetics of interfacial adsorption as well as the mechanical properties of the protein film for the application of 
BslA in multiphase formulations.
We have confirmed that YweA plays no obvious role in overall biofilm formation and morphology in vivo, 
as was demonstrated in previous studies8. However, the phenotype of the double deletion mutant bslA yweA 
Figure 6. In vitro and in vivo effects of the Bl_BslA cap mutations. (A) Wrinkle relaxation measurements for 
Bl_BslA (black squares), Bl_BslA(A76S) (red circles), Bl_BslA(G152S) (blue triangles), Bl_BslA(A76S G152S) 
(upside down pink triangles). Error bars represent standard deviation in relaxation times for at least N = 10 
separate wrinkles across the drop. (B) Regime I times of Bs_BslA (repeated from Fig. 3 for clarity) and the Bl_
BslA single and double mutants. (C) Heterologous expression of Bl_BslA variants shows no deleterious effects 
on biofilm morphology or hydrophobicity relative to both wild-type Bs_BslA (as determined using the parental 
NCIB3610 strain (3610)) and parental Bl_BslA constructs.
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indicates that YweA is indeed present within the biofilm and makes a small but noticeable contribution to surface 
hydrophobicity8 (Fig. 3). The major difference between YweA and the other BslA variants is the lack of both the 
N- and C-terminal domains. Since YweA cannot recover the characteristics of the wild-type biofilm phenotype, 
it is possible that the lack of one or both of these domains is functionally important for biofilm formation, in 
either mediating interactions between other BslA proteins, or interactions with other protein or polysaccharide 
components of the biofilm matrix.
Importantly, the biophysical characterization of YweA interfacial activity and self-assembly provides new 
insights into the relationship between the microscopic organization of the protein at the interface and result-
ing macroscopic properties of the surface layer. YweA interfacial films showed extremely rapid relaxation under 
applied compression (Fig. 5B), yet YweA films imaged by TEM showed the greatest order of all the variants 
(Fig. 5F). In previous studies, the cap mutant Bs_BslA(L77K) also formed films that relaxed within very short time 
scales. However, this variant demonstrated significant 2D disorder3, 7, and we suggested that the single mutation in 
the cap disrupted the ability of Bs_BslA(L77K) to form a space-spanning network by altering the orientation of the 
protein at an interface17. The behaviour of YweA runs counter to this hypothesis, indicating that film order does 
not necessarily correlate with film robustness. It can be concluded, then, that YweA has the ability to form interfa-
cial protein-protein lateral interactions but that these are weak, particularly compared to those formed by Bs_BslA.
As Bl_BslA differed markedly in its adsorption kinetics relative to the other BslA variants investigated here, 
this orthologue formed the focus of further analyses. The amino acids of Bl_BslA differ from Bs_BslA and the 
other variants by two non-conservative substitutions in Cap 1 (S → A) and Cap 3 (S → G). Examination of the 
interfacial conformation of BslA reveals the two serines to be immediately adjacent to one another, both orien-
tated towards the interior of protein (Fig. S1), and are likely to form a sidechain-sidechain hydrogen bond. In 
contrast, when the protein is in aqueous solution and the cap region is disordered, these serines are oriented 
outward towards the aqueous environment. The switch from an outward to an inward orientation would facilitate 
the conformational switch of the cap region upon contact with a hydrophobic interface, with hydrogen bonding 
between the residues further stabilising the interfacial conformation.
The Bl_BslA cap is more hydrophobic than Bs_BslA and the other orthologues - the polar serines are replaced 
by nonpolar amino acids (A76 and G152). Counter-intuitively, the higher hydrophobicity of the cap region overall 
does not result in faster adsorption (Fig. 5A). The resolution of this apparent paradox resides in the fact that the 
cap is a flexible, plastic structure. In an aqueous environment, the more hydrophobic residues of the Bl_BslA cap 
will most likely be oriented inwards, away from the aqueous phase, whereas in Bs_BslA the equivalent hydro-
philic side chains are oriented outwards. We propose that the driving force for cap rearrangement in Bs_BslA is 
reorientation of these serines away from the hydrophobic interface and that this mechanism is lost in Bl_BslA, 
resulting in slower adsorption. Thus, we hypothesize that it is the hydrophilic residues within the cap that act as a 
‘sensor’ for hydrophobic interfaces. Interaction with an apolar interface induces a reorientation of the hydrophilic 
amino acid(s), which in turn triggers the larger scale reorganization of the cap such that the hydrophobic residues 
become surface-exposed and subsequently restructure to form a three-stranded β-sheet.
Interestingly, the single cap mutants of Bl_BslA show shorter adsorption times, very similar to the Regime I 
time of YweA (Figs 5A and 6B). YweA has a similar amino acid cap content as the Bl_BslA(A76S) mutant, with a 
serine in Cap 1 and a glycine in Cap 3. For Bl_BslA(G152S), there is a hydrophobic residue in Cap 1 and a hydro-
philic residue in Cap 3. We hypothesize that this combination of a hydrophilic residue in one cap strand, and a 
hydrophobic residue in the other, may cause a tension within the aqueous conformation of the cap as a whole or, 
alternatively, facilitate a rapid interconversion between states. This tension or interconversion then primes the 
cap to more easily undergo the conformational change when it encounters an interface, effectively lowering the 
energy barrier to re-structuring. Moreover, when in the interfacial conformation, the remaining serine will be 
unfavourably partitioned into the hydrophobic protein core, but without a second serine present with which to 
form a hydrogen bond. This may explain why the proteins are displaced from the interface under compression.
Taking the result of this work together, we propose a categorization of BslA and its variants based upon their 
wrinkle relaxation behaviour:
•	 Surfactant-like: The surfactant-like proteins comprise YweA, Bp_BslA and the Bs_BslA mutants L77K and 
L79K3. Whilst YweA differs from the other three BslA variants in its ability to form ordered lattices at an inter-
face, wrinkles formed under compression of all four proteins relax within very short time scales. This implies 
that the interfacial lateral protein-protein interactions either cannot form correctly due to incorrect orienta-
tion at the interface (in the case of L77K and L79K17) or are weak due to substitution of critical amino acids.
•	 Transiently wrinkling film formers: The proteins that belong to this category are Ba_BslA, Bl_BslA, Bl_
BslA(A76S), and Bl_BslA(G152S). In these cases, wrinkles persist for longer time scales than those formed 
by the surfactant-like proteins, but do eventually relax over time. Such behaviour suggests relatively weak 
lateral interactions between proteins at the interface, but stronger than those exhibited by the surfactant-like 
proteins.
•	 Rigid film formers: Bs_BslA and Bl_BslA(A76S + G152S) are members of this group. The stresses imposed 
via our methods are insufficient to dislodge protein from the interface, and moreover the entire droplet shape 
distorts under compression. This implies that there exist not only strong protein-interface interactions but 
well established protein-protein interactions within the film.
Categorizing the BslA variants in this manner allows us to identify links between the in vivo morphology of 
Bacillus biofilms (Figs 3 and 4) and the interactions the proteins experience at an interface. Thus the extent to 
which each BslA variant rescues the wild type B. subtilis biofilm may be ranked and mapped to the classification 
system outlined above (Table 2). Bs_BslA produces rigid, elastic films in vitro and creates the highly wrinkled 
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and hydrophobic biofilm phenotype associated with B. subtilis pellicles and colonies. Ba_BslA and Bl_BslA share 
similar film characteristics in vitro and in both cases the biofilm morphology is similar to the B. subtilis wild-type 
phenotype with some small, but discernible differences. Bp_BslA falls within the surfactant-like class and is the 
least effective of the orthologues at recovering the wild-type B. subtilis biofilm morphology. Finally, the paralogue 
YweA is the most surfactant-like of the proteins investigated and clearly cannot recover any features of the bio-
film phenotype. Relating the biofilm morphology to the classes of film formed in vitro shows a clear correlation 
between film robustness and biofilm structure.
This classification provides useful insights into which residues are important for protein-protein interactions 
within the film. A large proportion of outward-facing, non-cap residues are conserved across all four variants. 
However, amino acids that are conserved between Bl_BslA and Bs_BslA but not between these two proteins and 
Ba_BslA and Bp_BslA are likely to affect the strength of the interaction between the proteins in the film. This sug-
gests roles for S49, T105, Q107, N111 and E128 in the formation of the optimal lateral interactions that give rise 
to stable films (Fig. 7). Specifically, comparing the amino acid sequences of each orthologue reveals that Bp_BslA 
possesses non-conservative substitutions in four out of these five positions, Ba_BslA has one non-conservative 
substitution, and Bl_BslA is identical to Bs_BslA. This correlates well with our observations of interfacial protein 
lattice structure (Fig. 5C–F). The subtle difference in lattice structure between Bl_BslA and Bs_BslA, despite the 
conservation of these putative lateral interaction sites, we hypothesize originates from the key serine residues 
(A76S, G152S) identified in this work. These residues may influence how the protein is tilted at an interface, 
which may in turn influence the extent and strength of lateral interactions between adjacent proteins. We have 
previously modeled how changes in the cap region influence average protein tilt17.
Further in vivo investigation will be required to determine whether the biophysical differences measured as 
part of this study have evolved specifically to generate a fitness benefit in the distinct environmental habitat or 
niche occupied by each species of bacteria.
Experimental Procedures
Bacterial strains and growth conditions. Escherichia coli and Bacillus subtilis strains used and con-
structed in this study are detailed in Table S1. All strains were routinely grown in Lysogeny broth (LB; 10 g NaCl, 
5 g yeast extract and 10 g tryptone per litre) or on LB solidified with 1.5% (w/v) select agar (Invitrogen) at 37 °C. 
B. subtilis biofilms were grown in MSgg medium (5 mM potassium phosphate and 100 mM MOPS at pH 7.0 
supplemented with 2 mM MgCl2, 700 μM CaCl2, 50 μM MnCl2, 50 μM FeCl3, 1 μM ZnCl2, 2 μM thiamine, 0.5% 
(v/v) glycerol, and 0.5% (v/v) glutamate). When required, antibiotics were used at the following concentra-
tions: 100 μg ml−1 ampicillin, 100 μg ml−1 spectinomycin, 25 μg ml−1 kanamycin, 1 μg ml−1 erythromycin and 
25 μg ml−1 lincomycin. Ectopic gene expression was induced with 25 μM isopropyl β-D-1 thiogalactopyranoside 
(IPTG). E. coli strain MC1061 [F’lacIQ lacZM15 Tn10 (tet)] was used for the routine construction and main-
tenance of plasmids. B. subtilis 168 derivatives were generated by transformation of competent cells with plas-
mids using standard protocols18. SPP1 phage transductions, for the introduction of DNA into B. subtilis strain 
NCIB3610, were performed as previously described19.
Plasmid construction. The primers and plasmids used in this study are presented in Tables S2 and S3 
respectively. Single amino acid substitutions were generated by PCR site-directed mutagenesis using KOD Hot 
Start DNA Polymerase (Novagen) and the appropriate primer pairs from Table S2, with reaction conditions cal-
culated according to the Stratagene manual for QuikChange Site-Directed Mutagenesis. The resulting mutant 
plasmids were digested with DpnI and transformed into competent E. coli MC1061 cells. All mutations were ver-
ified by DNA sequencing. For expression of BslA orthologues in B. subtilis under control of the IPTG-inducible 
Phyper-spank promoter, the bslA gene was amplified from genomic DNA isolated from Bacillus licheniformis 
DSM13; Bacillus amyloliquefaciens FZB42; and Bacillus pumilus SAFR-032 using the primer pairs NSW812/
NSW813; NSW829/NSW830; and NSW819/NSW820 respectively. Resulting PCR products were digested 
with HindIII and SphI, and ligated into the B. subtilis shuttle vector, pDR111 (also digested HindIII/SphI), 
to enable subsequent gene integration into the non-essential amyE locus of the B. subtilis chromosome (final 
pDR111-derived plasmids are listed in Table S3). Expression of yweA was achieved in a similar manner. The yweA 
gene was amplified from B. subtilis NCIB3610 genomic DNA using primers NSW810 and NSW811, digested 
HindIII/SphI and ligated into HindIII/SphI-digested pDR111.
Plasmid pNW1420, for over-expression of YweA31–155 in E. coli, was generated as follows: yweA31–155 was 
amplified from B. subtilis NCIB3610 genomic DNA using primers NSW1853 and NSW1854 and ligated into 
the expression vector pET15bTEV using the NdeI and XhoI restriction sites. The resulting plasmid encodes the 
N-terminally His6-tagged fusion protein, His6-YweA31–155, which contains the recognition site of Tobacco Etch 
Virus (TEV) protease between His6 and YweA31–155 coding regions, allowing removal of the His6 tag by digestion 
Rank Protein Film category
1 Bs_BslA Rigid film
2 Ba_BslA Transient wrinkling film
3 Bl_BslA Transient wrinkling film
4 Bp_BslA Surfactant-like
5 YweA Surfactant-like
Table 2. Ranking of biofilm phenotype vs in vitro film classification.
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with TEV. Plasmids for production of BslA orthologues from B. amyloliquefaciens, B. licheniformis, and B. pum-
ilus encoded truncated proteins corresponding to B. subtilis BslA42–181 (determined by sequence alignment; see 
Fig. 2A), on which previous analyses were based3, 8, and were generated as follows. For over-expression of B. 
amyloliquefaciens BslA42–181 (referred to herein as Ba_BslA), the appropriate DNA fragment was amplified from B. 
amyloliquefaciens FZB42 genomic DNA using primers NSW2011 and NSW2012, and ligated into the GST expres-
sion vector pGEX-6-1P via BamHI and XhoI sites. The resulting plasmid, pNW1422, encodes the N-terminally 
tagged fusion protein GST-Ba_BslA, from which the GST tag can be removed by TEV protease digestion Plasmid 
pNW1423 for over-expression of B. licheniformis BslA40–179 (Bl_BslA) and pNW1424 for over-expression of B. 
pumilus BslA37–177 (Bp_BslA), were generated in an identical manner using primer pairs NSW2013/NSW2014 
and B. licheniformis DSM13 genomic DNA, and NSW2015/NSW2016 and B. pumilus SAFR-032 genomic DNA 
respectively. All resulting constructs were sequence-verified.
Biofilm analysis. Biofilm analysis was performed as previously described, with minor modifications19. For 
complex colony formation, 10 μL of the appropriate Bacillus culture, grown to mid-exponential phase in LB, 
was spotted onto MSgg medium solidified with 1.5% (w/v) agar and incubated at 30 °C for 48 hours. For pellicle 
analysis, the LB starter culture was diluted 1:100 (v/v) in MSgg medium and incubated at 25 °C for 72 hours. Both 
colony and pellicle biofilms were imaged using a Leica MZ16 stereoscope (Leica Microsystems).
Colony hydrophobicity contact angle measurements. Biofilms were grown on MSgg agar plates (as 
described above). A section through the mature biofilm was extracted using a scalpel and placed on a micro-
scope slide. A 5 μl droplet of sterile double-distilled water was placed on the colony using the ThetaLite Optical 
Tensiometer with OneAttension software. The drop was allowed to equilibrate for 5 minutes prior to imaging and 
contact angle measurement.
Sporulation assays and FACS analysis. Strains harbouring the promoter PsspB fused with yfp coding 
sequence were used to assess sporulation levels in mature colonies by flow cytometry20. The experiments used bio-
films grown for 2 days at either 30 °C on MSgg agar without IPTG or supplemented with 25 μM IPTG. After incu-
bation, biofilms were collected, washed and fixed with 4% paraformaldehyde (PFA), as previously described14. 
Fluorescence was analysed at the single-cell level using a BD FACSCalibur (BD Biosciences)21.
Figure 7. Possible amino acids that mediate interfacial protein-protein interactions. 3D structure of BslA 
highlighting the hydrophobic residues involved in interfacial adsorption (orange) and the residues identified as 
putatively involved in protein-protein interaction S49, T105, Q107, N111 and E128 (green = S, light green = T, 
cyan = Q, purple = N, red = E).
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Protein Purification. BslA proteins were purified as previously described7, with minor changes as follows. 
E. coli BL21 (DE3) pLysS cells were transformed with the appropriate plasmids for over-expression of GST-BslA 
fusion proteins (described above; Table S3). For protein production, the transformed cells were grown in autoin-
duction medium22 supplemented with ampicillin (100 μg mL−1) at 37 °C and 200 rpm until an OD600 of 0.9 was 
reached, at which point protein expression was induced by reducing the temperature to 18 °C for further incu-
bation overnight. Cells were collected by centrifugation at 4000 × g for 45 min and stored at −80 °C until further 
use. For purification, bacterial pellets were thawed and resuspended in purification buffer (50 mM HEPES pH 7.5, 
300 mM NaCl (for YweA), or 50 mM HEPES pH 7.5, 250 mM NaCl (for all other purifications)) supplemented 
with Complete EDTA-free Proteinase Inhibitors (Roche) before lysis using an Emulsiflex cell disruptor (Avestin). 
Unlysed cells and cell debris were removed by centrifugation at 27000 × g for 20 min, and the cleared lysates 
incubated with Glutathione Sepharose 4B resin (GE Healthcare; for BslA) or Ni-nitrilotriacetic acid (Ni-NTA) 
agarose (Qiagen; for YweA) at a ratio of 750 μL resin per 1 L bacterial culture with gentle rotation for 4 h at 4 °C. 
To isolate the bound fusion proteins, the mixture of lysate plus beads was passed through a single-use 25-mL 
gravity flow column (Bio-Rad), and the collected beads washed twice with 20 mL of the appropriate purification 
buffer. Untagged BslA variants were generated by resuspending the washed beads in 25 mL purification buffer 
supplemented with 1 mM DTT and 0.5 mg TEV protease prior to gentle rotation overnight at 4 °C. To generate 
untagged YweA from the His6-YweA fusion protein, the overnight mixture was additionally supplemented with 
250 mM imidazole. Following overnight cleavage, mixtures were again passed through gravity flow columns and 
the flow-through collected. To the flow-through, 750 μL fresh Glutathione Sepharose plus 250 μL Ni-NTA aga-
rose (for BslA variants), or 100 μL Ni-NTA agarose (for YweA), was added and the solution incubated with gentle 
rotation overnight at 4 °C to remove the TEV protease and any unbound GST or His6. The mixtures were passed 
through the gravity flow columns for a final time, and purified proteins collected in the flow-through. The puri-
fied proteins were then concentrated (with simultaneous exchanges into 25 mM phosphate buffer pH 7.0 where 
appropriate) and further purified by size exclusion chromatography (SEC) as previously described7.
SDS-PAGE analysis. SDS-PAGE analysis of BslA variants was performed using 30 μg purified sam-
ples of BslA diluted 4:1 (v/v) in 4X loading buffer (6.2 g SDS, 40 mL 0.5 M Tris pH 6.8, 6.4 mL 0.1 M EDTA, 
32 mL glycerol, 1 mg Bromophenol blue) either with or without β-mercaptoethanol at 4% (v/v). Samples to 
which β-mercaptoethanol was added were boiled at 100 °C for 5 min prior to analysis, whilst samples without 
β-mercaptoethanol were not subjected to boiling. Proteins were run on a standard 14% polyacrylamide denatur-
ing gel at 200 V for 60 min and visualised by staining with Coomassie Blue.
Mass spectrometry analysis. Purified proteins were identified by excision of protein bands from 
SDS-PAGE gels and LC-MS-MS following tryptic digest. Protein size estimation was performed using MS-TOF 
and peptides identified from the MASCOT database. All procedures were performed by FingerPrints Proteomics 
service, School of Life Sciences, Dundee.
Bioinformatics. BslA orthologues were identified using BLASTP23, 24 using the non-reduntant protein 
sequence database for each of the organisms of interest using the protein sequence of BslA from B. subtilis as 
the query. BslA orthologues were distinguished from YweA based on the presence of a C-terminal region not 
present in YweA8 (see Fig. 2A and Table S4). BslA and YweA protein sequences were aligned using Clustal Omega 
with the default settings25. The signal sequences were predicted using the SignalP 4.1 server26 and the aligned 
sequences were manually coloured to highlight the ‘cap’ regions and identity. A maximum likelihood tree was cal-
culated from the Clustal Omega alignment using phylogeny.fr’s standard workflow27, where Gblocks28 was used 
to eliminate divergent and poorly aligned columns, and a tree computed with PhyML29 using a WAG substitution 
model30 and 100 bootstrap replicates. The outputted tree was visualised using TreeDyn31.
Pendant drop tensiometry & and surface wrinkle relaxation quantification. Pendant drop experi-
ments were performed on a Krüss EasyDrop tensiometer. Protein samples were diluted in buffer and immediately 
placed in a syringe with a needle diameter of 1.83 mm. Images of the pendant drop are captured by a CCD camera 
and Krüss software fits the Young-Laplace equation to the drop shape to determine the interfacial tension. For 
measuring the dynamic interfacial tension, samples were prepared by diluting each protein in phosphate buffer 
to a concentration of 0.03 mg ml−1. Droplets were expelled in air and the interfacial tension was determined by 
fitting the droplet shape to the Young-Laplace equation. For the film relaxation experiments, a protein concen-
tration of 0.2 mg ml−1 was used. A droplet of the protein in aqueous solution was expelled into glyceryl trioc-
tanoate oil and allowed to equilibrate at room temperature for 30 minutes. Images were acquired at 2 fps using a 
digital camera. Wrinkle relaxation experiments were performed following compression of the droplet, which was 
achieved by retracting 5 μL of the protein solution. Compression induced the formation of wrinkles in the surface 
layer. The wrinkles were monitored over a 10 minute period. To analyze the relaxation of the wrinkles, a line pro-
file was drawn across the wrinkles. The line profile was plotted using the greyscale values (from 0 to 255) of each 
pixel along this line using the ImageJ. At least 10 wrinkles were monitored over the time course of the experiment. 
To plot the relaxation rate, the greyscale value of the pixels was normalized and background corrected.
Transmission electron microscopy (TEM). Protein samples were deposited onto carbon-coated copper 
grids (Cu-grid) (TAAB Laboratories Equipment Ltd) and imaged using a Philips/FEI CM120 BioTwin trans-
mission electron microscope. A 5 μL droplet of protein (0.025 mg mL−1) was pipetted onto a grid and allowed to 
equilibrate for 5 mins before being wicked with filter paper from the side. A 5 μL droplet of 2% uranyl acetate was 
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then applied to the grid and similarly left for 5 min before being wicked from the side. The Fast Fourier Transform 
(FFT) of the images was performed using ImageJ software.
Circular dichroism analysis. Circular dichroism spectropolarimetry (CD) was performed using a Jasco 
J-810 spectropolarimeter. Samples were analysed at a concentration of 0.03 mg mL1 in a 1 cm quartz cuvette. 
Measurements were performed with a scan rate of 50 nm sec−1, a data pitch of 0.1 nm and a digital integration 
time of 1 sec. Twenty accumulations were measured and averaged to produce the final curve. Refractive index 
matched emulsions (RIMEs) were made by first preparing a 20% (v/v) decane emulsion with 0.2 mg ml−1 of pro-
tein. The emulsion was mixed for 1 min using a rotor stator (IKA Ultra-Turrax T10) at 30,000 RPM. The emulsion 
was washed three times in order to remove any residual protein not adsorbed to an oil/water interface. Washes 
were performed by centrifuging at 1000 rpm for 20 sec, a portion of subphase was removed and replaced with 
buffer, then gently re-dispersed. Finally, subphase was removed and replaced with glycerol such that the final wt% 
of glycerol was 59% (w/v). The emulsion was then gently remixed on a rollerbank and then allowed to cream. The 
cream was placed in a 1 mm pathlength quartz cuvette for spectrum measurement. To prevent creaming during 
the experiment, the cuvette was briefly inverted between measurements to re-disperse the droplets.
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